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ABSTRACT 
68Ge/68Ga generators ensure the supply of 68Ga for positron emission tomography (PET), for instance 
for somatostatin receptor imaging with 68Ga-DOTA-labelled somatostatin analogues. There are 
various generators available and their eluates are processed differently for radiolabelling of peptides.  
 
The objectives of this study were to investigate various aspects of the elution characteristics of the 
generator, to optimize labelling conditions using different eluate processing techniques such as 
fractionation and cation exchange chromatography and to develop user-friendly kit formulations.  
 
This study was approved by the Stellenbosch University Health Research Ethics Committee and 
permission was granted for the experimental work to be conducted at iThemba LABS. Elution 
efficiencies were determined using different HCl concentrations (0.2 M – 1.0 M). Metal analysis and 
68Ge breakthrough determination were performed on eluates. Radiolabelling parameters were 
optimized, using fractionated eluates and different DOTA-peptide masses (15 to 50 µg) at pH 3.5 – 
4.0 in sodium acetate buffer. Different heating times and heating methods and the influence of various 
periods of non-elution of the generator on radiolabelling results were investigated. Cationic resins 
were investigated for eluate processing. Radiolabelling parameters, using cationic resin-processed 
eluates, were optimized. Labelling was conducted at various pH values, using different quantities of 
buffer. DOTA-peptide kits for both fractionated and resin-processed eluates were developed and 
tested for sterility, endotoxin content and stability. Radiochemical yields, radiolabelling efficiency 
and radiochemical purity of 68Ga-DOTA-peptides were determined.  
 
The elution efficiency of the generator increased with an increase in the concentration of HCl eluent. 
The 68Ge breakthrough increased dramatically at 0.8 M HCl. Most metal contaminants were lowest 
when eluting with 0.2 M HCl and the Zn content increased with the increase in HCl concentration. 
The eluent of choice for the SnO2-based generator was confirmed to be 0.6 M HCl. 
 
For radiolabelling, 35 µg DOTA-peptide (9.2 – 9.4 µM) was the most favourable. Extended heating 
times and heating method did not significantly impact on the radiolabelling. The radiolabelling 
efficiencies were consistently above 90 % even after 3 weeks of non-elution of the generator, but 
radiochemical yields dropped after 7 days. DOTA-peptide kits for fractionated eluates were 
successfully developed and the radiolabelling quality was found to be superior over peptide stock 
solutions. 
 
Stellenbosch University  https://scholar.sun.ac.za
 
 
iv 
A radiolabelling method using a cationic exchange resin was successfully adapted for the SnO2 
generator. 68Ga was efficiently adsorbed on a Bond Elut SCX (100 mg) cartridge and desorbed by 
acidified solutions of NaCl. The SCX resin effectively removed about 98 % of deliberately “spiked” 
metals from the 68Ga eluate. An optimized labelling method based on the use of SCX-purified eluates 
was developed, producing radiochemical yields of almost 85 % and lead to the successful formulation 
of DOTATATE kits. The quality was found to be suitable over a 3-month period. 
 
In conclusion, a kit type labelling procedure, using cationic resin purified 68Ga eluates, provides the 
most practical method to produce 68Ga-labelled DOTA-peptides. 
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OPSOMMING 
68Ge/68Ga generators verseker beskikbaarheid van 68Ga vir positron emissie tomografie (PET), bv. 
vir somatostatien reseptor beelding met 68Ga-DOTA-gemerkte somatostatien analoë. Verskillende 
tipes generators is beskikbaar waarvan die eluate op verskillende maniere vir die radiomerking van 
peptiede geprossesseer word. 
 
Die doelstellings van hierdie studie was om verskeie aspekte van die elueringskarakteristieke van die 
generator te ondersoek, om radioaktiewe merkingsparameters deur middel van verskillende 
eluaatverwerkingstegnieke soos fraksionering en katioonuitruil chromatografie te optimaliseer en om 
gebruikersvriendelike kitsstelformulerings te ontwikkel.   
 
Goedkeuring vir hierdie studie is deur die Komitee vir Navorsing en Etiek van die Universiteit van 
Stellenbosch toegestaan en toestemming is ook deur iThemba LABS verleen vir die uitvoer van alle 
eksperimentele werk by hierdie fasiliteit. Elueerdoeltreffendheid met verskillende HCl konsentrasies 
(0.2 M – 1.0 M) is bepaal. Metaalanalises en bepalings van 68Ge deurbraak is op eluate uitgevoer. 
Radiomerkingsparameters is geoptimaliseer met gefraksioneerde eluate en verskillende 
peptiedmassas (15 tot 50 µg) by pH 3.5 – 4.0 in ‘n natriumasetaat buffer. Verkillende verhittingstye 
en -metodes is ondersoek. Die invloed van verskeie tye van nie-eluering van die generator op 
radiomerking, is ondersoek. Katioonuitruilharse is ondersoek vir suiwering van eluate. Merking is by 
verskillende pH vlakke en met verskillende hoeveelhede buffer uitgevoer. DOTA-peptiedkitsstelle is 
vir beide gefraksioneerde en hars-gesuiwerde eluate ontwikkel en is vir steriliteit, endotoksieninhoud 
en stabiliteit getoets. Radiochemiese opbrengs, radiomerkingsdoeltreffendheid en radiochemiese 
suiwerheid van 68Ga-DOTA-peptiede is bepaal.  
 
Die elueringsdoeltreffendheid van die generator het stelselmatig toegeneem met ‘n toename in die 
konsentrasie van HCl elueermiddel. 68Ge deurbraak het aansienlik toegeneem by 0.8 M HCl. Die 
meeste metaalonsuiwerhede was die laagste wanneer met 0.2 M HCl ge-elueer is en die Zn inhoud 
het konsekwent toegeneem met toename in HCl konsentrasie. ‘n HCl konsentrasie van 0.6 M HCl is 
bevestig as die voorkeur elueermiddel vir die SnO2-gebaseerde generator. 
 
Vyf-en-dertig µg DOTA-peptied (9.2 – 9.4 µM) is as optimaal vir die radiomerkingsproses gevind. 
Nòg verlengde verhittingstye, nòg die tipe verhittingsmetode het enige noemenswaardige invloed op 
radiomerkingsresultate gehad. Die radiomerkingsdoeltreffendheid was konsekwent hoër as 90 %, 
selfs na 3 weke van nie-eluering van die 68Ge/68Ga generator, maar radiochemiese opbrengste het 
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begin afneem na 7 dae. DOTA-peptied kitsstelformulerings vir gebruik met gefraksioneerde eluate is 
suksesvol ontwikkel en die radiomerkingsgehalte was beter as dié van peptied voorraadoplossings.  
 
‘n Radiomerkingsmetode waarin eluate deur middel van ‘n katioonuitruilhars geprossesseer is, is 
suksesvol aangepas vir die SnO2 generator, wat met hoër konsentrasies HCl ge-elueer word. Die 68Ga 
is doeltreffend op ‘n Bond Elut SCX (100 mg) kolom ge-adsorbeer en daarna -elueer met aangesuurde 
NaCl oplossing herwin. Die SCX hars het ongeveer 98 % van metale wat doelbewus by eluate gevoeg 
is, doeltreffend verwyder. ‘n Ge-optimaliseerde merkingsmetode, gebaseer op die gebruik van SCX-
gesuiwerde eluate, is ontwikkel wat radiochemiese opbrengste van nagenoeg  
85 % tot gevolg gehad het en tot die suksesvolle formulering van gebruikersvriendelike DOTATATE 
kitsstelle gelei het. Die kwaliteit is gedurende ‘n 3 maande stoorperiode deurlopend geskik bevind. 
 
Hierdie studie het getoon dat ‘n kitsstel vir merking met katioon-hars gesuiwerde 68Ga eluate die mees 
praktiese metode vir bereiding van 68Ga-gemerkte DOTA-peptiede is. 
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Chapter 1: Introduction and Literature Review 
68Ge/68Ga generator systems provide a reliable source of the positron-emitter 68Ga (half-life of 68 
min) which is used to produce radiopharmaceuticals for Positron Emission Tomography (PET) 
studies. These generators contain different sorbent materials (such as TiO2, SiO2 and nanoceria-
polyacrylonitrile) onto which the 68Ge is loaded. Additional investigation into aspects of the 
radiolabelling with the SnO2 generator is required because of the different composition of the 68Ga 
eluates obtained from these generators. These include the different acidity of the generator eluents, 
68Ge breakthrough, metal contaminants and the volume of the 68Ga eluate. This study focuses largely 
on optimisation of radiolabelling procedures and increasing the user-friendliness of the labelling 
procedures with 68Ga eluates from a SnO2-based 68Ge/68Ga generator. 
 
1.1 Clinical background 
Neuroendocrine tumours (NETs) are a heterogeneous group of slow-growing neoplasms, 
arising from endocrine cells. The value of advanced diagnostic techniques lies in the improved 
management of the disease, in determining the extent and activity of the disease, selecting 
appropriate treatment (non-radioactive or radiolabelled somatostatin only if the lesions are 
somatostatin-avid), follow-up after treatment and disease management. 
 
Somatostatin receptors 1 – 5 (SSRs 1 – 5) are over-expressed in NETs such as pituitary 
adenoma, pancreatic islet cell tumour, carcinoid, pheochromocytoma, paraganglioma, 
medullary thyroid cancer, and small cell lung carcinoma (Krenning et al., 1993; Reubi, 1997; 
Reubi, 2003). Somatostatin receptor scintigraphy (SRS) is used to detect NET lesions and in 
staging of NETs. Because of its superior imaging properties, PET is preferred to Single Photon 
Emission Computed Tomography (SPECT) for SRS. The diagnosis of patients with NET 
mainly relies on morphological imaging techniques such as computed tomography (CT), 
ultrasound (US) and magnetic resonance imaging (MRI) combined with functional imaging, 
including PET, which reveals physiological activity within the tumour. The study by Kayani, 
et al. (2008) showed that functional imaging with PET tracers containing positron emitters 
such as fluorine-18 (18F) and gallium-68 (68Ga) can provide a map of the spread of pathology 
in a non-invasive manner. 
 
The diagnostic applications of 68Ga-labelled DOTA-conjugated peptides for PET have been 
well documented (Hofmann et al., 2001; Henze et al., 2001; Meyer et al., 2003a, 2003b, 2004; 
Maecke et al., 2005; Breeman et al., 2005). The 68Ga-DOTA-peptides have a wide clinical 
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importance, which is described in various studies with [68Ga]DOTATOC (Kroiss et al., 2011; 
Henze et al., 2001; Jindal et al., 2010; Kowalski et al., 2003), [68Ga]DOTATATE (Conry et 
al., 2010; Mojtahedi et al., 2014), and [68Ga]DOTANOC (Ambrosini et al., 2008, 2010a, 
2010b, 2012; Prasad et al., 2010; Wild et al., 2013). 68Ga-labelled DOTA-peptides showed 
better preclinical and pharmacological performance than other radiotracers such as 111In-
labelled peptides (Antunes et al., 2007). Although uptake of the different 68Ga-DOTA-
somatostatin analogues in lesions differ due to different affinities for somatostatin receptor 
subtypes, the clinical significance of these differences and their impact on the interpretation 
of scans is still debated (Bozkurt et al., 2017).  
 
[68Ga]DOTA-labelled somatostatin analogues [68Ga]DOTATOC (1,4,7,10-
tetraazacyclododecane-N,N',N",N'"-tetraacetic acid-D-Phe1-Tyr3-octreotide), [68Ga]-
DOTATATE (1,4,7,10-tetraazacyclododecane-N,N',N",N'"-tetraacetic acid-D-Phe1-Tyr3-
octreotate), and [68Ga]DOTANOC (1,4,7,10-tetraazacyclododecane-N,N',N",N'"-tetraacetic 
acid-1-Nal3-Octreotide), have become a standard for SSR imaging and assessment of NETs 
using PET and PET/CT (Kwekkeboom et al., 2010; Henze et al., 2001; Hoffman et al., 2001; 
Meyer et al., 2004; Maecke et al., 2005; Breeman et al., 2005). The European Association of 
Nuclear Medicine has published guidelines for their use in imaging neuroendocrine 
neoplasms (Bozkurt et al., 2017). 
 
1.2 DOTA-somatostatin analogues 
DOTA (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) is an organic molecule 
consisting of a central 12-membered tetraaza ring which is an excellent chelating moiety for 
binding of metals, including gallium, and therefore, DOTA-linked peptides can be rapidly and 
efficiently labelled with 68Ga at high specific activities (Breeman and Verbruggen, 2007). The 
three DOTA-derivatives DOTATOC, DOTANOC and DOTATATE display differences in 
receptor affinity and selectivity towards human somatostatin receptor-subtypes. All three have 
very high affinity for subtype 2, while DOTANOC also has very high affinity for subtype 5 
(Antunes, et al., 2007; Reubi, et al., 2000). DOTANOC is more lipophilic than DOTATATE 
and DOTATOC (Wild et al. 2003, 2013). 
 
 
 
 
Stellenbosch University  https://scholar.sun.ac.za
 
 
3 
The structural formulae of the three DOTA-peptides (DOTATOC, DOTANOC and 
DOTATATE) are illustrated below. 
 
 
Figure 1.1: Structural formulae of DOTATOC, DOTANOC AND DOTATATE  
(reproduced from Breeman et al., 2011) 
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1.3 Gallium chemistry 
Gallium is a post-transition metal that is found primarily in the +3 oxidation state. Gallium 
ions can exist in two oxidation states, Ga1+ and Ga3+, but only Ga3+ is stable in aqueous 
conditions. The Ga3+ is only stable under acidic conditions and hydrolysis occurs when the 
pH is increased. At pH higher than 3, the Ga3+ forms oxide and hydroxide species which have 
limited solubility and result in the formation of colloids. Only the dissolved Ga3+ is available 
for complexation with chelators. Hydrolysis should be avoided when producing 
radiopharmaceuticals. Ga(OH)3 precipitates when the pH is increased but dissolves again as 
Ga(OH)4- between pH 7.4 and 9. The gallate anion Ga(OH)4- has a very slow ligand exchange 
with trans-chelation to other complexing agents (Green and Welch, 1989). 
 
68Ga3+ is obtained as [68Ga]GaCl3 from the 68Ge/68Ga generator. As discussed above, the pH 
is very important during radiolabelling with 68Ga due to hydrolysis and forming of insoluble 
colloids at higher pH. According to Roesch and Riss (2010) 68Ga is labelled to chelators such 
as DOTA at pH 2.8 to 3.8 in buffered solution where it is present as [Ga(H2O)6]3+. The most 
common buffers are acetate, citrate and HEPES. These compounds will form semi-stable 
complexes with Ga3+, protecting it from hydrolysis to Ga(OH)3. Trans-chelation to the more 
desired labelling precursor, sometimes with heating, can be achieved at pH values up to 7 
(Roesch and Riss 2010). Two other important factors in radiolabelling with 68Ga are the 
concentration of precursor and the buffer concentration.   
 
1.4 68Ge/68Ga generators 
The 68Ge/68Ga generator is the main source of 68Ga for routine availability independent from 
an on-site cyclotron. Advantages of the 68Ge/68Ga generator include the potential to prepare 
multiple radiotracer preparations daily and the use of the same generator over a fairly long 
period of time (Fani et al., 2008; Maecke et al., 2005). 68Ge is mainly commercially produced 
in a high energy cyclotron from stable 69Ga via the reaction 69Ga(p,2n)68Ge (Roesch, 2012). 
The 68Ge is isolated from the bombarded gallium target by chemical means and then loaded 
as a solution onto a column containing a sorbent material where it decays to 68Ga, which can 
be eluted from the generator. 68Ge/68Ga generators contain different sorbent materials for the 
68Ge parent radionuclide, such as inorganic substrates such as SiO2 (Neirinckx and Davis, 
1979), TiO2 (Zhernosekov et al., 2007) and SnO2 (Aardaneh and Van der Walt, 2006) as well 
as organic anion exchange resins (Neirinckx and Davis, 1980) and composite sorbents such 
as nanoceria-polyacrylonitrile (PAN) (Chakravarty et al., 2010). Table 1.1 summarises the 
most commonly available generators. 
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Table 1.1: Examples of commercially available 68Ge/68Ga generators  
Producer Column Material 
Eckert & Ziegler, Berlin, Germany TiO2 
Cyclotron Co, Obninsk, Russia TiO2 
iThemba LABS, Somerset West, SA SnO2 
Isotope Technologies Garching (ITG), Germany SiO2/organic 
IRE ELiT Not specified 
 
The TiO2 and SnO2 generators are two of the most commonly used commercially available 
68Ge/68Ga generators. These generators are eluted with aqueous acidic eluents (see 1.3) in 
order to release the 68Ga daughter radionuclide from the solid support sorbent. 
 
1.5 Eluents used to elute 68Ga eluates from the 68Ge/68Ga generators 
Due to the different chemical natures of the sorbent materials, eluents with different acidities 
are required for optimal generator performance in terms of elution profiles and 68Ga yield. 
This results in eluates with different characteristics such as acidity, which could have an 
impact on the radiolabelling of DOTA-peptides. Table 1.2 (reproduced from Velikyan, 2015) 
summarises the various sorbents based on inorganic, organic or mixed materials. 
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Table 1.2: 68Ge/68Ga generator column matrixes and recommended eluents 
68Ge/68Ga Generator Column Matrix and Eluents 
Inorganic 
Matrix Eluent 
SnO2 0.6 – 1.0 M HCl 
TiO2 0.1 M HCl 
CeO2 0.02 M HCl 
ZrO2 0.1 M HCl 
Zr-Ti ceramic 0.5 M NaOH/KOH; 4 M HCl; acetate; citrate 
Nano-zirconia 0.01 M HCl 
Organic 
N-methylglucamine 0.1 M HCl; 0.1 M NaOH; citrate; EDTA 
Pyrogallol-formaldehyde 0.3 M HCl 
Nanoceria-polyacrylonitrile 0.1 M HCl 
 
1.6 Impurities in the 68Ga eluates 
1.6.1 Metal contaminants 
The presence of metallic impurities in the 68Ga eluate can affect the use of the product by 
competing with 68Ga in the labelling process, as higher quantities of the ligand are needed and 
specific radioactivity of the radiolabelled product is reduced (Velikyan, 2015). Some metal 
cations compete with Ga3+ and may form more stable complexes with the same chelator or 
form colloids and absorb 68Ga3+, preventing it from complexation (Velikyan, 2015). Gallium 
metal targets (used in the production of SnO2 generators) are irradiated and small traces of 
Ga3+ and other chemical non-radioactive impurities from the target components could remain 
in the final 68Ge solution. The eluate from 68Ga generators contain small quantities of stable 
Zn2+ that is generated from the decay of 68Ga and is a strong competitor in complexation with 
DOTA-ligands (Velikyan, 2015). Regular elution of the generator reduces the Zn2+ 
concentration (de Blois, et al. 2011). Fe3+ is the most critical competitor to Ga3+ due to the 
similar chemistry of these two ions in terms of the complexation reaction and resin adsorption 
of the tetrachloride anion. Oehlke, et al. (2013) performed studies on the influence of, amongst 
others, Cu2+ and Fe3+ on 68Ga-labelling of DOTATATE and found that the metal ion/ligand 
ratio plays a critical role in labelling efficiency. The European Pharmacopoeia (2013) 
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specification for gallium (68Ga) chloride solution for Fe and Zn content states that no more 
than 10 µg of each of these metals should be present per GBq 68Ga in the eluate used for 
radiolabelling. 
 
1.6.2 68Ge breakthrough 
68Ge breakthrough is also a major safety concern in terms of its presence in the generator 
eluate because of its long half-life (271 days) that may result in an increased radiation dose to 
the patient as well as present major challenges in dealing with it as radioactive waste. The 
European Pharmacopoeia (2013) specification states that no more than 0.001 % of 68Ge should 
be present in the 68Ga eluate for radiolabelling. Higher breakthroughs have been reported, 
particularly when the generator was not eluted regularly (de Blois et al., 2011). This is a 
concern since the 68Ge content of a 68Ga preparation cannot be determined before it is injected 
into the patient (Decristoforo et al., 2012). The 68Ge in an eluate can only be determined more 
than 24 h after decay of the 68Ga eluate and then measuring the 68Ga, which is generated due 
to the decay of the 68Ge present. 
 
1.7 Eluate processing methods and their challenges 
Different techniques have been developed for radiolabelling DOTA-conjugated peptides, 
often using semi- or fully automated synthesis units. The methods are either based on using a 
fraction of the generator eluate directly for radiolabelling or pre-purification and concentration 
of the generator eluate using an anion exchange or cation exchange technique. 
 
In order to reduce the influence of metal contaminants that could interfere with radiolabelling, 
and 68Ge breakthrough, the pre-purification of the 68Ga eluates (anion and cation exchange 
resin purification) is important for the radiolabelling of DOTA-peptides (Meyer et al., 2003a, 
2003b, 2004; Zhernosekov et al., 2007; Velikyan et al., 2008). An added advantage of the pre-
purification process is that it reduces the volume of 68Ga solutions, since the labelling at 
nanomolar peptide concentration levels requires small reaction volumes to maximise labelling 
yields (Meyer et al., 2003a, 2003b, 2004; Zhernosekov et al., 2007). The time needed to 
process the generator eluate, and to synthesize and purify the labelled product reduces the 
overall yields of the product. The fractionation technique (Breeman et al., 2005) has also been 
used to reduce the volume of the 68Ga eluate.  
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1.7.1 Anion exchange resin purification 
Meyer et al. (2004) described a method in which the 68Ga is adsorbed onto a Bio-Rad AG 1X8 
(100 – 200 mesh) anion exchange resin cartridge. Two types of generators were used, the 
pyrogallol/formaldehyde type (which was eluted with 25 – 30 ml of 5.5 M HCl) and the TiO2-
based generator (which was eluted with 8 ml of 0.1 M HCl). The HCl concentration of the 
eluates from the generators which are eluted with 0.1 M HCl, had to be adjusted to a 
concentration of 5.5 M HCl, in order to adsorb the 68Ga as a negatively charged complex on 
the anion exchange resin. The 68Ga is subsequently rinsed from the anion exchange resin with 
small volumes of water. The method described by Meyer et al. (2004) separates 68Ge, but the 
68Ga3+ (in 0.1 M HCl) cannot be loaded directly on the anion exchange resin, nor is the Ga3+ 
purified from metallic impurities such as Zn2+ and Fe3+. The use of high hydrochloric acid 
concentrations is a disadvantage, especially in automated systems, because excess acid has to 
be removed to ensure that the labelling conditions are appropriate. 
 
1.7.2 Cation exchange resin purification 
The main step in the cation exchange procedure, as described by, amongst others, Roesch et 
al. (2006); Zhernosekov et al. (2007) and Asti et al (2008), consists of the transfer of the 0.1 
M HCl 68Ga eluate onto a cation exchange resin (e.g. Bio-Rad AG 50W-X8). In these studies, 
a TiO2 generator served as the source of 68Ga. The 68Ga is adsorbed on the resin directly from 
the generator eluate and low volumes of HCl/acetone mixtures are applied to desorb the 68Ga 
from the resin. More than 97 % of the 68Ga is recovered in the acetone/0.05 M HCl solution 
(Roesch et al., 2006; Zhernosekov et al. 2007). This cation-exchange purification method 
results in smaller 68Ga eluate volumes and removes almost all metallic impurities including 
Ge4+, Ti4+, Zn2+ and Fe3+. The purified 68Ga eluate can therefore be used for direct labelling. 
A disadvantage of this purification method is that it requires the use of acetone as desorption 
agent, which has to be eliminated completely from the final preparation as acetone is not 
approved for intravenous use (Kibbe, 2009). Quality control of the final product should 
therefore include testing for acetone by gas chromatography. 
 
Variations of the Zhernosekov et al. (2007) method were investigated, including combining 
this method with an anion exchange cartridge (Loktionova et al., 2011) or using a different 
resin and NaCl solution as an eluent (Mueller et al., 2012). Ocak et al. (2010) performed 
studies on a TiO2 generator for the synthesis of 68Ga-labelled DOTA-peptides using Bio-Rad 
AG 50W-X4 (60 mg) cation exchange resin and Strata-X-C 30 mg cation exchange cartridge 
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for the purification of the 68Ga eluate. For both resins, more than 90 % of 68Ge was removed 
and more than 85 % of 68Ga was recovered. The Bio-Rad AG 50W-X4 cation exchanger 
reduced the Fe, Al and Ti content in the eluate significantly more than the Strata-X-C cation 
exchange cartridge. They showed that their method could be fully automated and used 
successfully and reproducibly for the preparation of [68Ga]DOTATOC in high yields. It 
resulted in a smaller volume of 68Ga eluate and reduced Fe and Zn contaminants. The duration 
of the process was longer (20 – 25 min compared to 10 min) than the fractionated method of 
Decristoforo et al. (2007) due to the 68Ga eluate purification on the cation exchanger as well 
as the additional testing for acetone. The fractionated elution technique however, requires C18 
Sep-Pak purification of the labelled DOTA-peptide. 
 
Mueller et al. (2012) described an alternative cation exchange concentration/purification 
method for 68Ga eluates obtained from a TiO2 generator. Their method was based on the use 
of an acidified aqueous sodium chloride (NaCl) solution instead of acetone as the desorption 
agent. A 5 M NaCl solution containing a small volume of HCl is used to convert the bound 
68Ga, which is adsorbed onto a SCX cation exchange cartridge, into the [68GaCl4]- species. 
The [68GaCl4]- is then eluted from the SCX cartridge. A labelling method was described that 
enables high-efficiency labelling of DOTA conjugated peptides in high radiochemical purity 
(Mueller et al., 2012).  
 
Schultz et al. (2013) adapted the NaCl based method of Mueller et al. (2012) for preparation 
of 68Ga-labelled radiophamaceuticals for use with an automated system using 68Ga eluates 
(from a TiO2 generator) which were purified on a cation exchange cartridge (SCX). 
Advantages of this method included reduced preparation time (< 15 min) largely due to the 
omission of organic solvents and not requiring the C18 final purification step.  
 
Martin et al. (2014) investigated purification methods using various (commercial) cation 
exchange resins and 68Ga eluates from a SnO2-based generator. These methods to compare 
the 68Ga-trapping efficiency of the resins as well as elution of the 68Ga from the cartridges 
were also aimed to reduce the eluate volume and adjust the HCl concentration. Chromafix PS-
H+ gave better results than the other six cation exchange cartridges that were also tested. 
 
Seemann et al. (2015) compared three cation exchange resin based post-processing methods 
(acetone, ethanol and NaCl), using the TiO2 generator and the three precursors (DOTATOC, 
NO2APBP, and DATAm). The acetone and ethanol based methods provided greater 
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reproducibility and yields. For the acetone-based method, the generator was eluted with 5 ml 
of 0.1 M HCl and 68Ga was trapped on the Bio-Rad AG 50W-X8-400 cation exchange resin. 
For the ethanol-based method, the generator was also eluted with 5 ml of 0.1 M HCl and 68Ga 
was trapped on the Bio-Rad AG 50W-X4 cation exchange resin. For the NaCl-based method, 
68Ga (in 10 ml of 0.1 M HCl) was trapped on the Merck Lichrolut SCX resin. In the acetone-
based method further purification steps are required because the acetone has to be removed. 
The NaCl method offers the advantage of not using acetone, however, in general it resulted in 
lower yields as a result of longer labelling times, and changes to the pH and temperature had 
a large effect on the labelling yield. The ethanol method resulted in labelling yields greater 
than 98 % 
 
1.7.3 Combined cation-anion exchange resin purification 
Müller et al. (2011) investigated the use of a combined cationic and anionic purification 
method. In this procedure the 68Ga is eluted from the generator in 10 ml 0.1 M HCl. The 68Ga 
eluate is loaded and adsorbed on a strong cation exchange (SCX) cartridge. A small volume 
of 5.5 M HCl converts the 68Ga to [68GaCl4]- and elutes it from the SCX cartridge. The 
[68GaCl4]- is then adsorbed onto a strong anion exchange (SAX) cartridge. The 68Ga is finally 
eluted with small quantities of water for the radiolabelling process. Their method however 
requires two cartridges and the use of 5.5 M HCl during the synthesis.  
 
Loktionova et al. (2011) developed a method for 68Ga eluates from a TiO2 generator (eluted 
with 0.1 M HCl) based on processing of the 68Ga eluate on micro resin columns. Pre-
concentration and purification of the 68Ga eluate was performed on a cation-exchange resin 
(50 mg of wet AG 50W-X8), using 80 % acetone/0.15 M HCl solution to remove most of the 
chemical and radiochemical impurities. The purified 68Ga was then desorbed from the cation 
exchanger with 4 or 5 M hydrochloric acid solutions. The 68Ga was then loaded on a micro-
column containing an anion exchange resin (50 mg of wet AG 1-X8) or 100 mg 
tetraalkyldiglycolamide-based resin, which allowed direct re-adsorption of 68Ga eluted from 
the cation exchanger with the high concentration of HCl solution. The 68Ga was finally 
desorbed from the anion exchange resin with a small volume of water. The aim of their study 
was to develop a purification technique that combines aspects of the cationic and anionic 
exchange methods. 
 
Patrascu et al., (2011) performed experiments with an iThemba LABS SnO2 generator to 
investigate the purification of the eluate on a cation exchange column (Dowex-50 200 – 400 
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mesh), an anion exchange column (Dowex-1, 200 – 400 mesh) or both. For the anion 
separation, the generator was eluted with 1 M HCl and the eluate was adjusted to obtain a 5.5 
– 6 M HCl solution, which was loaded onto the anion exchange column. The 68Ga was retained 
on the column and finally desorbed with water. They found this purification method optimal 
based on the process time (30 min) and recovered 68Ga (up to 90 %). In the cation separation, 
the 1.0 M HCl 68Ga eluate was loaded onto the column and the column was washed with 
different acetone/HCl mixtures. They found this method to be non-reproducible because of 
the inconsistent recovered 68Ga activity. In the combined anion/cation separation method, the 
0.6 M HCl eluate was loaded on the cation exchange column and 68Ga was desorbed from the 
column with 4 M HCl. The solution was then loaded onto the anion exchange column and 
recovered in 1 ml water. The combined method offered a good concentration and purification 
of the eluate, but the process time was too long (40 – 60 min). 
 
1.7.4 Fractionation 
The fractionation method uses the fraction of the generator eluate that contains the highest 
concentration of 68Ga and this fraction is used for radiolabelling (Roesch, 2012). Breeman et 
al. (2005) found that 80 % of the radioactivity was recovered in 1 ml of the eluate, using 
fractionated elution. The technique aims to overcome problems associated with the large 
volume of the eluates (Breeman et al., 2005; de Blois et al., 2011; Rossouw and Breeman, 
2012). This may, however, result in a complicated labelling system and loss of activity. This 
approach also aims to overcome problems with acidic pH, 68Ge content and chemical 
impurities. The 68Ge and metallic impurities are not removed but are lower because the eluate 
volume used is lower. Users of this approach have to take care to avoid metallic impurities in 
the eluate, and purify the radiolabelled peptide after radiolabelling. Contaminants such as 
68Ge, which cannot be completely removed with this technique, can be removed with post-
labelling purification techniques such as C18 chromatography (Decristoforo et al., 2007). 
Consistently high labelling efficiencies were obtained using fractionated, un-purified 68Ga 
eluates from a SnO2-based generator to label DOTATATE (de Blois et al., 2011; Rossouw 
and Breeman, 2012). 
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1.8 General radiolabelling conditions 
The literature on the labelling conditions for the radiolabelling of DOTA-peptide ligands is 
largely based on the TiO2-based generator. Although the characteristics of the iThemba LABS 
SnO2 generator were well described by de Blois et al. (2011) and Sudbrock et al. (2014), 
additional investigation into aspects of the radiolabelling is required on this generator because 
of the difference in composition of the 68Ga eluates obtained from these two generators. This 
is particularly applicable when using eluates in their original matrices (such as fractionated 
eluates) that have not been pre-processed by means of resin chromatography. For example, in 
order to achieve optimal elution efficiencies with the SnO2-based 68Ge/68Ga generator, it has 
to be eluted with a more acidic eluent as opposed to the 0.1 M HCl required for the TiO2-
based generator. DOTA-peptide labelling is pH-dependent and is conducted at pH values 
between 3 and 5 (Meyer et al., 2003a, 2004; Breeman et al., 2005). Therefore, when more 
acidic un-processed 68Ga-containing eluates are used in peptide labelling, labelling methods 
need to be adapted. 
 
Rossouw and Breeman (2012) investigated a method to prepare 68Ga-labelled DOTATATE 
using fractionated, un-purified 68Ga eluates by maximising the eluted activity for the labelling 
and adapting existing labelling methods to accommodate for the large volume and more acidic 
eluate. Their study describes a rough optimization of the DOTATATE content of labelling 
mixtures to ensure optimal radiolabelling yields by employing two peptide masses (30 and 50 
µg). De Blois et al. (2011) performed DOTATATE-labelling studies with 68Ga eluted from 
this generator, but with maximum reaction volumes of 1.5 ml. Their study was only performed 
with DOTATATE and its main focus was to investigate the characteristics of the SnO2 
generator and eluate purification with less focus on radiolabelling. The study by Sudbrock, et 
al. (2014) on 68Ga-DOTATATE, investigated the influence of several factors on the 
radiochemical synthesis, including the quantity of DOTATATE, the influence of Fe3+ salts 
and replacement of HEPES buffer with sodium acetate. Their study was only performed with 
DOTATATE and with peptide masses of 1 – 15 µg in a reaction volume of approximately 2 
ml.  
 
1.9 Development of user-friendly kits 
In order to improve the user-friendliness of the 68Ga labelling process, there is a need to 
develop stable kit formulations based on optimized labelling methods. This allows instant 
preparation of 68Ga-labelled DOTA-peptides within a radiopharmacy environment. By 
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definition, a kit for radiopharmaceutical preparation contains all reagents required except the 
radionuclide, in a vial. Production of the radiopharmaceutical preparation may require 
additional steps such as heating. Kit preparations may be lyophilised (freeze-dried).  
 
Single vial freeze-dried DOTA-peptide kits were developed and evaluated for the preparation 
of 68Ga-labelled DOTA-peptides (Mukherjee et al., 2014a, 2014c). The 68GaCl3 was eluted 
from a nanoceria-polyacrylonitrile (PAN), composite-sorbent-based 68Ge/68Ga generator 
using 0.1 M HCl, which was directly added to the kits. Sodium acetate was used as the buffer 
and a peptide mass of 50 µg was used for the kit formulation. The stability of the kits was 
investigated over a 4-month period (Mukherjee et al., 2014a).  
 
In another study by the same author (Mukherjee et al., 2014b) freeze-dried DOTATATE kits 
for radiolabelling with both 68Ga and 177Lu were formulated as a theranostic 
radiopharmaceutical preparation. They report that the 68Ga was eluted from a SnO2-based 
generator with 0.1 M HCl which was loaded on a Strata-X-C cartridge. (According to the 
literature, 0.6 – 1.0 M HCl is used as the eluent for this generator and the 0.1 M HCl would 
probably result in a low generator elution yield.) The resin was washed with acetone/0.1 M 
HCl (80/20) solution to remove the metal impurities. The purified 68Ga was eluted in an 
acetone/0.02 M HCl (97.6/2.4) solution and directly added to the kit vial. The kits contained 
DOTATATE quantities of 30, 50 or 200 µg and HEPES buffer. The final preparation was 
purified by a Sep-Pak C18 cartridge to remove the HEPES and colloids. HEPES buffer was 
used because ammonium acetate buffer was found to be unstable during the lyophilisation 
process and sodium acetate buffer was not able to maintain pH 4 after lyophilisation when 
68Ga in 0.1 M HCl was used for complexation. The kits were evaluated over a period of 6 
months. 
 
A study by Asti et al. (2015) to develop and optimise direct labelling of DOTATOC through 
a kit-based approach was conducted using eluates from a TiO2- and a silica-based generator 
and two synthesis methods. Fractionated 2 ml of 0.1 M HCl 68Ga eluates were added to vials 
containing 30 µl (1 mg/ml) DOTATOC, sodium acetate buffer and ascorbic acid solution 
(scavenger). The vial was heated to 100 °C in a heating block for 5 min and the reaction 
mixture (pH = 3.3) was passed through a C18 cartridge.  
 
DOTA-peptide kits (SomaKit TOC and NETSPOT) have recently been licensed for 68Ga-
labelling of somatostatin analogues. SomaKit TOC is used for the preparation of 68Ga-
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DOTATOC and NETSPOT is used for the preparation of 68Ga-DOTATATE. These kits 
consist of one vial of lyophilized powder (containing 40 µg edotreotide/DOTATOC or 
DOTATATE and excipients) and one vial containing a buffer. The generator is eluted directly 
into the vial containing the peptide, the buffer is added and the vial is heated at 
95 °C for no more than 10 minutes, after which it is removed from the heat and left to cool at 
room temperature for about 10 minutes. Eluates from the GalliaPharm generator (0.1 M HCl) 
by Eckert & Ziegler Radiopharma GmbH are compatible with both SomaKit TOC and 
NETSPOT. Although the cost of these licensed kits may be higher than any unlicensed kits, 
the major advantage of using licensed kits is that they have passed all the required preclinical 
and clinical tests to ensure patient safety and they are produced according to GMP 
specifications. These kits make the compounds available to PET centres that may not have 
the necessary infrastructure or capacity to prepare their own kits. 
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1.10 European Pharmacopoeia specifications 
The following specifications are prescribed in the European Pharmacopoeia 8.0 (2013): 
 
1.10.1 Gallium (68Ga) chloride solution for radiolabelling 
 Appearance:   Clear and colourless solution 
 Half-life:   62 to 74 min 
 Radionuclidic identity (gamma-ray spectrometry): 0.511 MeV and 1.077 MeV 
 Radionuclidic purity (gamma-ray spectrometry): ≥ 99.9 % 
 Germanium-68:   ≤ 0.001 % 
 Radiochemical purity (TLC):  ≥ 95 % 
 pH:    ≤ 2 
 Iron:    ≤ 10 µg/GBq 
 Zinc:    ≤ 10 µg/GBq 
Bacterial endotoxins: < 175 IU/V (where v is the maximum 
volume to be injected) 
 
1.10.2 Gallium (68Ga) Edotreotide injection (DOTATOC) 
 Appearance:   Clear and colourless solution 
 Half-life:   62 to 74 min 
 Radionuclidic purity (gamma-ray spectrometry): ≥ 99.9 % 
 Germanium-68:   ≤ 0.001 % 
 Radiochemical purity:  ≥ 91 % 
 pH:    4.0 to 8.0 
Bacterial endotoxins: < 175 IU/V (where v is the maximum 
volume to be injected) 
Sterility: Sterile  
  
Stellenbosch University  https://scholar.sun.ac.za
 
 
16 
Problem Statement 
Based on the literature, extensive radiolabelling studies have been performed on the TiO2 generator, 
however labelling studies using 68Ga eluates from the SnO2-based 68Ge/68Ga generator are relatively 
limited and need to be further investigated. One of the important aspects is the high acidity of the 
eluates, which affects the radiolabelling process. An eluent with lower acidity but similar elution 
capacity would be preferred. Another aspect that requires investigation is 68Ge breakthrough and 
finding the most efficient way to eliminate its presence in the final radiopharmaceutical product. 
Metal contaminants and the large volume of the 68Ga eluate also need further investigation. In 
addition, a more thorough optimization of parameters such as DOTA-peptide content of labelling 
mixtures and post labelling purification techniques, using all three DOTA-peptides, is required. The 
labelling process needs to be optimised with real-life constraints within the clinical and research 
environment (such as the infrequent use of the generator) and improved user-friendliness, such as the 
development and the use of labelling kit formulations. Furthermore, the purification and processing 
of eluates prior to labelling warrant additional investigation. 
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Chapter 2: Aim and Objectives 
2.1 Aim 
The aim of the study was to investigate the effect of various parameters on the radiolabelling 
of somatostatin DOTA-peptide derivatives with 68Ga eluted from a tin dioxide (SnO2)-based 
68Ge/68Ga generator, using differently processed 68Ga eluates. 
 
2.2 Objectives  
Different 68Ge/68Ga generator elution and eluate processing techniques exist. The initial 
objective of this study was to present radiolabelling optimization parameters, using 68Ga 
eluates processed with different techniques. It was anticipated that the final results of this 
study would indicate which of the eluate processing techniques is the most efficient in terms 
of radiolabelling yields and radiochemical purities of labelled products. This study aimed to 
highlight all probable pitfalls that could be associated with the radiolabelling of DOTA-
peptides, using 68Ga eluates from a SnO2-based generator, as well as finding efficient ways to 
eliminate them. It should result in the development of reliable and user-friendly procedures to 
obtain 68Ga-labelled peptides of high radiopharmaceutical quality. The objectives of this study 
are listed below: 
 
2.2.1 To investigate elution of the 68Ge/68Ga generator with different eluents in order to obtain 
elution data across a wide range of eluent acidity: 
• Investigation of elution of the SnO2-based generator with alternative eluents such as 
the more acidic 0.8 M hydrochloric acid (HCl) and 1.0 M HCl solutions as well as the 
less acidic 0.4 M HCl and 0.2 M HCl solutions. 
•  Comparison of elution efficiencies, 68Ge breakthrough and the content of various 
metals in eluates. 
 
2.2.2 To optimise radiolabelling parameters using the fractionated elution method: 
The work is based on the post-labelling purification method of Rossouw and Breeman (2012), 
but aimed to further optimize and adjust methods according to the requirements for other 
DOTA-peptides. In addition to DOTATATE, this study was also planned to include other 
important DOTA-peptides such as DOTATOC and DOTANOC and involved a more 
comprehensive investigation of the influence of peptide mass on labelling (15 to 50 µg) in a 
fixed reaction volume of approximately 2.6 ml. The following aspects were investigated: 
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• Optimization of the peptide (DOTATATE, DOTATOC and DOTANOC) content of 
radiolabelling formulations, using fractionated 68Ga eluates, with the aim to obtain 
optimal radiolabelling efficiencies and radiochemical yields of radiolabelled peptides. 
In order to obtain optimal radiochemical yields for all the DOTA-peptides, the Sep-
Pak C18 purification technique of the labelled peptides was optimized by using 
varying eluent mixtures for final elution of the product; 
• Comparison of the heating capabilities of two different heating modes used in the 
radiolabelling process (a water-bath versus a heating block) and investigation of the 
effect on the radiolabelling efficiency and radiochemical yield; and 
• Determination of the influence of varying periods up to 21 days of non-elution of the 
68Ge/68Ga generator (e.g. after weekends, long weekends, maintenance periods) on 
radiolabelling results as well as on the metal ion content of the 68Ga eluates. 
 
2.2.3 To develop and evaluate user-friendly single vial DOTA-peptide kit formulations, using the 
fractionated elution method: 
• Development of single vial DOTA-peptide kit formulations based on the optimized 
labelling conditions using the fractionated elution method. These kits containing the 
peptide and buffer were aimed at improving the convenience and user-friendliness of 
the labelling procedure.  
• Evaluation of the long-term stability of the single vial DOTA-peptide kits, as reflected 
by the labelling results; and 
• Comparison between the use of DOTA-peptide single vial kits versus the use of 
DOTA-peptide stock solutions (using the fractionated elution method). 
 
2.2.4 To investigate the concentration and purification of 68Ga eluates on different cation exchange 
resins. 
 
2.2.5 To purify various concentrations of metal-spiked (Ga, Zn, Fe and Cu) 68Ga eluates on a cation 
exchange resin. 
 
2.2.6 To optimize the radiolabelling of DOTATATE, using 68Ga eluates that have been pre-
concentrated on a suitable cation exchange resin cartridge. 
 
2.2.7 To develop and evaluate user-friendly single vial DOTATATE kit formulations, using the 
cation exchange resin-processed 68Ga eluates. 
Stellenbosch University  https://scholar.sun.ac.za
 
 
19 
Chapter 3: Study Design and General Methods 
The study mainly involved an investigation into the radiolabelling of three peptide ligands with 68Ga 
eluted from the SnO2-based generator developed at iThemba LABS. The selected ligands were the 
somatostatin derivatives 1,4,7,10-tetraazacyclododecane-N,N',N",N'"-tetraacetic acid-D-Phe1-Tyr3-
octreotate (DOTATATE), 1,4,7,10-tetraazacyclododecane-N,N',N",N'"-tetraacetic acid-D-Phe1-Tyr3-
octreotide (DOTATOC) and 1,4,7,10-tetraazacyclododecane-N,N',N",N'"-tetraacetic acid-1-Nal3-
Octreotide (DOTANOC).  
 
Initially, various elution characteristics of a SnO2-based generator with different concentrations of 
HCl were investigated. The next phase of the study involved investigations into the use of differently 
processed 68Ga eluates (fractionated and cation resin purified) in radiolabelling. Initially these 
investigations involved the optimization of radiolabelling parameters, using fractionated eluates, 
followed by an investigation into the improvement of the user-friendliness of the labelling procedure, 
using kit formulations. The latter part covered the processing/purification of eluates on various types 
of cation exchange resins followed by the selection of the most efficient resin and the use of the 
processed eluates emanating from this resin in conventional labelling and eventually in kit labelling. 
The ability of this resin to remove metals, which were deliberately introduced into eluates, was also 
investigated.  
 
3.1 General 
All experiments were repeated for a minimum number of three times, as well as on more than 
one generator and different batches of peptides to confirm repeatability of results. At least 
three SnO2 68Ge/68Ga generators, which were produced by and obtained from iThemba LABS 
(Somerset West, South Africa), were used. The number of experiments and generators decided 
upon were to ensure reliable results but limit the radiation exposure to the investigator. 
Radiolabelling efficiency and radiochemical purity were determined by means of high 
performance liquid chromatography (HPLC) and instant thin layer chromatography (iTLC). 
All 68Ga activity data are expressed as decay corrected. Sterility and endotoxin testing were 
performed on DOTA-peptide kits. All quality control methods were validated and some of 
these validations formed part of another study (Davids, 2017). All chemicals used were of 
analytical grade. 
 
The researcher is a registered radiation worker. The radiation exposure (finger and whole-
body doses) was monitored and recorded with the required dosimetry (electronic personal 
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dosimeter, finger rings and thermoluminescent dosimeter). The radioactive waste produced 
was handled according to iThemba LABS’ radiation safety policies and procedures. No 
human studies were conducted as part of this research project. This study was approved by 
the Stellenbosch University Health Research Ethics Committee (Approval no. S15/09/214) 
and permission was granted for the experimental work to be conducted at iThemba LABS. 
 
3.2 Equipment  
Radioisotope Dose Calibrator: Capintec CRC-55tR 
Semi-micro Balance: Mettler Toledo XP105DR 
Radio-TLC scanner: Carroll & Ramsey Omni-rad EZ Scan 
Incubator (32.5 ºC): Labcon FSIM16 
Incubator (22.5 ºC): Labcon LTIM10 
Endotoxin Testing System: 
Microplate reader: Bio-Tek ELx800 
Microplate Incubator/Shaker: BMG THERMOstar 
HPLC System: 
Binary HPLC Pump: Perkin Elmer Series S200 
HPLC Injector: Rheodyne model 7125 
HPLC column: Phenomenex Luna C18 (250 X 4.6mm, 5µm) 
Integrator: Shimadzu Chromatopac C-R8A 
HPLC detector: RadiationNa(Tl) radiation flow detector coupled to a 
high voltage power supply and ratemeter (Ortec) 
Gamma Spectrometer System: 
Genie 2000 software: Canberra 
Germanium detector: DSG Detector Systems GmbH 
Inductively coupled plasma optical  
emission spectrometer (ICP-OES): Horiba Jobin Yvon Ultima 
Freeze dryer: Edwards Freeze dryer Modulyo 
Vacuum Pump: N 726 FT.18 Vacuum Pump 
Vortex mixer: Vortex – Genie 2 G560E 
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3.3 Solutions 
3.3.1 0.6 M HCl Eluent 
A volume of 63.41 ml of 30 % hydrochloric acid (HCl) Suprapur (9.642 M), catalogue number 
1.00318.0025, (Merck, Darmstadt, Germany) was diluted with ultra-pure water and made up 
to 1000 ml 0.6 M HCl. 
 
3.3.2 Stock solutions of the three DOTA-peptide ligands  
The DOTA-peptides (DOTATATE, DOTATOC, and DOTANOC) were purchased from JPT 
Peptide Technologies GmbH (Berlin, Germany). 1 mg/ml DOTA-peptide stock solutions 
were prepared using ultra-pure pharmaceutical grade water and stored at -20 °C. Frozen stock 
solutions were thawed to room temperature before being used in radiolabelling. These frozen 
stock solutions were frozen and thawed for a total number of cycles of up to 10 times. 
 
3.3.3 HPLC Mobile Phases 
HPLC mobile phase A: 
0.1 % (w/v) trifluoracetic acid (TFA) 
A volume of 0.67 ml of TFA, catalogue number 302031, (Sigma-Aldrich, St. Louis, Missouri, 
United States) was made up to 1000 ml with ultra-pure water. 
HPLC mobile phase B: 
Acetonitrile, catalogue number 34851, (Sigma-Aldrich, St. Louis, Missouri, United States) 
 
3.3.4 TLC Mobile Phase: 1 M ammonium acetate:methanol (1:1) 
77.08 g of ammonium acetate, catalogue number 431311, (Sigma-Aldrich, St. Louis, 
Missouri, United States) was weighed and diluted to 1 litre using ultra-pure water. A 1:1 
solution of ammonium acetate:methanol was prepared by adding equal volumes of 1 M 
ammonium acetate solution and methanol, catalogue number 34860 (Sigma-Aldrich, St. 
Louis, Missouri, United States). 
 
3.3.5 ICP standard solutions (1 ppm, 5 ppm and 10 ppm) of zinc (Zn), iron (Fe), tin (Sn), copper 
(Cu), gallium (Ga) and aluminium (Al) 
1000 ppm standards solutions (catalogue numbers: Zn in 5 % HNO3 – 88118, Fe in 5 % HNO3 
– 88073, Sn in 20 % HCl – 88112, Cu in 5 % HNO3 – 88061, Ga in 5 % HNO3 / trace (tr) HCl 
– 88066 and Al in 5 % HCl – 33557) were purchased from Alfa Aesar (Haverhill, 
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Massachusetts, United States) and diluted to 100 ppm with 0.6 M HCl before using to prepare 
1 ppm, 5 ppm and 10 ppm solutions of each metal. 
 
3.3.6 Tryptic soy broth (TSB) for sterility testing 
15 g of TSB powder, catalogue number 22092, (Sigma-Aldrich, St. Louis, Missouri, United 
States) was dissolved in 500 ml of ultra-pure water, heated with stirring and boiled for 1 min. 
This solution was transferred to storage containers and was sterilized by autoclaving at 121 
ºC for 15 min. 
 
3.3.7 Thioglycollate broth (TB) for sterility testing 
14.5 g of TB, catalogue number 70157, (Sigma-Aldrich, St. Louis, Missouri, United States) 
was dissolved in 500 ml of ultra-pure water, boiled until the TB was completely dissolved and 
transferred to storage containers. It was then sterilized by autoclaving at 121 ºC for 15 min. 
 
3.3.8 2.5 M sodium acetate solution (NaOAc) 
A 2.5 M NaOAc solution was prepared by dissolving 34 g of sodium acetate trihydrate salt, 
catalogue number SAAR5821010EM, (Merck, Darmstadt, Germany) in 100 ml ultra-pure 
pharmaceutical grade water. 
 
3.3.9 5.5 M HCl 
A 5.5 M HCl was prepared by making up 290.70 ml of 30 % HCl Suprapur (9.642 M), 
catalogue number 1.00318.0025, (Merck, Darmstadt, Germany) to 500 ml with ultra-pure 
pharmaceutical grade water. 
 
3.3.10 5 M NaCl / 5.5 M HCl 40:1 (v/v) 
5 M NaCl was prepared by dissolving 29.22 g of NaCl salt, catalogue number 31434 (Riedel-
de Haën, Honeywell, Morris Plains, New Jersey, United States) in 100 ml water. 
The 5 M NaCl / 5.5 M HCl 40:1 (v/v) solution was prepared by mixing 10 ml of 5 M NaCl 
and 0.25 ml of 5.5 M HCl. 
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3.4 General Methods 
3.4.1 Elution of the generator 
The SnO2-based 68Ge/68Ga generator (double-loaded with 68Ge activity) was supplied by 
iThemba LABS (Somerset West, South Africa). The generator has an inlet and outlet 
polyethylene tube with luer fittings. A sterile polyethylene 10 ml syringe is attached to the 
inlet tube via the luer fitting to elute the 68Ga from the generator with 0.6 M HCl (except when 
different eluents were investigated) (refer to 3.3.1 for preparation of the eluent). The generator 
was eluted (for up to 1 year) daily on weekdays, except when the experiments were performed 
to assess the effects of various periods of non-elution of the generator on the radiolabelling 
results. All 68Ga activities were measured using a Capintec Dose Calibrator CRC-55tR (New 
Jersey, United States). 
 
3.4.2 Sep-Pak C18 post-radiolabelling purification 
The radiolabelled mixtures were loaded on a 500 mg, 3 cc, Sep-Pak C18 cartridge, catalogue 
number WAT036815, (Waters, Milford, Massachusetts, USA) which was attached to a needle 
that had been pushed through the centre of a rubber stopper sealing a glass vial. A second 
needle was connected to a syringe via polyethylene tubing and was also pushed though the 
stopper. The Sep-Pak C18 cartridge had been pre-conditioned with 4 ml absolute ethanol, 
catalogue number 32221, (Sigma-Aldrich, St. Louis, Missouri, United States) followed by 2 
ml deionised water. Elution was conducted at a rate of approximately 1 – 1.5 ml/min and was 
controlled with a syringe plunger. The empty reaction vial was rinsed with 2 ml 0.9 % sodium 
chloride solution (Fresenius Kabi, Port Elizabeth, South Africa), which was then transferred 
onto the cartridge and eluted. The Sep-Pak C18 cartridge was eluted with a further 6 ml 0.9 
% sodium chloride solution. During both these steps, the cartridge was not completely 
drained. The collection vial (S1) was then removed and replaced with another vial (S2). The 
reaction vial was rinsed with 0.7 ml ethanol:saline mixtures (50:50 unless specified 
otherwise), which was then transferred to the Sep-Pak C18 cartridge and used to desorb the 
labelled peptide. The cartridge was not completely drained and 2.25 ml 0.9 % sodium chloride 
solution was transferred to the C18 cartridge to rinse. The retained ethanol:saline mixture on 
the cartridge from the previous elution step was displaced and the cartridge was completely 
drained to remove any retained ethanol (C18 cartridge dead volume @ 0.6 ml). The measured 
desorbed activity in S2 was expressed as the radiochemical yield of labelled peptide. 
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3.4.3 HPLC Analysis 
Refer to section 3.2 for the HPLC equipment. 
The mobile phases were: 
Mobile phase A: 0.1 % (m/v) TFA  
Mobile phase B: Acetonitrile 
A sample with a maximum volume of 50 µl (depending on the radioactivity concentration) 
was taken from the pre-purified and post-purified 68Ga-DOTA-peptide solutions for HPLC 
analysis.  
Elution was carried out at a flow rate of 1 ml/min, using the following elution programme:  
0 – 2 min (100 % A); 2 – 12 min (70 % B); 12 – 15 min (100 % B). Under these conditions 
free 68Ga eluted at 2.6 – 3.7 min, small traces of radiochemical impurities, which were 
occasionally present but not quantifiable, eluted at 6.3 – 9.3 min, while [68Ga]DOTATATE 
eluted at 12.2 – 12.8 min, [68Ga]DOTATOC eluted at 12.2 – 12.7 min and [68Ga]DOTANOC 
eluted at 12.7 – 13.2 min. See Annex 1 for examples of chromatograms. 
 
3.4.4 Sterility Testing 
Sampling for sterility was performed in a Class A laminar airflow unit. Each sample was 
tested using soybean-casein digest medium for aerobic bacteria and fungi, and fluid 
thioglycollate medium for anaerobic bacteria. The volume of the sample did not exceed 10 % 
of the volume of the medium. The soybean-casein digest medium and fluid thioglycollate 
medium were added to the samples aseptically. The sample containing soybean-casein digest 
medium was incubated at 22.5 ± 2.5 °C and the sample containing fluid thioglycollate medium 
was incubated at 32.5 ± 2.5 °C. A positive E. Coli sample (E. Coli + broth only) plus a 
negative sample were incubated together with the other samples. Samples were incubated for 
two weeks and checked on a daily basis for appearance of growth. The appearance of the 
media would have changed from clear to cloudy if bacterial growth was present. 
 
3.4.5 Endotoxin Testing 
The chromogenic method was used to test for endotoxins. A LAL Test Chromogenic kit, 
catalogue number 50-647U (Lonza, Basel, Switzerland) was used which contained the 
endotoxin stock solution, LAL reagent, substrate and LAL reagent water. The LAL reagent 
water was used to reconstitute the endotoxin stock solution, the LAL reagent and substrate. A 
set of endotoxin standards, ranging from 0.1 international units per millilitre (IU/ml) to 1.0 
IU/ml, was prepared using the endotoxin stock solution. The pH of the samples was adjusted 
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to pH 6.0 – 8.0 with 0.1 N sodium hydroxide (NaOH) prepared from 1 N NaOH titrisol, 
catalogue number 1.09956.0001, (Merck, Darmstadt, Germany) and LAL reagent water. The 
absorbance was determined with a BioTek ELx800 plate reader (BioTek, Winooski, United 
States) and was plotted against the concentration of the standards to create a calibration curve. 
The calibration curve was used to determine the concentration of endotoxins in the samples. 
The maximum dilution volume was determined to be 10. An endotoxin standard (0.25 IU/ml) 
was used as a positive control and the negative control contained LAL reagent water instead 
of the endotoxin standard. At this dilution volume and pH there was no inhibition of the LAL 
reaction. 
 
3.4.6 Determination of 68Ge Breakthrough in eluates and 68Ga-labelled preparations 
The 68Ge breakthrough was determined at least 24 hours after elution or preparation of the 
labelled product in order to allow all 68Ga in the initial sample to decay, so that any 68Ga 
present was due to the decay of 68Ge. A Canberra gamma spectrometer with a germanium 
detector and Genie 2000 software was used. A standard solution was prepared by diluting 
1.11 MBq of 68Ge solution to a volume of 10 ml with 0.6 M HCl. The 68Ge in the sample was 
quantified using the 511 keV peak (of the 68Ga). Counts on the gamma spectrometer were 
performed for 1000 seconds each and spectra of the sample, standard solution and background 
were obtained.  The breakthrough (expressed as a percentage) was defined as the ratio of 
activity of 68Ge divided by the initial 68Ga activity.  
 
3.4.7 Determination of Metal Contaminants 
The metal contaminants in the samples were determined using a Horiba Jobin Yvon Ultima 
inductively coupled plasma optical emission spectrometer (ICP-OES) (Jobin-Yvon, Paris, 
France). The concentration of metals in the samples was determined from calibration curves 
ranging from 1 ppm to 25 ppm. 
 
3.4.8 Determination of elution efficiency (yield) 
The elution efficiency (yield) was determined as follows: 
The generator was eluted with a total of 10 ml eluent and the activity in the 68Ga eluate was 
measured in a dose calibrator. The elution efficiency was based on the nominal 68Ge activity 
on the generator column and calculated in the following way: 
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Elution Efficiency (%) = 
68Ga activity at time of elution x 100 
68Ge activity (nominal) on the column at the time of elution 
 
3.4.9 Statistical Analysis 
The Univariate Tests of Significance were used to analyse the different effects. Where the p-
value was found to be significant (p < 0.05), further statistical tests (LS Means test, LSD test 
and weighted means) were performed. 
 
3.4.10 Concentration of 68Ga eluates on a cation exchange resin 
A cation exchange resin cartridge was pre-conditioned by eluting with 1 ml 5.5M HCl, 
followed by 5 ml deionised water at an elution rate of approximately 1 – 1.5 ml/min by 
applying a negative pressure inside the vial. The vial was replaced with a 10 ml borosilicate 
vial and its content was discarded. The 68Ga eluate was loaded onto the pre-conditioned 
cartridge and eluted into the waste vial (Fr1). The resin was run dry and eluted with 1 ml 
water into the same waste vial (Fr1). The vial was sealed and replaced with another vial. The 
cartridge was loaded with 0.5 ml of a mixture of 5 M NaCl and 5.5 M HCl 40:1 (v/v) and the 
68Ga was eluted from the resin. The resin was run dry, the vial (Fr2) sealed and the activities 
of both vials (Fr1 and Fr2), as well as the residual activity in the cartridge, were determined. 
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Chapter 4: Investigation of elution of the 68Ge/68Ga generator with different hydrochloric 
acid concentrations 
4.1 Introduction 
Due to the different chemical natures of sorbent materials, eluents with different acidities are 
required for optimal generator performance in terms of elution profiles and 68Ga yield. A 
SnO2-based generator requires higher acid concentrations than a TiO2-based generator 
(Aardaneh and Van der Walt, 2006; de Blois et al., 2011; Decristoforo et al., 2012; Sudbrock 
et al., 2014; Velikyan, 2015). Studies on the use of the SnO2-based generator go back as far 
as 1980. A study by Loc’h et al. (1980), using a SnO2-based generator, found that the higher 
acidity of the eluent improves the 68Ga elution yield but resulted in greater 68Ge 
contamination. The authors used HCl concentrations of 1 to 8 M in their investigations, but 
eventually resorted to using 1 M HCl as the most suitable compromise. Aardaneh and Van 
der Walt (2006) used 1 M and 4 M HCl solutions for elution of the iThemba LABS SnO2 
generator initially to compare with Loc’h et al (1980). De Blois et al. (2011) investigated 
iThemba LABS SnO2 generators in HCl ranges of 0.3 – 1.0 M and 68Ga elution yields were 
established. Das et al. (2013) eluted their in-house prepared SnO2 generator with 1.0 M HCl. 
Rossouw and Breeman (2012) eluted a more than 12-month old iThemba LABS SnO2 
generator with 0.6 M HCl. 
 
The manufacturer recommends that the iThemba LABS SnO2-based generator should be 
eluted with 0.6 M HCl compared to the 0.1 M HCl used for the TiO2-based generator to 
achieve optimal elution yields (68Ga activity at time of elution, expressed as a percentage of 
the nominal 68Ge activity on the column at the time of elution). There is, however, to the 
author’s knowledge, only limited published data available on the characteristics of eluates 
(only elution efficiency/yields) resulting from the elution of a SnO2-based generator with 
eluent concentrations lower than 0.6 M HCl.  
 
4.2 Aim 
The purpose of this investigation was to elute the SnO2-based generator with various 
concentrations of HCl (0.2 M, 0.4 M, 0,6 M, 0.8 M and 1.0 M) in order to obtain and compare 
data on the elution efficiencies, 68Ge breakthrough and metal contaminants of the 68Ga eluates 
using each of these eluents and to qualify the “possible benefits over the risks” of using any 
particular eluent over the recommended 0.6 M HCl. 
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4.3 Materials and Methods 
General methods are summarised in chapter 3. This section describes variations and details 
specific to the work described in this chapter. 
 
4.3.1 Preparation of eluents 
The HCl solutions (0.2 M – 1.0 M) were prepared as follows: 
0.2 M HCl: 
A volume of 21.14 ml of 30 % HCl was diluted with ultra-pure water and made up to 1000 
ml 0.2 M HCl. 
0.4 M HCl: 
A volume of 42.27 ml of 30 % HCl was diluted with ultra-pure water and made up to 1000 
ml 0.4 M HCl. 
0.6 M HCl: 
A volume of 63.41 ml of 30 % hydrochloric acid (HCl) Suprapur (9.642 M), catalogue number 
1.00318.0025, (Merck, Darmstadt, Germany) was diluted with ultra-pure water and made up 
to 1000 ml 0.6 M HCl. 
0.8 M HCl: 
A volume of 84.55 ml of 30 % HCl was diluted with ultra-pure water and made up to 1000 
ml 0.8 M HCl. 
1.0 M HCl: 
A volume of 105.7 ml of 30 % HCl was diluted with ultra-pure water and made up to 1000 
ml 1.0 M HCl. 
 
4.3.2 Elution of the generator and determination of elution profiles 
68Ga was eluted from a 1 to 2- month old 1110 MBq (double-loaded with 2220 MBq 68Ge) 
SnO2-based 68Ge/68Ga generator up to thrice daily on weekdays, allowing at least 5 hours 
between each elution. The generator was eluted at least 6 times in total with 10 ml of each 
concentration of HCl (in the following sequence: 0.6 M, 0.4 M, 0.2 M, 0.8 M and 1.0 M) with 
rinses of 10 ml between each concentration of HCl. The generator was eluted with 0.5 ml 
fractions of the different HCl concentrations up to a volume of 10 ml to construct elution 
profiles for each eluent. 
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4.3.3 Determination of the elution efficiency (yield) 
The terms elution efficiency and elution yield can be used interchangeably and hereafter, the 
term elution yield will be used. The generator was eluted with a total of 10 ml eluent (see 
4.3.1 for preparation of eluents) and the activity in the 68Ga eluate was measured in a dose 
calibrator. This data were used to determine the elution yield of the generator. The elution 
yield was based on the nominal 68Ge activity on the generator column (1110 MBq) and 
calculated as in 3.4.8. 
 
4.3.4 Determination of 68Ge breakthrough 
The 68Ge breakthrough was determined in each sample as described in 3.4.6. The same 
samples were used hereafter to determine the concentration of metals in each sample. 
 
4.3.5 Determination of metal contaminants  
Standard solutions (1 ppm, 5 ppm and 10 ppm) of zinc (Zn), iron (Fe), copper (Cu) and gallium 
(Ga) were prepared as in 3.3.5. These standards were used to determine the metal 
contaminants in the samples by means of the Horiba Jobin Yvon Ultima inductively coupled 
plasma optical emission spectrometer (ICP-OES) (see 3.4.7). 
 
4.4 Results 
The results in Table 4.1 represent data on the effect of eluents containing different HCl 
concentrations on generator elution yield, 68Ge breakthrough and metal contaminants. 
 
Table 4.1: Effect of different eluents on generator elution yield, 68Ge breakthrough and 
metal contaminants  
HCl Conc. 
 
Elution 
Effic. (%) 
68Ge break-
through (%) 
(%) 
Metals (ppm) 
Fe Zn Ga Cu Total 
0.2 M 
(n=4) 18 ± 0.6 0.004 ± 0.001 0.32 ± 0.02 0.42 ± 0.13 0.15 ± 0.03 0 0.89 
0.4 M 
(n=4) 66 ± 2 0.008 ± 0.003 0.34 ± 0.01 1.35 ± 0.08 0.17 ± 0.01 0 1.86 
0.6 M 
(n=4) 99 ± 3 0.008 ± 0.003 0.39 ± 0.01 1.55 ± 0.01 0.16 ± 0.01 0 2.10 
0.8 M 
(n=4) 118 ± 3 0.591 ± 0.06 0.23 ± 0.06 1.67 ± 0.41 0.40 ± 0.03 0 2.30 
1.0 M 
(n=4) 126 ± 3 0.620 ± 0.02 0.34 ± 0.05 2.31 ± 0.9 0.47 ± 0.1 0.03 ± 0.02 3.15 
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4.4.1 Determination of the elution profiles for the different eluents 
Figures 4.1 – 4.5 represent the elution profiles of 68Ga obtained when eluting a 1 – 2-month 
old generator with different concentrations of HCl (0.2 M – 1.0 M) as eluents. 
 
 
Figure 4.1: Elution profile of 68Ge/68Ga generator using 0.2 M HCl as eluent 
 
Figure 4.2: Elution profile of 68Ge/68Ga generator using 0.4 M HCl as eluent 
 
Figure 4.3: Elution profile of 68Ge/68Ga generator using 0.6 M HCl as eluent  
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Figure 4.4: Elution profile of 68Ge/68Ga generator using 0.8 M HCl as eluent 
 
 
Figure 4.5: Elution profile of 68Ge/68Ga generator using 1.0 M HCl as eluent 
 
 
Figure 4.6 below represents the combined elution profiles of the various eluents containing 
different concentrations of HCl. 
 
 
Figure 4.6: Combined elution profiles of 68Ge/68Ga generator using various HCl concentrations as eluents 
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4.4.2 Determination of the elution efficiency (yield) 
The elution yield of the generator increased steadily with an increase in the concentration of 
the HCl eluent. The elution yield was the lowest (18 %) when the generator was eluted with 
0.2 M HCl, and increased to 66 % with 0.4 M HCl, 99 % with 0.6 M HCl, 118 % with 0.8 M 
HCl and 126 % with 1.0 M HCl.  
 
4.4.3 Determination of 68Ge breakthrough 
The 68Ge breakthrough was the lowest at 0.004 % when eluting the generator with 0.2 M HCl, 
then remained the same (0.008 %) when eluting with 0.4 M and 0.6 M HCl. There was 
however a radical increase in the 68Ge breakthrough when using 0.8 M HCl (0.591 %) and 1.0 
M (0.62 %) as eluents. 
 
4.4.4 Determination of metal contaminants  
The metal contaminants (with the exception of Fe) were consistently lowest when eluting with 
0.2 M HCl. The Fe content was fairly consistent with no particular trend and was 0.32 ppm 
when 0.2 M HCl was used as the eluent, 0.34 ppm for 0.4 M HCl, 0.39 ppm for 0.6 M HCl, 
0.23 ppm for 0.8 M HCl and 0.34 ppm for 1.0 M HCl. 
 
The Zn content increased consistently with the increase in HCl concentration of the eluents 
with the lowest Zn content (0.42 ppm) using 0.2 M HCl as eluent, 1.35 ppm for 0.4 M HCl, 
1.55 ppm for 0.6 M HCl, 1.67 ppm for 0.8 M HCl and 2.31 ppm for 1.0 M HCl. 
 
The Ga content remained fairly constant between 0.2 M – 0.6 M HCl concentration of the 
eluents (0.15 ppm – 0.17 ppm) and then increased consistently to 0.40 ppm for 0.8 M HCl and 
0.47 ppm for 1.0 M HCl. 
 
There was no Cu present in any of the 68Ga eluates from the different eluent HCl 
concentrations except for the 1.0 M HCl (0.03 ppm). 
 
4.5 Discussion 
The elution profiles (Figures 4.1 – 4.6) show that the 68Ga activity eluted (generator elution 
yield) decreased consistently when using lower HCl concentrations as eluents. This result 
concurs with the study of de Blois et al. (2011), which showed that elution with 0.6 M HCl 
resulted in 25 % less activity than elution with 1 M HCl. The elution yield results of the current 
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study show that an HCl concentration of 0.2 M HCl resulted in an extremely low  
18 % elution yield, while concentrations of 0.6 M and upwards resulted in average elution 
yields above 99 % with the maximum of 126 % with 1.0 M. Activities in excess of 100 % 
were due to the double-loading of 68Ge onto the generator column and the expression of eluted 
activity as a percentage of the nominal 68Ge activity. The study by Loc’h et al. (1980) found 
the elution yield to be 78 – 80 %, using 1 M HCl as eluent, while 75 % of the generator activity 
was eluted in 2.5 ml eluate. Aardaneh and Van der Walt (2006) found that 3 ml 1 M HCl 
eluted more than 95 % of available activity (65 % of total 68Ga on the double-loaded column). 
Das et al. (2013) found the elution yield to be 65 % after initially loading the 68Ge activity but 
dropped to about 55 % after 200 days. Rossouw and Breeman (2012) found that 95 % of the 
total 68Ga activity eluted in the first 4 ml 0.6 M fraction. Due to the different calculation 
methods used, the elution yield data given for some of the other studies cannot be directly 
compared with those obtained in this study, in which the iThemba LABS generator was used, 
and are therefore only given for the record. 
 
In this study, the 68Ge breakthrough increased consistently with increase in HCl concentration 
as an eluent. The 68Ge breakthrough was lowest when eluting the generator with 0.2 M HCl 
(0.004 %) and 0.008 % when using both 0.4 M and 0.6 M as eluents. However, the 68Ge 
breakthrough increased dramatically to 0.591 % and 0.620 % when eluting with 0.8 M and 
1.0 M HCl respectively. This result is in contrast with that of Das et al. (2013), in which the 
68Ge breakthrough was 0.023 % after 140 elutions, using 1 M HCl as eluent. These contrasting 
results could probably be attributed to differences in the generator column matrix preparation. 
Loc’h et al. (1980) also found that the stronger acidity of the eluent resulted in greater 68Ga 
activity eluted but also a greater 68Ge contamination (the 68Ge contamination was 10-4 % per 
elution in 1.0 M HCl). In the study by Aardaneh and Van der Walt (2006), the breakthrough 
of 68Ge was found to be 6.1 x 10-4 % (in 1.0 M HCl). De Blois et al. (2011) found that the 68Ge 
activity in the eluates remained constant when eluting the generator with lower concentration 
eluents.  
 
The eluates from the different eluents (0.2 M to 1.0 M) contained only small quantities (< 3.2 
ppm) of the total quantity of metal ions tested and increased consistently with increasing HCl 
molarity. The concentration of the total metals was lowest in the 0.2 M HCl eluate and 
increased consistently with increase in HCl concentration of the eluent. Of all the metals 
tested, Zn is the only one to increase consistently with increasing molarity of HCl, and is 
therefore by far the main contributor to the increase of total metals with increase in HCl 
Stellenbosch University  https://scholar.sun.ac.za
 
 
34 
concentration of the eluent. The relatively low levels of Fe and, especially Cu, obtained in this 
study, are very important considering the findings by Oehlke et al. (2013). According to their 
findings, Cu2+ and Fe3+ are the metal cations with the strongest competitive behaviour for 
Ga3+ in the radiolabelling of DOTA-peptides. When 68Ga eluates are not pre-purified, high 
levels of Cu2+ and Fe3+ could lead to lower labelling yields. High Zn2+ levels have a much 
lower effect in this respect. Loc’h et al. (1980) also tested for metal contaminants (Sn, Ba, Co, 
Cr, Fe, Hg, Sb and Zn) in 5 ml 1 M HCl eluate. The highest metal contamination was from 
Sn (0.5 µg/ml), then Fe (0.18 µg/ml) and Zn (0.16 µg/ml). In the study by de Blois et al. 
(2011), concentrations of Ga, Ge, Zn, Ti, Sn, Fe, Al and Cu were determined only for the 0.6 
M HCl eluates. They found that metal ions in the eluate were always < 10 ppm and for Zn < 
3 ppm and for all the other metals < 1 ppm. In the study by Das et al. (2013), Sn was the only 
metal tested for and found to be 0.03 ppm. Rossouw and Breeman (2012) tested for metal ion 
content (Zn, Fe, Sn, Ti, Cu, Al) using 0.6 M HCl and found the following content in a 1 month 
old generator: Zn (1.33 ppm), Fe (0.24 ppm), Sn (0.24 ppm), Ti (0.08 ppm), Cu (0.02 ppm) 
and Al (0.72 ppm). They found that the metal content did not change significantly over a 
period of 1 year with no significant increase of Sn in eluates over time (SnO2 does not leak 
despite continuous elution with 0.6 M HCl). 
 
The European Pharmacopoeia (2013) specification states that no more than 0.001 % of 68Ge 
should be present in the 68Ga eluate for radiolabelling. 68Ge breakthrough level specifications 
of all producers is less than 0.01 %, but it may be higher, particularly when the generator is 
not eluted daily (de Blois et al., 2011). Metal and 68Ge contamination can be reduced by 
regular elution, elution prior to the synthesis and purification of the eluate or labelled product 
(Velikyan, 2015). Zn ions are present in the eluate because 68Ga decays to 68Zn. 
 
4.6 Conclusion 
An increase in the HCl concentration of the eluent resulted in increasing generator elution 
yields but also higher 68Ge breakthrough, especially with HCl concentrations in excess of 0.6 
M. The latter finding is in contrast with those of a few other investigators. Zn is the only metal 
tested for that shows a consistent increase with increasing HCl concentrations. This could 
affect labelling if eluents contain very high concentrations of HCl and eluates are not pre-
purified, even taking into account that Zn2+ has a lower effect on labelling than metals such 
as Fe3+ and Cu2+. The increased 68Ge breakthrough, resulting from the use of eluents 
containing high concentrations of HCl, could be problematic with regards to radiation safety 
and radioactive waste control. Even if 68Ge can be efficiently excluded from 
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radiopharmaceutical products by means of pre-labelling purification of eluates and/or post-
labelling purification of labelled products, the proper disposal of 68Ge-containing waste 
should still be dealt with. In order to compromise optimal elution yield with minimal 68Ge 
breakthrough, based on the results of this study, 0.6 M HCl should therefore be the eluent of 
choice for a SnO2-based generator. 
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Chapter 5: Optimization of radiolabelling parameters using the fractionated elution method 
5.1 Introduction 
The SnO2-based generator, as well as radiolabelling conditions, using the 0.6 M HCl 
containing eluates, was well described by de Blois et al. (2011), Rossouw and Breeman (2012) 
and Sudbrock et al. (2014), but additional investigation into aspects of radiolabelling with 
68Ga from this generator is required.  
 
De Blois et al. (2011) performed DOTATATE-labelling studies with 68Ga eluted from a SnO2-
based generator, but with maximum reaction volumes of 1.5 ml. Their study was only 
performed with DOTATATE and its main focus was to investigate the characteristics of the 
SnO2 generator and eluate purification with less focus on radiolabelling. Rossouw and 
Breeman (2012) investigated a method to prepare [68Ga]DOTATATE using fractionated, un-
purified 68Ga eluates by maximising the eluted activity for the labelling and adapting existing 
labelling methods to accommodate for the large volume and more acidic eluate. Their study 
also describes a rough optimization of the DOTATATE content of labelling mixtures to ensure 
optimal radiolabelling yields by employing two peptide masses (30 and 50 µg). In this same 
study labelling efficiencies were compared after 2 – 3 days of non-elution of the generator. 
The study by Sudbrock, et al. (2014) on [68Ga]DOTATATE, investigated how factors such as 
the quantity of DOTATATE, addition of Fe3+ salts and the use of sodium acetate buffer 
(instead of HEPES) influence the radiochemical synthesis. Their study was only performed 
with DOTATATE and with peptide masses of 1 – 15 µg in a reaction volume of approximately 
2 ml. 
 
In this investigation, some of the gaps left by the aforementioned investigations were 
addressed, as outlined in section 2.2.2. For this purpose, the three important DOTA-
conjugated somatostatin analogues DOTATATE, DOTATOC and DOTANOC were all 
selected to serve as labelling substrates. The study has the additional value of the labelling 
and subsequent processing of all three of these DOTA-peptides being described together.  
 
5.2 Aim 
The main purpose of this investigation was to determine the influence of various quantities 
(15 – 50 µg) of three DOTA-conjugated peptide ligands (DOTATATE, DOTATOC and 
DOTANOC) on labelling efficiencies and radiochemical yields when labelled with 
fractionated 68Ga eluates obtained from a SnO2-based 68Ge/68Ga generator. Further aims were 
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to investigate the influence of extended heating times (25 minutes versus 15 minutes), as well 
as the heating capabilities of two different heating modes (water-bath versus a heating block) 
on labelling efficiency and yield. A final aim was to determine the influence of various periods 
of non-elution of the 68Ge/68Ga generator on labelling efficiencies, RC yields and metal ion 
content of the 68Ga eluates.  
 
5.3 Materials and methods 
General methods are summarised in chapter 3. This section describes variations and details 
specific to the work described in this chapter. 
 
5.3.1 Elution of the generator  
68Ga was eluted from the 1850 MBq (50 mCi) SnO2-based 68Ge/68Ga generator with 0.6 M 
HCl (see section 3.4.1). The generator was eluted daily on weekdays, except when the 
experiments were performed to assess the effects of various periods (3, 7, 14 and 21 days) of 
non-elution of the generator on the radiolabelling results. For labelling purposes, a 
fractionated elution method was used, and fractions were collected in 10 ml borosilicate glass 
vials. 
 
Elution was conducted in two ways. In method 1, a fraction of 1.5 ml was firstly eluted in a 
pre-elution step, followed by a second fraction of 6.0 ml and finally a third fraction of 
approximately 2.5 ml in a post-elution step. The first and third fractions were not used for 
radiolabelling. The second fraction of 6.0 ml was divided into three 2.0 ml sub-fractions with 
activities ranging from 111 MBq to 630 MBq. These 2 ml fractions were used for the 
radiolabelling of the three peptide ligands immediately after elution.  
 
In method 2, a fraction of 1.5 ml was firstly eluted in a pre-elution step, followed by a second 
single fraction of 2.0 ml (with activities ranging from 1006 MBq to 1169 MBq), and finally a 
third fraction of approximately 6.5 ml in a post-elution step. The second 2 ml fraction was 
used for high activity labelling of only one peptide ligand at a time.  
 
5.3.2 Radiolabelling of the three DOTA-peptide ligands  
The 1 mg/ml DOTA-peptide (DOTATATE, DOTATOC and DOTANOC) stock solutions 
were prepared using ultra-pure pharmaceutical grade water and stored at -20 °C (see 3.3.2). 
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For most experiments, a 2 ml portion of the 6 ml second fraction of the eluate was mixed by 
a vortex action with 575 µl of 2.5 M sodium acetate solution in a glass vial to render a buffered 
mixture at a suitable pH. Various quantities of the three peptide ligands (15, 25, 35 and 50 µg) 
were introduced to the buffered 68Ga activity from their respective stock solutions, the vials 
were sealed and labelling mixtures were heated in a heating block for 15 min at 95 °C. 
Experiments with heating times of 25 min, using 35 µg DOTA-peptide, were also conducted, 
as well as experiments using a water-bath set at 95 °C instead of a heating block. The higher 
activity 2 ml fraction eluted from the generator was buffered in a similar way and 
radiolabelling was conducted using only 35 µg of DOTA-peptide, followed by heating in a 
heating block for 15 min at 95 °C. Radiolabelling experiments were also performed using 
68Ga eluted after various periods of non-elution of the 68Ge/68Ga generator (3, 7, 14 and 21 
days). The eluate fractionation and sub-division of the second fraction was carried out 
similarly to method 1 described above. 
 
5.3.3 Sep-Pak C18 post-radiolabelling purification 
After the heating process, a sample with a maximum volume of 50 µl (depending on the 
radioactivity concentration) was taken from the radiolabelling reaction solution for HPLC 
analysis (see 5.3.4 below). The radiolabelled mixtures were then purified on a 500 mg, 3 cc, 
Sep-Pak C18 cartridge according to the method described in 3.4.2. Sep-Pak purification 
conditions for 68Ga-labelled DOTANOC were established as follows: Radiolabelling mixtures 
(in which 35 µg DOTANOC had been used) were loaded on a pre-conditioned Sep-Pak C18 
cartridge according to the procedure described in 3.4.2. Ethanol:saline mixtures of either 
50:50 or 70:30 were used to collect the labelled DOTATATE in the S2 fraction. 
 
5.3.4 Quality Control 
Radiolabelling efficiency or labelling efficiency was obtained from the HPLC analysis of the 
unpurified labelled product as described in chapter 3. Radiochemical purities of purified 68Ga-
labelled DOTA-peptides were determined by means of HPLC.  
 
For radiochemical yield, refer to 3.4.2. The activities in the collected fractions (S1 and S2), 
as well as the remaining activities in the reaction vial and on the Sep-Pak C18 cartridge were 
measured in a dose calibrator. 
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The Fe, Zn, Ga, Sn and Cu concentrations were determined in the 68Ga eluates after various 
periods of non-elution of the generator. Standard solutions (1 ppm, 5 ppm and 10 ppm) of Fe, 
Zn, Ga, Sn and Cu were prepared as described in section 3.3.5. 
 
5.4 Results 
5.4.1 Elution of the generator  
At the end of 12 months, a total activity of 555 MBq could still be eluted from the generator. 
In method 1 of the elution of the generator, activities in the 2 ml sub-fractions of the eluate 
used for the radiolabelling experiments ranged from 111 MBq to 630 MBq per sub-fraction, 
depending on the age of the generator. This represented a total of approximately 333 MBq to 
1890 MBq activity for the whole 6 ml fraction. The 6 ml fraction comprised of approximately 
95 % of the total activity per elution with each 2 ml sub-fraction further representing about 
32 % thereof. In method 2, activities in the 2 ml main fraction ranged from 1006 MBq to 1169 
MBq. The 2 ml fraction represented a concentrated activity of about 87 % of the total activity 
per elution. 
 
5.4.2 Radiolabelling results  
5.4.2.1 Sep-Pak C18 cartridge conditions for the purification of 68Ga-labelled DOTANOC 
 Purification data for [68Ga]DOTANOC using ethanol:saline 50:50 and 70:30 as eluent, are 
presented in Table 5.1. When 50 % ethanol was used as eluent, the eluted activity of the 
labelled product in the S2 fractions (radiochemical yield) was much lower than the S2 activity 
obtained when 70 % ethanol eluent was used as the eluent (37 – 41 % compared to 75 – 84 
%). The remaining activity on the Sep Pak C18 cartridge (S4) for the ethanol:saline 50:50 was 
about four to five times more than when ethanol:saline 70:30 was used as the eluent (35 – 37 
% compared to 7 – 9 %). 
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Table 5.1: Comparison of Sep-Pak C18 purification data of [68Ga]DOTANOC, obtained 
using eluents with different ethanol:saline volume ratios 
Sep-Pak C18 purification data of [68Ga]DOTANOC, using fractionated 68Ga eluates showing 
single values of decay-corrected activities in various fractions, expressed as percentages of 
starting activities. Radiolabelling conditions: 35 µg DOTANOC in reaction volume 2.61 ml; 
reaction temperature = 95 ˚C; reaction time = 15 min.; S1 = first Sep-Pak fraction collected with 
8 ml saline; S2 (Radiochemical Yield) = second Sep-Pak fraction collected with 0.7 ml 
ethanol:saline [50:50 or 70:30] + 2.25 ml saline; S3 = remaining activity in vial; and S4 = 
remaining activity in Sep-Pak C18 cartridge after collecting S2 
EtOH:saline ratio 
(v/v) 
S1 (%) S2 (%) S3 (%) S4 (%) 
50:50 
10 41 16 35 
13 37 14 35 
7 41 14 37 
70:30 
3 81 5 9 
3 84 4 7 
6 75 8 9 
 
5.4.2.2 Peptide ligand content 
Radiolabelling efficiency and Sep-Pak C18 purification data of the three 68Ga-labelled 
DOTA-peptides, using fractionated 68Ga eluates from a 68Ge/68Ga generator are presented in 
Table 5.2. The results present data on radiochemical yields (second fraction, S2) as a function 
of the molar concentration of DOTATATE, DOTATOC and DOTANOC used. Percentage 
activities present in the first washout fraction (S1), as well as retained activity in the reaction 
vial (S3) and on the C18 cartridge post desorption (S4) are also given. 
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Table 5.2: Radiolabelling efficiency and Sep-Pak C18 purification data of 68Ga-labelled 
DOTA-peptides, using fractionated 68Ga eluates from a 68Ge/68Ga generator 
 Radiolabelling efficiency and Sep-Pak C18 purification data of 68Ga-labelled DOTA-peptides, 
using fractionated 68Ga eluates from a 68Ge/68Ga generator, showing mean values of decay-
corrected activities in various fractions, expressed as percentages of the starting activity (111 – 
630 MBq or 1006 – 1169 MBq*). Radiolabelling conditions: 15 – 50 µg DOTA-peptide in 
reaction volume 2.59 – 2.63 ml; reaction temperature = 95 ˚C; reaction time = 15 min.; n = 
number of experiments; S1 = first Sep-Pak fraction collected with 8 ml saline; S2 
(Radiochemical Yield) = second Sep-Pak fraction collected with 0.7 ml ethanol:saline [50:50 or 
70:30 for DOTANOC] + 2.25 ml saline; S3 = remaining activity in vial; S4 = remaining activity 
in Sep-Pak C18 cartridge after collecting S2 
Peptide 
Peptide 
mass 
(µg) 
Peptide 
molar 
conc. 
(µM) 
Labelling 
efficiency 
(%) 
S1 
(%) 
S2  
(%) 
S3 
(%) 
S4 
(%) 
DOTATATE 
15 
(n=5) 4.0 84 ± 13 11 ± 10 55± 16 22 ± 9 9 ± 1 
25 
(n=6) 6.7 94 ± 5 5 ± 2 71 ± 4 17 ± 4 6 ± 3 
35 
(n=6) 9.3 97 ± 1 3 ± 1 72 ± 5 16 ± 4 8 ± 3 
35* 
(n=3) 9.3 98 ± 1 3 ± 1 75± 3 13 ± 2 8 ± 4 
50 
(n=4) 13.3 98 ± 1 3 ± 1 68 ± 4 20 ± 5 8 ± 2 
DOTATOC 
15 
(n=5) 4.1 80 ± 19 15 ± 15 56 ± 20 22 ± 8 6 ± 2 
25 
(n=6) 6.8 97 ± 2 4 ± 2 71 ± 4 17 ± 4 7 ± 2 
35 
(n=6) 9.4 97 ± 1 3 ± 2 75 ± 7 11 ± 4 9 ± 4 
35* 
(n=3) 9.4 99 ± 1 3 ± 1 73 ± 3 14 ± 3 10 ± 1 
50 
(n=4) 13.4 98 ± 1 2 ± 1 77 ± 3 13 ± 2 7 ± 2 
DOTANOC 
15 
(n=5) 4.0 56 ± 30 26 ± 23 34 ± 27 29 ± 11 9 ± 2 
25 
(n=3) 6.6 97 ± 1 3 ± 1 69 ± 5 17 ± 4 6 ± 4 
35 
(n=5) 9.2 96 ± 1 3 ± 2 76 ± 4 11 ± 4 6 ± 2 
35* 
(n=3) 9.2 100 ± 1 2 ± 0 71± 6 15 ± 2 11 ± 5 
50 
(n=4) 13.1 98 ± 2 3 ± 2 74 ± 3 17 ± 2 7 ± 1 
 
Statistically, there was a significant impact by the various peptide masses/molar 
concentrations on the labelling efficiencies of the three DOTA-peptides (p = 0.02) (see Figure 
5.1), particularly in case of the 4 µM DOTA-peptide concentration (15 µg in 2.59 ml). 
Labelling efficiencies for the three DOTA-peptides were all similar for all peptide masses, 
except for DOTANOC when 15 µg was used. The reason for this miss-match result is not 
clear. The use of 4 µM (15 µg) DOTA-peptide resulted in the lowest radiolabelling efficiency, 
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an average of 84 % with DOTATATE, 80 % with DOTATOC and 56 % with DOTANOC. 
This also resulted in the lowest and most inconsistent radiochemical yields (55 % for 
DOTATATE, 56 % for DOTATOC, 34 % for DOTANOC) and the highest retained activity 
on the glass vial with an average of 22 % for both DOTATATE and DOTATOC and 29 % 
for DOTANOC. A DOTA-peptide molar concentration of 6.6 – 6.8 µM (25 µg in 2.60 ml) 
resulted in labelling efficiencies of 94 – 97 %, with concurring radiochemical yields of 69 – 
71 %. A DOTA-peptide molar concentration of 9.2 – 9.4 µM (35 µg in 2.61 ml) resulted in 
labelling efficiencies consistently above 95 %, with concurring radiochemical yields of 72 – 
76 %. A similar result was obtained when using a higher activity 68Ga eluate fraction (elution 
method 2), except for DOTANOC where a slightly lower yield of 71 % was obtained. A 
DOTA-peptide molar concentration of 13.1 – 13.4 µM (50 µg in 2.625 ml) consistently 
resulted in labelling efficiencies of 98 % with concurring radiochemical yields of 68 – 77 %. 
The difference in the radiochemical yields obtained from the different peptide masses/molar 
concentration was found to be statistically significant (p = 0.000) particularly with 15 µg (4 
µM). The mass/molar concentration of 35 µg (9.2 – 9.4 µM) resulted in the highest 
radiochemical yield (see Figure 5.2). Combined data were presented in Figure 5.2 because 
there was no statistically significant difference between the three DOTA-peptides for the 
impact of various peptide masses/molar concentrations on the radiochemical yields.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1: Radiolabelling efficiency profile for various masses of three DOTA-peptides  
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Figure 5.2: Radiochemical yield profile for various masses of three DOTA-peptides, providing combined 
data 
 
5.4.2.3 Reaction heating time and comparison of heating methods 
The influence of extended reaction (heating) times (25 min versus 15 min) on labelling yields, 
radiochemical yields, and other parameters, is displayed in Table 5.3. The average labelling 
efficiency for DOTATATE was the same (97 %) for both 15 and 25 min, for DOTATOC it 
was slightly higher for 15 min (97 % compared to 96 %) and only for DOTANOC it was 
slightly higher for 25 min (98 % versus 96 %). The radiochemical yield (S2) however, was 
consistently marginally higher for all three DOTA-peptides for the 25 min heating time (p = 
0.006) (see Figure 5.3). 
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Table 5.3: Influence of two different reaction times on radiolabelling results of 68Ga-
labelled DOTA-peptides 
Radioabelling efficiency and Sep-Pak C18 purification data after labelling fractionated 68Ga 
eluates and 35 µg DOTA-peptide, comparing 25 min versus 15 min heating time, showing mean 
values of decay-corrected activities in various fractions, expressed as percentages of the starting 
activity, number of experiments given within brackets; S1 = first Sep-Pak fraction collected with 
8 ml saline; S2 (Radiochemical Yield) = second Sep-Pak fraction collected with 0.7 ml 
ethanol:saline [50:50 or 70:30 for DOTANOC] + 2.25 ml saline; S3 = remaining activity in vial; 
and S4 = remaining activity in Sep-Pak C18 cartridge after collecting S2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Determined by means of HPLC 
 
Radiolabelling results are compared for different heating methods (water-bath and heating 
block) in Table 5.4 and show no significant difference between the two methods. For two of 
the DOTA-peptides (DOTATATE and DOTANOC), the radiolabelling efficiency was 
slightly higher using the water-bath compared to the heating block. The average radiochemical 
yield (S2) for DOTATATE was also slightly higher for the water-bath experiments (75 % 
compared to 71 %), slightly higher for DOTATOC (73 % compared to 72 %) and the same 
for DOTANOC (76 %). The remaining activity on the vial for the heating block experiments 
was slightly lower for DOTATOC and DOTANOC (13 % compared to 11 % for both DOTA-
peptides) and slightly higher for DOTATATE (16 % compared to 12 %). 
  
 
Peptide 
 
Reaction 
time 
(min) 
*Labelling 
efficiency 
(%) 
S1 
(%) 
S2 
(%) 
S3 
(%) 
S4 
(%) 
DOTATATE 
 
15 
(n=5) 
97 ± 1 
 
3 ± 1 
 
71 ± 4 
 
16 ± 3 
 
8 ± 3 
 
25 
(n=4) 
97 ± 2 
 
2 ± 1 
 
75 ± 6 
 
15 ± 1 
 
8 ± 4 
 
DOTATOC 
 
15 
(n=5) 
97 ± 1 
 
3 ± 2 
 
72 ± 4 
 
12 ± 4 
 
9 ± 4 
 
25 
(n=5) 
96 ± 1 
 
3 ± 1 
 
77 ± 3 
 
12 ± 3 
 
7 ± 2 
 
DOTANOC 
 
15 
(n=5) 
96 ± 1 
 
3 ± 2 
 
76 ± 4 
 
11 ± 4 
 
6 ± 2 
 
25 
(n=5) 
98 ± 1 
 
2 ± 1 
 
82 ± 5 
 
9 ± 6 
 
6 ± 2 
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Table 5.4: Influence of two different heating methods on radiolabelling results of 68Ga-
labelled DOTA-peptides 
Radiolabelling efficiency and Sep-Pak C18 purification data of 68Ga-labelled DOTA-peptides, 
using fractionated 68Ga eluates and 35 µg DOTA-peptide, comparing 15 min heating time 
(reaction time) in a water-bath versus 15 min heating time (reaction time) in a controlled heating 
block, showing mean values of decay-corrected activities in various fractions, expressed as 
percentages of the starting activity, number of experiments given within brackets; S1 = first Sep-
Pak fraction collected with 8 ml saline; S2 (Radiochemical Yield) = second Sep-Pak fraction 
collected with 0.7 ml ethanol:saline [50:50 or 70:30 for DOTANOC] + 2.25 ml saline; S3 = 
remaining activity in vial; and S4 = remaining activity in Sep-Pak C18 cartridge after collecting 
S2 
 
 
 
 
 
 
 
 
*Determined by means of HPLC 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.3: Radiochemical yield profile for 35 µg DOTA-peptide, using different heating times, providing 
combined data 
Peptide 
Heating 
method 
(15min) 
*Labelling 
efficiency 
(%) 
S1 
(%) 
S2 
(%) 
S3 
(%) 
S4 
(%) 
DOTATATE 
Water-bath 
(n=3) 99 ± 1 3 ± 1 75 ± 2 12 ± 3 10 ± 3 
Heating block 
(n=5) 97 ± 1 3 ± 1 71 ± 4 16 ± 3 8 ± 3 
DOTATOC 
Water-bath 
(n=3) 95 ± 5 7 ± 4 73 ± 6 13 ± 3 6 ± 1 
Heating block 
(n=5) 97 ± 1 3 ± 2 72 ± 4 12 ± 4 9 ± 4 
DOTANOC 
Water-bath 
(n=3) 99 ± 2 3 ± 3 76 ± 1 13 ± 1 5 ± 3 
Heating block 
(n=5) 96 ± 1 3 ± 2 76 ± 4 11 ± 4 6 ± 2 
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5.4.2.4 The influence of non-elution of the 68Ge/68Ga generator 
Radiolabelling efficiency and Sep-Pak C18 purification data of 68Ga-labelled DOTA-
peptides, using fractionated 68Ga eluates obtained after various periods (3, 7, 14 and 21 days) 
of non-elution of the 68Ge/68Ga generator are displayed in Table 5.5.  
 
The combined data for the three DOTA-peptides show that there was no major decline in the 
radiolabelling efficiency until 7 days of non-elution, but during the period between 7 and 14 
days there appears to be the most significant decline. Statistically, there was found to be a 
significant difference between the radiolabelling efficiencies of the three DOTA-peptides  
(p = 0.03) after the various periods of non-elution of the generator (see Figure 5.4).  
 
If all three peptides are considered together, there was a statistically significant difference in 
the radiochemical yield over the periods of non-elution of the generator (p = 0.000) (see Figure 
5.5). Between the 0-day and 14-day period there was a steady decline in radiochemical yield 
(74 % to 63 %), but there was no further decline between 14 and 21 days of non-elution. The 
biggest drop in radiochemical yield was apparent between 7 and 14 days of non-elution. There 
was no significant difference between the radiochemical yields of the individual three DOTA-
peptides over the periods of non-elution (p = 0.11) (see Figure 5.6). From the 0 until the 21-
day period there was no major increase in free (un-complexed) 68Ga as shown by the S1 values 
in Table 5.5. Activity retained in reaction vials also appears to remain constant, but there was 
a steady increase in the remaining activity in the Sep-Pak C18 cartridge, especially between 
the 7 and 14-day period. The total metal ion content (11.1 ppm) (see Figure 5.7) as well as the 
Fe and Zn content (1.6 and 5.0 ppm respectively) of the 68Ga eluates was particularly high 
during this period of non-elution (see results in Table 5.6).  
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Table 5.5: Radiolabelling results of 68Ga-labelled DOTA-peptides, using fractionated 68Ga 
eluates obtained after various periods of non-elution of the 68Ge/68Ga generator 
Radiolabelling efficiency and Sep-Pak C18 purification data of 68Ga-labelled DOTA-peptides, 
using fractionated 68Ga eluates obtained after various periods of non-elution of the 68Ge/68Ga 
generator, showing mean values of decay-corrected activities in various fractions, expressed as 
percentages of the starting activity and number of experiments given within brackets. 
Radiolabelling conditions: 35 µg DOTA-peptide in reaction volume 2.61 ml; reaction 
temperature = 95 ˚C; reaction time = 15 min.; n = number of experiments; S1 = first Sep-Pak 
fraction collected with 8 ml saline; S2 (Radiochemical Yield) = second Sep-Pak fraction 
collected with 0.7 ml ethanol:saline [50:50 or 70:30 for DOTANOC] + 2.25 ml saline; S3 = 
remaining activity in vial; and S4 = remaining activity in Sep-Pak C18 cartridge after collecting 
S2 
Peptide No. of days of non-elution 
*Labelling 
effic. (%) S1 (%) S2 (%) S3 (%) S4 (%) 
DOTATATE 
0 
(n=6) 97 ± 1 3 ± 1 72 ± 5 16 ± 4 8 ± 3 
3 
(n=5) 98 ± 1 2 ± 2 73 ± 9 12 ± 7 11 ± 4 
7 
(n=5) 98 ± 1 3 ± 1 70 ± 4 16 ± 4 11 ± 4 
14 
(n=4) 91 ± 10 5 ± 5 59 ± 2 13 ± 4 20 ± 7 
21 
(n=5) 91 ± 6 7 ± 4 60 ± 12 14 ± 3 15 ± 5 
DOTATOC 
0 
(n=6) 97 ± 1 3 ± 2 75 ± 7 11 ± 4 9 ± 4 
3 
(n=5) 97 ± 2 2 ± 2 73 ± 9 12 ± 7 11 ± 4 
7 
(n=6) 96 ± 3 4 ± 3 71 ± 6 14 ± 4 10 ± 3 
14 
(n=5) 96 ± 2 3 ± 2 67 ± 11 11 ± 4 16 ± 11 
21 
(n=4) 95 ± 4 4 ± 4 65 ± 14 12 ± 3 16 ± 8 
DOTANOC 
0 
(n=5) 96 ± 1 3 ± 2 76 ± 4 11 ± 4 6 ± 2 
3 
(n=5) 98 ± 2 4 ± 2 71 ± 4 13 ± 3 10 ± 3 
7 
(n=6) 95 ± 3 5 ± 2 67 ± 11 15 ± 4 14 ± 10 
14 
(n=4) 94 ± 7 4 ± 3 61 ± 5 12 ± 2 21 ± 10 
21 
(n=3) 92 ± 12 3 ± 2 63 ± 15 13 ± 7 19 ± 7 
Combined 
data for 
DOTATATE, 
DOTATOC 
and 
DOTANOC 
0 
(n=17) 97 ± 1 3 ± 2 74 ± 6 13 ± 4 8 ± 3 
3 
(n=15) 97 ± 2 3 ± 2 72 ± 7 12 ± 6 11 ± 3 
7 
(n=17) 96 ± 3 4 ± 2 69 ± 8 15 ± 4 11 ± 6 
14 
(n=13) 94 ± 7 4 ± 3 63 ± 8 12 ± 3 19 ± 9 
21 
(n=12) 93 ± 7 5 ± 4 63 ± 12 13 ± 4 16 ± 6 
*Determined by means of HPLC 
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Table 5.6: Metal ion content of 68Ga eluates obtained after various periods of non-elution 
of the 68Ge/68Ga generator 
Period of 
non-elution 
(days) 
Labelling 
efficiency 
(%) 
Al 
(ppm) 
Fe 
(ppm) 
Sn 
(ppm) 
Zn 
(ppm) 
Cu 
(ppm) 
Total 
Metals 
(ppm) 
3 94 2.0 0.3 1.8 5.7 0.2 10.0 
7 94 2.6 0.6 1.1 1.7 0.1 5.9 
14 79 2.2 1.6 2.2 5.0 0.4 11.1 
21 94 4.2 0.7 1.6 3.4 0.4 10.1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4: Radiolabelling efficiency profile for 35 µg DOTA-peptide for different periods of non-elution 
of the generator, providing combined data 
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Figure 5.5: Radiochemical yield profile for 35 µg DOTA-peptide for different periods of non-elution of the 
generator, providing combined data 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.6: Radiochemical yield profile for three DOTA-peptides (35 µg) for different periods of non-
elution of the generator 
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Figure 5.7: Total metal contaminant profile of 68Ga eluates for different periods of non-elution of the 
generator 
 
 
5.5 Discussion 
Eluate fractionation and sub-division of fractions were employed as a means to introduce 68Ga 
to labelling mixtures. Labelling and post-labelling purification methods were largely based on 
the work done by Rossouw and Breeman (2012), but post-labelling purification procedures 
for radiolabelled DOTANOC was further adapted due to the more lipophilic nature of this 
peptide molecule (Wild, et al. 2003, 2013). The scales of the labelling and the purification 
parameters were slightly downsized in order to facilitate the labelling of all three DOTA-
peptides in a single elution. This study involved a more comprehensive investigation on the 
influence of peptide mass/molar concentration on radiolabelling efficiency and radiochemical 
yields, using all three mentioned DOTA-peptides. Different heating modes of labelling 
mixtures were implemented and extension of the heating period was performed in order to 
observe its impact on the labelling parameters of the DOTA-peptides. The influence of the 
period of non-elution of the generator on radiolabelling efficiencies and radiochemical yields 
was extended to a maximum period of 21 days. These results were related to the metal analysis 
of the eluates.  
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from 3.2 to 5.7 ml and resulted in DOTA-peptide concentrations ranging from 3.9 to 5.5 µM 
when using 30 µg of DOTATATE and 6.7 to 9 µM when using 50 µg DOTATATE. In this 
study labelling was conducted in a smaller volume of approximately 2.6 ml. When using 15 
µg peptide (4 µM molar concentration), this was found to be too low to result in an acceptable 
labelling efficiency and radiochemical yield (see S2, Table 5.2). The use of 25 µg peptide (6.6 
– 6.8 µM molar concentration) resulted in an acceptable but slightly inferior radiolabelling 
result than 35 µg (9.2 – 9.4 µM). These results corroborate the results of Rossouw and 
Breeman (2012) and support the assumption that peptide concentration rather than mass 
should be used as the main influencing parameter on labelling efficiency. It also illustrates the 
advantage of conducting labelling reactions in small volumes in order to avoid the use of 
excessive amount of peptide. The use of 13.1 – 13.4 µM (50 µg) shows no dramatic increase 
in radiolabelling efficiency and radiochemical yield and therefore 35 µg (9.2 – 9.4 µM) 
appears to be optimum under the conditions of this study. When higher specific activity is 
required, the use of 6.6 – 6.8 µM (25 µg) peptide could also suffice. 
 
The nature of the remaining activity on the vial (S3) is unknown but it is possibly un-reacted 
68Ga and not labelled peptide. This is supported by the fact that these S3 values are generally 
lower when using higher concentrations of DOTA-peptides, while the S1 values also drop 
accordingly. The use of higher peptide concentrations (50 µg, 13 µM), however, could not 
further reduce S3 values. The use of alternative types of reactor vials for radiolabelling of 
peptides might be worthwhile investigating.  
 
The use of 2 ml eluate for the radiolabelling of DOTA-peptides in this study originated from 
a practical point of view, i.e. to facilitate the simultaneous labelling experiments on three 
peptides with a single elution (elution method 1). In a real case scenario where probably only 
one peptide at a time will be labelled under similar conditions, the main eluted fraction volume 
will be only 2 ml instead of 6 ml (elution method 2). This would mean that a smaller 
percentage of total eluted activity would be used to label a peptide (approximately 87 %), but 
the activity (and therefore the concentration) will be higher. A few labelling experiments with 
higher activity were therefore also performed, using elution method 2 and only one peptide 
mass of 35 µg. The higher activity labelling results compare favourably with the lower activity 
(35 µg) results, as shown in Table 5.2.  
 
The HPLC method used in this study was based on gradient elution, whereas the European 
Pharmacopoeia describes an isocratic method. The rationale for using a gradient elution 
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method in this work was mainly to obtain a good separation between free 68Ga and labelled 
peptide, allowing at the same time a relatively fast elution of the latter, and not really to resolve 
probable impurity peaks. Nevertheless, no significant traces of radiochemical impurities or 
side-products were detected in HPLC chromatograms of unpurified labelling mixtures, 
applying the gradient elution method used in this study.  Such impurities were not even 
detected in labelling reactions involving high activity labelling, using 1006 – 1169 MBq 
starting activities. Other investigators (Mu et al., 2013) detected radiolytic breakdown 
impurities in 68Ga-labelled DOTATATE with gradient elution when labelling was conducted 
at high activity around 800 MBq, but a flatter gradient was used as opposed to the one used 
in this work. 
 
The Sep-Pak C18 purification method for [68Ga]DOTANOC had to be slightly adapted. The 
results in Table 5.1 show that an eluent ethanol content of 50 % did not suffice for 
[68Ga]DOTANOC due to the low radiochemical yields (approximately 40 %) with 
accompanying high remaining activity in the Sep-Pak C18 cartridge S4 (approximately  
36 %). An eluent with an ethanol content of 70 % resulted in acceptable radiochemical yields 
of about 80%. Further investigation of eluents containing higher percentages of ethanol, was 
not done in order to avoid excessive levels of ethanol in the purified labelled product. 
 
The slightly superior radiolabelling result of 68Ga-labelled DOTA-peptides for 25 min versus 
15 min heating/reaction time is no real advantage due to activity loss to decay. None of the 
heating modes appear to be superior to the other (see Tables 5.3 and 5.4). 
 
A period of three days of non-elution of the 68Ge/68Ga generator had no dramatic effect on 
labelling efficiency and radiochemical yield. This is in agreement with the results presented 
by Rossouw and Breeman (2012). A 7-day non-elution period resulted in a slight drop, while 
a 14-day period resulted in the biggest drop in radiochemical yield. The increased Fe content 
after 14 days of non-elution (see Table 5.6) coincides with a drop in radiochemical yields, 
especially in the case of DOTATATE (Table 5.5). This concurs with the study performed by 
Oehlke et al. (2013) on the influence of, amongst others, Cu2+ and Fe3+ on 68Ga-labelling of 
DOTATATE, which found that the metal ion/ligand ratio plays a critical role on labelling 
efficiency. There is no clear explanation for the variability in the metal content in eluates over 
time (Figure 5.7). The decrease in yield and increase in activity retained by the Sep-Pak C18 
cartridge appear to go hand in hand. According to Oehlke et al. (2016) higher quantities of 
Fe3+ could lead to the formation of Fe3+ colloids that can bind Ga3+. The retained activity on 
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the Sep-Pak cartridge could therefore most likely be colloidal-bound Ga3+, causing a decrease 
in radiochemical yield. This theory is further supported by the fact that free (un-complexed) 
68Ga washout from the Sep-Pak C18 cartridge remains fairly unchanged during extended 
periods of non-elution. 
 
5.6 Conclusion 
For all three DOTA-peptides, a molar concentration of 9.2 – 9.4 µM (35 µg in 2.61 ml) was 
found to be the optimum to ensure radiolabelling efficiencies consistently greater than 95 % 
and average radiochemical yields above 70 %. Extended heating periods and the use of various 
heating modes offer no advantage in terms of obtaining higher radiochemical yields. Results 
also suggest that radiochemical yields close to 70 % can still be achieved if generators are left 
non-eluted for up to 7 days. Even after 21 days of non-elution of the 68Ge/68Ga generator, 
average radiolabelling efficiencies were above 90 % and average radiochemical yields in 
excess of 60 %. The purification of [68Ga]DOTANOC on Sep-Pak C18 cartridges requires 
only a slight adjustment on the ethanol content of the eluent.  
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Chapter 6: Development and evaluation of user-friendly single vial DOTA-peptide kit 
formulations, using the fractionated elution method 
The work described in this chapter was published online on 24 March 2017 in Molecular Imaging 
and Biology Volume 19, pp 817-824 (DOI 10.1007/s11307-017-1077-7). 
 
6.1 Introduction 
In order to improve the user-friendliness of the 68Ga labelling process, there is a need to 
develop stable kit formulations based on optimized labelling methods. This allows instant 
preparation of 68Ga-labelled DOTA-peptides within a radiopharmacy environment. A kit for 
radiopharmaceutical preparation is usually contained in a vial and production of the 
radiopharmaceutical preparation may require additional steps such as heating.  
 
Various reports on the preparation and use of kits for DOTA-peptide labelling have been 
published. In most of these reports, kit formulations were based on the use of 68Ge/68Ga 
generators eluted with relatively low concentrations of HCl (0.1 M) (Mukherjee et al., 2014a, 
2014c). The stability of the kits was investigated over a 4-month period (Mukherjee et al., 
2014a). In another study (Mukherjee et al., 2014b) freeze-dried DOTATATE kits for 
radiolabelling with both 68Ga (eluted with 0.1 M HCl) and 177Lu were formulated as a 
theranostic radiopharmaceutical preparation and were evaluated over a period of 6 months. In 
a study by Das et al. (2014), freeze-dried mixed peptide kits of DOTATATE and DOTANOC 
were prepared using equal quantities of the two peptides and sodium acetate as a buffer. Kits 
were freeze-dried and stored at 0 °C. They were used with 68Ga eluted with 0.1 N HCl from a 
TiO2 generator and purified on a cation exchange column. Further purification of the 68Ga-
labelled mixed peptide was carried out using Sep-Pak C18 cartridges. The stability of the kits 
during extended storage periods was not reported. A study by Asti et al. (2015) to develop 
and optimise direct labelling of DOTATOC through a kit-based approach was conducted 
using eluates from a TiO2- and a silica-based generator. 
 
Despite the current available literature information on 68Ga-DOTA-peptide kit labelling, more 
studies are required. These include the composition of kits that are compatible with the use of 
other types of 68Ge/68Ga generators such as the SnO2-based generator in which eluents with 
higher acidity are generally used, different kit manufacturing procedures, evaluation of kit 
characteristics and stability over extended periods as well as comparison of kit labelling 
results with those of other labelling procedures. This investigation describes the development 
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of vacuum-dried single vial DOTA-peptide (DOTATATE, DOTATOC and DOTANOC) kits, 
formulated with sodium acetate as a buffer and to be used with fractionated 0.6 M HCl eluates 
from a SnO2-based 68Ge/68Ga generator. In addition, it includes the monitoring of 
radiochemical yields of the 68Ga-labelled DOTA-peptides obtained after Sep-Pak C18 
purification, radiolabelling efficiency and other quality control parameters (pH, sterility and 
apyrogenicity) over a 12-month period, as well as a comparison of kit labelling results with 
those of labelling procedures using aqueous DOTA-peptide stock solutions.  
 
6.2 Aim 
The aim of this study was to investigate the feasibility of using pre-prepared kit formulations 
of the three DOTA-peptides in labelling. The development of the single vial DOTA-peptide 
kit formulations was based on the optimized labelling conditions using the fractionated elution 
method (see Chapter 5). The primary aim with these kits containing the peptide and buffer 
was to improve the convenience and user-friendliness of the labelling procedure. The labelling 
and purification method was based on that in which the peptide stock solutions were used. 
 
A secondary aim was to carry out labelling over a period of 12 months in order to establish 
how long such frozen kits could be stored before any deterioration of labelling starts 
happening and to compare the results of kit labelling studies with those using aqueous DOTA-
peptide stock solutions kept frozen at -20 °C for up to 12 months. In addition, some kits were 
stored at room temperature overnight in order to assess the effect of this possible scenario in 
the clinical environment on the labelling results.  
 
6.3 Materials and methods 
General methods are summarised in chapter 3. This section describes variations and details 
specific to the work described in this chapter. 
 
6.3.1 Elution of the generator  
The 68Ga was eluted from an 1850 MBq (50 mCi) SnO2-based 68Ge/68Ga generator with 0.6 
M HCl (see chapter 3). For labelling purposes, fractionated elution was carried out in the 
following way: 1.5 ml was first eluted to be discarded, followed by a second fraction of 6 ml 
and finally a third fraction of 2.5 ml which was also discarded. Fractions were collected in 
sterilized and pre-weighed 10 ml borosilicate glass vials. The middle 6 ml fraction was divided 
into three 2 ml aliquots, which were each used for labelling of the DOTA-peptide. The 
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activities in these aliquots ranged from 602 MBq to 111 MBq depending on the age of the 
generator. 68Ga activities were measured in a dose calibrator. 
 
Elution was also carried out as described in section 5.3.1, elution method 2 in order to assess 
whether more concentrated, higher activity eluates would yield the same labelling results as 
the lower activity eluates. The activity contained in the 2 ml fraction ranged from 1006 MBq 
to 1169 MBq and was used for higher activity labelling of one peptide at a time.  
 
6.3.2 Determination of kit composition parameters, preparation of stock solution and single vial 
kits 
The results obtained following the work described in Chapter 5 were used as a guideline to 
determine the optimum kit composition parameters required for the preparation of DOTA-
peptide kit formulations. These parameters include the optimum quantity of sodium acetate 
trihydrate required for pH adjustment as well as the required optimum mass of DOTA-peptide 
to include in the kit. In these labelling experiments DOTA-peptide stock solutions were used, 
with masses ranging from 15 to 50 µg. It was found that 35 µg of DOTA-peptide was an 
optimal quantity for radiolabelling DOTA-peptides under the conditions of this study. The 
pre-determined mass of sodium acetate trihydrate salt required for the DOTA-peptide single 
vial kits was based on the sodium acetate content of the volume of 2.5 M sodium acetate 
required to adjust the pH of 2 ml 0.6 M HCl to a pH range of 3.5 to 4 suitable for DOTA-
peptide labelling.  
 
DOTATATE, DOTATOC AND DOTANOC stock solutions (1 mg/ml) were prepared as in 
3.3.2. Single vial kits were prepared by mixing 35 µl of the thawed DOTA-peptide stock 
solutions (DOTATATE, DOTATOC and DOTANOC), containing 35 µg of DOTA-peptide, 
with a pre-calculated and pre-weighed mass of 195.5 mg sodium acetate trihydrate salt in 
sterile 10 ml borosilicate glass vials. The unsealed single vial kits were individually vacuum-
dried under sterile conditions in a desiccator connected with a N 726 FT.18 vacuum pump 
(KNF Neuberger Inc., Trenton, USA) for 3 hours at room temperature. The vials were then 
sealed with rubber stoppers and aluminium caps and stored in a freezer compartment at -20 
°C for up to 12 months. Frozen DOTA-peptide stock solutions and single vial kits were 
removed from the freezer and brought to room temperature before being used in each labelling 
process. Three single vial kits (one of each DOTA-peptide) which had been stored for 12 
months at -20 °C, were removed from the freezer and stored at room temperature overnight 
to assess the effect of this likely scenario in the clinical environment on the labelling results.  
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6.3.3 Radiolabelling of the three DOTA-peptide ligands and post-purification process 
When using the DOTA-peptide kit, the 2 ml 68Ga eluate was added to the de-capped 10 ml 
vial containing the DOTA-peptide kit, which was then sealed again with a sterile rubber 
stopper and an aluminium cap. When using the DOTA-peptide stock solution, the 2 ml 68Ga 
eluate was added to a 10 ml vial, followed by 575 µl of 2.5 M sodium acetate solution and 
then 35 µl of DOTA-peptide stock solution (1 mg/ml). In both cases the mixture was 
homogenised for 5 seconds by means of gentle swirling in a vortex mixer and the vial 
containing the labelling mixture was heated for 15 minutes in a controlled heating block at 
95°C. The radiolabelled DOTA-peptide reaction mixture was removed from the heating block 
and homogenised again by means of gentle swirling in a vortex mixer. An aliquot was 
removed for HPLC testing before the reaction mixture was transferred onto a purification unit 
consisting of a 500 mg C18, 3 cc, Sep-Pak cartridge. See 3.4.2 for the post-radiolabelling 
purification process.  
 
6.3.4 Quality Evaluation of the DOTA-peptide kits and the DOTA-peptide stock solution 
The quality and stability of the DOTA-peptide single vial kits, as well the DOTA-peptide 
stock solution was evaluated at monthly intervals over a 12-month period as described below. 
 
6.3.4.1 Radiolabelling efficiency and radiochemical yield  
Radiolabelling efficiency or labelling efficiency (LE) was obtained from the HPLC analysis 
of an un-purified labelling mixture as described in chapter 3. Radiochemical purities of 
purified 68Ga-labelled DOTA-peptides were determined by means of HPLC.  
 
For radiochemical yield, refer to 3.4.2. The activities in the collected fractions (S1 and S2), 
as well as the remaining activities in the reaction vial and on the Sep-Pak C18 cartridge were 
measured in a dose calibrator. 
 
Radiolabelling efficiency and radiochemical yields of the 68Ga-labelled DOTA-peptides from 
the single vial kits and stock solutions were monitored over a one-year period.  
 
6.3.4.2 Microbiological evaluation 
Sterility testing on the DOTA-peptide stock solution and kits was performed before labelling 
according to the methods prescribed in the European Pharmacopeia (2013). A total of six 
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samples of the DOTA-peptide single vial kits and six aliquots of 35 µl DOTA-peptide stock 
solution were tested. These samples (DOTA-peptide kits and 35 µg DOTA-peptide stock 
solution dissolved in sterile 2 ml 0.6 M HCl) were analysed for bacterial growth. The sterile 
2 ml 0.6 M HCl was used instead of 2 ml 0.6 M HCl 68Ga eluate to closely represent the eluate 
that would be added to the kit but avoid false negative results that may occur due to the 
presence or the 68Ga. See 3.4.4 for further details of the sterility testing. 
 
Endotoxin testing was performed on the 68Ga eluate, the DOTA-peptide kit and 35 µg DOTA-
peptide stock solution dissolved in sterile 0.6 M HCl according to the European 
Pharmacopoeia (2013) using the chromogenic method (see 3.4.5).  
 
6.3.4.3 pH  
The pH value of the DOTA-peptide kits dissolved in 2 ml 0.6 M HCl eluate was determined 
using pH indicator strips (Merck, Darmstadt, Germany). For the DOTA-peptide stock 
solutions, the pH value of the 2 ml 0.6 M HCl eluate mixed with 35 µl DOTA-peptide stock 
solution and 575 µl 2.5 M sodium citrate solution was determined. 
 
6.4 Results 
6.4.1 Pre-studies 
The activity in the aliquots used in the radiolabelling experiments ranged from 111 MBq to 
602 MBq. The radiolabelling results obtained with the different peptide masses showed that 
the radiolabelling efficiency with 15 µg of DOTA-peptide were less than 85%, the 
radiolabelling efficiencies with 35 µg were consistently higher than 95 % and the results with 
50 µg were not significantly higher than 95 % (see Chapter 5). Based on these results, 35 µg 
of DOTA-peptide was used in the formulation of the kits and for all the radiolabelling 
experiments. The inclusion of 195.5 mg sodium acetate trihydrate salt as buffer in the kit 
formulation ensured a radiolabelling mixture (after the addition of 2 ml 68Ga eluted from the 
generator with 0.6 M HCl) with a consistent pH of 3.5 – 4.0. The radiolabelling process of 
heating the reaction mixture in a controlled heating block at 95 °C for 15 minutes resulted in 
a consistent radiolabelling efficiency above 95 % when the optimum DOTA-peptide mass and 
sodium acetate buffer was used. 
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6.4.2 Quality Evaluation of the DOTA-peptide kits and the DOTA-peptide stock solution 
6.4.2.1 Radiolabelling efficiency and radiochemical yield 
During the 12-month period, if all three peptides are considered together, there was a 
statistically significant difference in the radiolabelling efficiencies (determined by HPLC) for 
the DOTA-peptide kits compared to the stock solutions (p = 0.01). The difference between 
the DOTATATE and DOTATOC kits compared to the stock solutions was significant, 
however the difference between the radiolabelling efficiencies of the DOTANOC kits and 
stock solutions was not (p = 0.08) (see Figure 6.1). At 11 – 12 months, radiolabelling 
efficiency results on pre-purified 68Ga-labelled DOTA-peptides, obtained from DOTA-
peptide single vial kits were consistently above 95 %, with the exception of one result (93 % 
for DOTANOC) (see Table 6.1). Similar results were obtained when using DOTA-peptide 
stock solutions. The average radiolabelling efficiency of 68Ga-labelled DOTA-peptides 
obtained from the DOTA-peptide single vial kits at the end of the 12-month storage period 
was the same as the average obtained from the DOTA-peptide stock solution after the same 
period (96 %) (see Figure 6.2). 
 
Table 6.1: Comparison of radiolabelling efficiency of DOTA-peptide kits and stock 
solutions 
HPLC pre-purification radiolabelling efficiency results are shown for 68Ga-DOTA-peptides 
obtained from DOTA-peptide single vial kits and DOTA-peptide stock solutions, stored for 
various periods at -20 ˚C 
DOTA-peptide kits DOTA-peptide stock solution 
Peptide 
Storage 
Period 
Radiolabelling efficiency (%) 
DOTATATE DOTATOC DOTANOC DOTATATE DOTATOC DOTANOC 
1-2 months 99.5 (n=4) 99.8 (n=4) 100 (n=4) 95.5 (n=2) 96.3 (n=3) 95.5 (n=2) 
3-4 months 98.3 (n=4) 99.5 (n=4) 99.5 (n=4) 97.8 (n=4) 97.7 (n=3) 97.0 (n=2) 
5-6 months 100 (n=4) 98.8 (n=4) 95.0 (n=4) 97.0 (n=3) 96.3 (n=4) 98.3 (n=3) 
7-8 months 98.7 (n=3) 99.8 (n=4) 98.7 (n=3) 96.5 (n=3) 97.0 (n=3) 98.5 (n=3) 
9-10 months 98.5 (n=2) 99.0 (n=2) 96.0 (n=2) 95.0 (n=2) 97.0 (n=2) 96.0 (n=2) 
11-12 months 96.5 (n=2) 97.7 (n=3) 93.0 (n=3) 96.0 (n=2) 96.0 (n=2) 97.3 (n=3) 
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Figure 6.1: Radiolabelling efficiency profile of DOTA-peptide kits and stock solutions 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.2: Radiolabelling efficiency profile of DOTA-peptide kits and stock solutions during a 12-month 
period 
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DOTA-peptide kits ranged from 73 – 83 % and were similar for all three DOTA-peptides (see 
Table 6.2). No obvious decline in the radiochemical yields was observed over a 12-month kit 
storage period. Radiochemical yields obtained using stock solutions of 35 µg DOTA-peptide 
ranged from 64 – 79 % (see Table 6.3). The average radiochemical yield obtained from the 
kits after a 12-month storage period was 76 % compared to 67 % for the DOTA-peptide stock 
solution after the same storage period (see Table 6.4).  
The radiochemical purity post C18 purification was always in the order of 100 % (not 
tabulated). 
 
Table 6.2: Sep-Pak C18 radiochemical yields of 68Ga-DOTA-peptides obtained from single 
vial kits containing 35 µg DOTA-peptide, stored for various periods at  
-20 ˚C  
Kit Storage 
Period at 
-20 ˚C 
Radiochemical Yield (%) Activity lost in reaction vial (%) 
DOTATATE DOTATOC DOTANOC DOTATATE DOTATOC DOTANOC 
1-2 months 77 (n=4) 77 (n=4) 73 (n=4) 9 (n=4) 8 (n=4) 9 (n=4) 
3-4 months 82 (n=4) 74 (n=4) 79 (n=4) 9 (n=4) 11 (n=4) 8 (n=4) 
5-6 months 78 (n=4) 80 (n=4) 73 (n=4) 8 (n=4) 7 (n=4) 9 (n=4) 
7-8 months 79 (n=3) 83 (n=4) 77 (n=3) 8 (n=3) 7 (n=3) 9 (n=3) 
9-10 months 76 (n=2) 74 (n=2) 80 (n=2) 12 (n=2) 12 (n=2) 9 (n=2) 
11-12 months 74 (n=2) 75 (n=3) 78 (n=3) 14 (n=2) 13 (n=3) 8 (n=3) 
 
The average radiolabelling efficiency obtained from three of the kits, which had been stored 
for 12 months at -20 °C, and then overnight at room temperature, was 98 ± 3 % and the average 
radiochemical yield was 72 ± 6 % (results not displayed in table form). 
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Figure 6.3: Radiochemical yield profile of DOTA-peptide kits and stock solutions 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.4: Activity remaining on vial after radiolabelling with DOTA-peptide kits and stock solutions 
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Table 6.3: Sep-Pak C18 radiochemical yields of 68Ga-DOTA-peptides obtained with 35 µg 
DOTA-peptide stock solution 
Age of 
stock 
solution at 
-20 ˚C 
Radiochemical Yield (%) Activity lost in reaction vial (%) 
DOTATATE DOTATOC DOTANOC DOTATATE DOTATOC DOTANOC 
1-2 months 79 (n=2) 79 (n=3) 78 (n=2) 11 (n=2) 8 (n=3) 8 (n=2) 
3-4 months 69 (n=4) 71 (n=3) 76 (n=2) 18 (n=4) 13 (n=3) 15 (n=2) 
5-6 months 67 (n=3) 75 (n=3) 77 (n=3) 16 (n=3) 14 (n=3) 15 (n=3) 
7-8 months 66 (n=2) 69 (n=3) 70 (n=2) 16 (n=2) 16 (n=3) 17 (n=2) 
9-10 months 64 (n=2) 69 (n=3) 68 (n=2) 20 (n=2) 15 (n=3) 16 (n=2) 
11-12 months 67 (n=3) 68 (n=3) 67 (n=3) 20 (n=3) 19 (n=3) 17 (n=3) 
 
6.4.2.2 Microbiological evaluation 
All the samples were found to be clear and sterile with no anaerobic bacterial, aerobic bacterial 
or fungal growth. The endotoxin content of the 68Ga eluates was 1.12 – 1.66 IU/ml, the 
endotoxin content of the radiolabelled DOTA-peptide kits was 1.02 – 1.09 IU/ml (with an 
average of 1.05 IU/ml) and that of the radiolabelled DOTA-peptide stock solution was 1.36 – 
1.97 IU/ml (with an average of 1.65 IU/ml) (see Table 6.4). There was no inhibition of the 
reaction because the maximum dilution volume was determined to be 10. The European 
Pharmacopoeia (2013) specification for bacterial endotoxin is less than 175 IU/V, where V is 
the maximum volume to be used for the preparation of a single patient dose, if intended for 
use in the manufacture of parenteral preparations without a further procedure for the removal 
of bacterial endotoxins. The total volume of the solution (S2) post-purification is 3.55 ml. 
 
6.4.2.3 pH 
The pH values of the DOTA-peptide kit radiolabelling solution as well as the pH of the 
DOTA-peptide stock radiolabelling solutions made up with 2 ml 68Ga eluate were all between 
3.5 and 4.0. 
 
A summary of the quality control results between DOTA-peptide single vial kits and DOTA-
peptide stock solutions after respective storage periods of 12 months at -20 °C is given in 
Table 6.4. 
Stellenbosch University  https://scholar.sun.ac.za
 
 
64 
 
Table 6.4: Averages of the combined quality control results of three DOTA-peptides, 
DOTATATE, DOTATOC, DOTANOC, comparing results obtained from single 
vial kits with those from DOTA-peptide stock solutions after respective storage 
periods of 12 months at -20 °C 
Quality Control Parameters DOTA-peptide kits DOTA-peptide stock solution 
Radiolabelling Efficiency (%) 96 96 
Radiochemical Yield (%) 76 67 
Activity lost in reaction vial (%) 12 19 
Endotoxin Count (IU/ml) 1.05 1.65 
Sterility Sterile Sterile 
pH 3.5 – 4.0 3.5 – 4.0 
 
6.5 Discussion 
In most of the currently available literature studies on DOTA-peptide kit labelling, a titanium 
dioxide (Eckert & Ziegler) or a nanoceria-PAN based generator was employed as the source 
of 68Ga, using 0.1 M HCl as the eluent. In some of these studies (Mukherjee et al, 2014b; Das 
et al., 2014), post-elution processing procedures such as cation exchange purification were 
also employed. Furthermore, various types of buffer agents such as HEPES, ammonium 
acetate or sodium acetate were used. Ammonium acetate was found to be unsuitable because 
the pH changed after lyophilisation of the formulation (Mukherjee et al., 2014a). Kit stability 
was evaluated over a maximum period of only 6 months (Mukherjee et al., 2014b) and found 
to be stable with no significant decrease in the radiochemical yields. 
 
This study focused on DOTA-peptide kits, which were formulated specifically for 
radiolabelling with 68Ga eluted with 0.6 M HCl from a SnO2-based 68Ge/68Ga generator. 
Furthermore, this kit-based approach focused more on improving the user-friendliness of the 
labelling procedure rather than following the approach followed in 99mTc radiopharmaceutical 
kit formulations in which heating and post-labelling purification steps are generally not 
required. A heating step would generally always be required for labelling DOTA-peptides 
with 68Ga, while the latter would be required to remove 68Ge that might be present in non-
purified 68Ga eluates. The DOTA-peptide kits in this study were developed based on results 
from pre-formulation studies (see Chapter 5) and on radiolabelling processes adapted for the 
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larger volume and more acidic 68Ga eluates, using fractionated generator eluates. While 
various buffers such as HEPES have been used in DOTA-peptide radiolabelling studies 
(Mukherjee et al., 2014b), other investigators (Hoffman et al., 2001; Henze et al., 2001; 
Breeman et al., 2005; De Blois et al., 2011; Rossouw and Breeman, 2012; Decristoforo et al., 
2007; Mukherjee et al., 2014a, 2014c; Das et al., 2014) used acetate buffer in their DOTA-
labelling experiments. This buffer type was therefore preferred for this study. The results 
obtained in Chapter 5 show that 575 µl of a 2.5 M sodium acetate buffer solution was 
appropriate to adjust the pH of 2 ml 0.6 M HCl eluate to a pH range of 3.5 – 4.0. The stated 
volume of acetate buffer solution contains 195.5 mg sodium acetate trihydrate salt, which was 
therefore the quantity used in the kit formulation. The use of eluate volumes in excess of 2 ml 
was not investigated in this study, as this would result in a lower pH due to the kit design and 
would therefore most probably result in lower labelling efficiencies. Higher activity can be 
introduced into labelling mixtures by rather using eluates with higher activity concentration, 
as shown in Chapter 5. The results described in Chapter 5 also indicated that 35 µg DOTA-
peptide resulted in labelling efficiencies consistently above 95 % when used in the volume 
range of 2.0 – 2.6 ml. This quantity of DOTA-peptide was therefore used in the kit formulation 
and was added from a pre-prepared 1 mg/ml stock solution to pre-weighed acetate salt. As the 
kit formulation contained only a minimal volume of water (35 µl from the peptide stock 
solution), each single vial kit was only vacuum dried for a relatively short period prior to 
storage at -20 °C compared to the kit studies above (Mukherjee et al., 2014a, 2014b, 2014c) 
which employed lyophilisation instead. The sodium acetate buffer appeared to remain stable 
during and after the vacuum drying process (as suggested by the pH results displayed in Table 
6.4), unlike in the study above (Mukherjee et al., 2014b) where HEPES was used as a buffer 
due to the instability of both ammonium acetate (Mukherjee et al., 2014a, 2014b) and sodium 
acetate (Mukherjee et al., 2014b) buffer both during and after lyophilisation. The kit-based 
radiolabelling process entailed a post-labelling purification on a Sep-Pak C18 reverse phase 
cartridge in order to compare radiochemical yields with those obtained using the more 
conventional stock solution approach. Although the radiochemical purities of labelling 
mixtures before C18 purification (as reflected by the labelling efficiency results) were 
generally high, post labelling purification was still required in order to remove traces of 68Ge 
that are generally still present in fractionated 68Ga eluates. Post labeling purification in kit 
labelling can only be omitted when using pre-purified eluates. The kits were evaluated over 
an extended 12-month period, which according to the investigator’s knowledge, is the longest 
evaluation period reported for in-house DOTA-peptide kit preparation.  
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The radiolabelling and quality control results achieved from the single vial DOTA-peptide 
kits compared favourably and, in some aspects, were even superior to those achieved from the 
DOTA-peptide stock solution. The superior average radiochemical yield for the DOTA-
peptide kits after a 12-month storage period (76 % compared to 67 % for the DOTA-peptide 
stock solution) can largely be attributed to the difference in the activity lost in the reaction 
vial for the DOTA-peptide kits compared to the DOTA-peptide stock solution (p = 0.006) (see 
Table 6.4 and Figure 6.4). The reason for the lower activity loss during kit labelling is not 
entirely clear, but it might be attributed to a slightly higher stability of the DOTA-peptide in 
the kit formulation than in the frozen stock solution. These results demonstrate that the single 
vial DOTA-peptide kits are stable for at least up to 12 months. In the likely clinical scenario 
where the single vial kits may be un-intentionally left outside the freezer overnight (at room 
temperature), the average radiolabelling efficiency of 98% and the average radiochemical 
yield of 72 % demonstrated that the radiolabelling results should not be adversely affected by 
such an action. The average endotoxin count for the DOTA-peptide kits was also lower (1.05 
IU/ml) compared to the DOTA-peptide stock solution (1.65 IU/ml). Based on the 
microbiological evaluation results, the radiolabelled DOTA-peptide kits were found to be 
sterile, pyrogen-free and microbiologically suitable for clinical intravenous application 
according to the European Pharmacopoeia (2013) specifications. 
 
The pH of the DOTA-peptide kits and stock solutions were both between 3.5 and 4.0, which 
fall within the acceptable pH range required for the DOTA-peptide labelling process. 
 
Further improvements to the radiolabelling procedure can be made for quality assurance in a 
clinical environment. These improvements may include adding the 68Ga eluate to the peptide 
by piercing the stopper (instead of de-capping the vial) as well as replace the mixing by vortex 
with a gentle swirling action. 
 
6.6 Conclusion 
After fractional elution, the use of DOTA-peptide single vial kits offers a significant 
advantage in terms of convenience, stability and user-friendliness of the radiolabelling 
procedure. The kit manufacturing procedure described in this study is relatively simple and 
does not require a lyophilisation step. An added advantage is the reduced activity lost during 
C18 purification of the [68Ga]-DOTA-peptide, resulting in slightly higher radiochemical 
yields. The use of the labelling kit formulations (using the fractionated elution method) 
appears to be highly feasible and the quality of the DOTA-peptide kits was found to be 
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superior over DOTA-peptide stock solutions, as reflected by the radiochemical yield results 
obtained after an extended kit storage period. 
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Chapter 7: Concentration and purification of 68Ga eluates on cation exchange resins 
7.1 Introduction 
Despite the favourable radiolabelling results obtained by using fractionated 68Ga eluates (see 
Chapter 5), the relatively large volumes and high concentration of HCl in the fractionated 
eluates (especially when using a SnO2-based generator as source of 68Ga) still complicate the 
direct use thereof in the labelling reactions. In some instances, the use of pre-labelling 
purification of eluates might also be preferred over the post-labelling purification techniques 
to remove traces of 68Ge contaminants. Different alternative pre-labelling processing 
techniques of 68Ga eluates have been developed for radiolabelling DOTA-conjugated 
peptides. They have been described for either semi- or fully automated systems. These 
methods are based on pre-purification and concentration of the 68Ga eluate using either anion 
exchange resins, cation exchange resins or combined cationic/anionic resin purification. 
Anion exchange purification can be somewhat cumbersome as explained in Section 1.7.1, 
while the same could apply to a combined anionic/cationic technique. According to Mueller 
et al. (2012), the cation exchange technique appears to be more favourable. This chapter 
therefore deals exclusively with the use of cation exchange resins. 
 
In the cation exchange concentration and purification method described by Zhernosekov et al. 
(2007), the 0.1 M HCl 68Ga eluate (from a TiO2-based generator) is loaded onto a cation 
exchange resin. Due to the high distribution coefficient, the 68Ga is adsorbed on the resin. The 
column is then eluted with HCl/acetone mixtures (80 % acetone and 0.1 – 0.2 M HCl) to 
remove the Ge4+, Ti4+, Zn2+ and Fe3+ while the 68Ga remains on the resin and is subsequently 
eluted with 400 µl of a 97.6 % acetone/0.05 M HCl solution. This cation-exchange 
purification method results in smaller 68Ga eluate volumes and removes almost all chemical 
and radiochemical impurities including 68Ge. The purified 68Ga eluate can be used for direct 
labelling. A drawback of this method is that it requires the use of acetone, which has to be 
removed from the final formulation because acetone is not approved for intravenous use.  
 
Mueller et al. (2012) described an alternative, user-friendlier cation exchange 
concentration/purification method for 68Ga eluates obtained from a TiO2 generator. This 
method was based on the use of an acidified aqueous sodium chloride (NaCl) solution instead 
of acetone as the desorption agent, using a silica-based strong cation exchange (SCX) 
cartridge. A subsequent labelling method was also described that enables high-efficiency 
labelling of DOTA conjugated peptides in high radiochemical purity (Mueller et al., 2012). 
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The Mueller method used eluates containing 0.1 M HCl, which were directly loaded on the 
SCX resin. 
 
Martin et al. (2014) tested and compared various commercial cation exchange cartridges for 
0.6 M HCl 68Ga eluates from a SnO2 generator adapting the Mueller et al. (2012) method. 
They found that the Chromafix PS-H+ (size M) gave the best overall results for the 68Ga-
trapping efficiency and the efficiency of subsequent 68Ga elution from these cartridges. 
 
This chapter describes investigation into various aspects of the work of Mueller et al. (2012) 
and Martin et al. (2014) in order to identify the best cationic resin and conditions for the 
cationic resin purification of 68Ga eluates obtained from a SnO2-based generator containing 
0.6 M HCl. 
 
7.2 Aim 
The aim of this study was to investigate the concentration and purification of 68Ga eluates 
from a SnO2-based generator on different cation exchange resins, including a silica-based 
Bond Elut SCX 100 mg resin. The ultimate aim was to identify the resin that can optimally 
retain 68Ga in 0.6 M HCl as well as to be able to optimally release the 68Ga with the desorption 
mixture that was described in the Mueller et al. (2012) method. Alternatively, if no resin is 
found to be suitable to fulfil both these criteria, methods would be investigated on how to 
adapt the Mueller method, using eluates in 0.6 M HCl. 
 
7.3 Materials and methods 
General methods are summarised in chapter 3. This section describes variations and details 
specific to the work described in this chapter.  
 
7.3.1 Elution of the generator 
The 68Ga was eluted from an 1110 MBq (30 mCi) SnO2-based 68Ge/68Ga generator with 0.6 
M HCl (see chapter 3). The elution was carried out with 12 ml 0.6 M HCl for the comparative 
resin experiments (see Table 7.1) and 10 ml 0.6 M HCl for the specific SCX resin experiments 
(see Table 7.2 and Figure 7.1). Eluates were collected in borosilicate glass vials. 
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7.3.2 Types of cation exchange resins used 
Comparative experiments were performed using three different commercially available 
cationic resin cartridges (Bond Elut SCX from Agilent Technologies, 100 mg sorbent, 
Chromafix PS-H+ (S) from Machery-Nagel, average 230 mg sorbent, and the Phenomenex 
Strata-X-C Polymeric Strong Cation 100 mg/3 ml) as well as four alternative cationic resin 
cartridges prepared in-house (AG 50W-X2, AG 50W-X4, AG 50W-X8 and AG MP-50) (see 
also 7.3.3). 
 
7.3.3 Preparation of alternative cation exchange resin cartridges 
Cartridges of the cationic exchange resins, AG 50W-X2 (catalogue number 1421241), AG 
50W-X4 (catalogue number 1421341), AG 50W-X8 (catalogue number 1421451) and AG 
MP-50 (catalogue number 1430841) (all from Bio-Rad, California, United States), were in-
house prepared as follows:  
Four used Bond Elut SCX 100 mg (1 ml) cartridges, catalogue number 12102013, (Agilent 
Technologies, Santa Clara, United States) were emptied of the resin, rinsed, dried and 
individually labelled with the different cation exchange resin names. 100 mg of each resin 
was weighed into the corresponding labelled cartridges. 
 
7.3.4 Concentration of 68Ga eluates on the cation exchange resins (see also 3.4.10) 
The cation exchange resin cartridges were pre-conditioned as described in chapter 3. For the 
specific Bond Elut SCX resin experiments (see Table 7.2 and Figure 7.1), the 10 ml 0.6 M 
HCl 68Ga eluates were either divided into smaller aliquots, which were loaded directly on the 
resin cartridge in separate experiments, or diluted with ultrapure pharmaceutical grade water 
to pre-determined HCl concentrations, then divided into suitable smaller aliquots which were 
subsequently loaded on the resin in separate experiments. For the comparative resin 
experiments (see Table 7.1), the 12 ml 0.6 M HCl 68Ga eluates were not diluted, but divided 
into three 4 ml aliquots for separate experiments. The 4 ml 68Ga eluate was loaded onto the 
pre-conditioned resin cartridge and eluted into a waste vial (Fr1). The resin was run dry and 
eluted with 1 ml water into the same waste vial. This vial was replaced with another vial and 
the 68Ga was eluted from the resin with 0.5 ml of a mixture of 5 M NaCl and 5.5 M HCl 40:1 
(v/v). The resin was run dry into the same vial (Fr2) and the activities of Fr1 and Fr2 as well 
as the residual activity on the resin cartridge were determined. Refer to 3.4.10 for additional 
details. 
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7.4 Results 
The results in Table 7.1 present data on the retention of 68Ga activity in 0.6 M HCl medium 
on different cation exchange resins, as reflected by the eluted activity in the waste vial (Fr1). 
Low activity in the waste implies greater retention of 68Ga on the resin, while higher activity 
implies poorer retention. Data on the subsequent recovery of activity in Fr2, using 0.5 ml of 
a mixture of 5 M NaCl and 5.5 M HCl 40:1 (v/v), is also given. The activity in the waste vial 
Fr1 (average values) was the lowest (2 %) for AG 50W-X8 and Chromafix PS-H+ (S), and 
highest (88 %) for Strata-X-C.  
 
The highest 68Ga activity recovered from the cation exchange resin cartridge (in the second 
eluate fraction Fr2) (average values) was for the Bond Elut SCX (80 ± 1 %). The lowest 68Ga 
activity (4%) in Fr2 was for Strata-X-C due to its low capacity to trap Ga3+ ions. 
 
Table 7.1: Comparison of eluate purification performance of different cation exchange 
resins 
Data on the retention of 68Ga activity in 0.6 M HCl on different cation exchange resins as well 
as the subsequent recovery of activity using 0.5 ml of a mixture of 5 M NaCl and 5.5 M HCl 
40:1 (v/v) 
Type of cation  
exchange resin 
Activity in 
waste Fr1 (%) 
Recovered 68Ga 
 in Fr2 (%) 
Residual Act. in cation 
exchange resin (%) 
AG 50W-X2 
100 mg 
56 15 29 
56 15 28 
64 10 26 
AG 50W-X4 
100 mg 
26 35 44 
25 34 41 
30 30 42 
AG 50W-X8 
100 mg 
2 33 67 
2 37 63 
2 34 68 
AG MP-50 
100 mg 
3 60 36 
6 45 50 
9 45 47 
Bond Elut SCX 
100 mg 
19 80 1 
19 79 2 
18 80 2 
Chromafix PS-H+ (S) 
230 mg 
1 54 45 
2 58 40 
3 51 46 
Strata-X-C 
100 mg 
88 4 8 
88 4 8 
88 4 8 
Stellenbosch University  https://scholar.sun.ac.za
 
 
72 
 
The activity remaining on the cation resin (average values) was the lowest for the Bond Elut 
SCX cartridge (2 ± 0.6 %), followed by Strata-X-C (8 %), then AG 50W-X2 (28 ± 1.5 %), 
followed by the AG 50W-X4 (42 ± 1.5 %), slightly higher for both the AG MP-50 and 
Chromafix PS-H+ (S), (44 ± 7 % and 44 ± 3 % respectively) and highest for the AG 50W-X8 
(66 ± 3 %). 
 
The results in Table 7.2 and Figure 7.1 present data on the influence of HCl molar 
concentration and volume of 68Ga-containing load solutions in HCl on the retention of 68Ga 
activity on the Bond Elut SCX resin. Table 7.2 also presents data on the subsequent recovery 
of activity using 0.5 ml of a mixture of 5 M NaCl and 5.5 M HCl = 40:1 (v/v), as illustrated 
by the activity in Fr2. 
 
In 0.6 M HCl, the eluted activity in the waste vial (Fr1) increased from 2.5 % to 18.4 % as 
the volume of diluted 68Ga aliquot increased from 2 to 4 ml and the activity in Fr2 decreased 
from 95.8 % to 79.9 % accordingly. The activity retained on the Bond Elut SCX cartridge did 
not exceed 1.5 %. 
 
In 0.5 M HCl, the eluted activity in the waste vial (Fr1) increased from 1.5 % to 6.7 % as the 
volume of diluted 68Ga aliquot increased from 3 to 5 ml and the activity in Fr2 decreased only 
slightly from 95.8 % to 91.3 %. The activity retained on the Bond Elut SCX cartridge 
decreased from 2.4 % to 1.8 % 
 
In 0.4 M HCl, the eluted activity in the waste vial (Fr1) remained fairly constant (from 0.2 to 
0.3 %) as the volume of diluted 68Ga aliquot increased from 4 to 6 ml and the activity in Fr2 
remained fairly constant and decreased only slightly from 97.5 % to 96.2 %. The activity 
retained on the Bond Elut SCX cartridge also remained fairly constant and only decreased 
slightly from 2.1 % to 2 %. 
 
In 0.3 M HCl, the eluted activity in the waste vial (Fr1) remained constant (0.4 %) as the 
volume of diluted 68Ga aliquot increased from 2 to 6 ml and decreased to 0.2 % in a volume 
of 8 ml. The activity in Fr2 consistently increased slightly from 96.5 % to 97.8 % as the 
volume of diluted 68Ga aliquot increased from 2 to 8 ml. The activity retained on the Bond 
Elut SCX cartridge decreased consistently from 2.4 % to 1.6 % as the volume of diluted 68Ga 
aliquot increased.  
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Table 7.2: Effect of HCl concentration and volume on eluate purification 
Data on the retention of 68Ga activity in HCl on a Bond Elut SCX cartridge as a function of HCl 
concentration and volume of 68Ga/HCl load solution as well as the subsequent recovery of 
activity using 0.5 ml of a mixture of 5 M NaCl and 5.5 M HCl 40:1 (v/v) 
Vol. of diluted  
68Ga aliquot (ml) 
HCl conc. after 
dilution (M) 
Activity in waste 
vial Fr1 (%) 
Recovered 68Ga 
 in Fr2 (%) 
Residual Activity 
in SCX (%) 
2 0.6 2.5 95.8 1.1 
3 0.6 7.5 90.1 1.5 
4 0.6 18.4 79.9 1.0 
3 0.5 1.5 95.8 2.4 
4 0.5 4.1 93.9 1.8 
5 0.5 6.7 91.3 1.8 
4 0.4 0.2 97.5 2.1 
5 0.4 0.2 97.6 2.0 
6 0.4 0.3 96.2 2.0 
2 0.3 0.4 96.5 2.4 
4 0.3 0.4 97.2 2.0 
6 0.3 0.4 97.5 1.8 
8 0.3 0.2 97.8 1.6 
 
 
 
Figure 7.1: Influence of HCl molar concentration and volume of 68Ga-containing load solutions in HCl on 
the retention of 68Ga activity on a SCX cartridge, as illustrated by the eluted activity in the waste 
vial Fr1. The following load solution volumes (in brackets) were associated with the various 
HCl concentrations: 0.3 M n (2 ml, 4 ml, 6 ml, 8 ml); 0.4 M n (4 ml, 5 ml, 6 ml); 0.5 M n (3 
ml, 4 ml, 5 ml); 0.6 M n (2 ml; 3 ml, 4 ml) 
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7.5 Discussion 
Various cation exchange resins (Bond Elut SCX 100mg, Chromafix PS-H+ (S), Strata-X-C, 
AG 50W-X2, AG 50W-X4, AG 50W-X8 and AG MP-50) were investigated to assess their 
suitability for adsorption of 68Ga in 0.6 M HCl, which is the eluent of choice for the elution 
of 68Ga from a SnO2-based generator. The adsorption abilities of the resins were assessed by 
means of the un-retained activity in the waste vial (Fr1). Based on the 68Ga activities in the 
waste vial, the most suitable resins for the adsorption of 68Ga in 0.6 M HCl appear to be AG 
50W-X8 resin and Chromafix PS-H+ (S) cartridges (2 ± 0 % and 2 ± 1 % respectively), while 
the AG MP-50 resin (6 ± 3 %), the Bond Elut SCX cartridge (19 ± 1 %) and the AG 50W-X4 
resin (27 ± 3 %) show less efficient adsorption in this medium. Strata-X-C resin proved to be 
the least suitable, displaying the most activity in the waste vial (88 %). However, the relatively 
large residual activity in AG 50W-X8 (66 ± 3 %), AG MP-50 (44 ± 7 %), Chromafix PS-H+ 
(S) (44 ± 3 %) and AG 50W-X4 (42 ± 1.5 %) after elution result in lower activities in Fr2 for 
these resins (35 ± 2 %, 50 ± 9 %, 54 ± 4 % and 33 ± 2 % respectively), in other words, less 
68Ga could be recovered from these columns. Martin et al. (2014) found that the Bond Elut 
SCX cartridge (100 mg) displayed a low adsorption efficiency of 7 % compared to this study 
(almost 80 %). They however, used an HCl concentration of 1.0 M as well as bigger volumes 
(10 ml). They did find that the adsorption of 68Ga3+ on this cartridge was influenced by 
different concentrations of HCl, which concurred with this study. They also found that the 
adsorption yield increased from 7 % to 42 % with a larger quantity of resin (Bond Elut SCX 
cartridge 500 mg instead of 100 mg). Martin et al. (2014) also used larger Chromafix PS-H+ 
cartridges (size M with 430 mg resin) with 1 M HCl (10 ml), which resulted in 69 % 
adsorption with a single resin cartridge. The Chromafix PS-H+ (size M) cartridges gave them 
the best desorption results from seven cation exchange cartridges that they tested. They also 
found that the adsorption of the 68Ga3+ on the Chromafix PS-H+ cartridge increased when the 
eluate was diluted with water prior to loading the solution onto the cartridge. In contrast, in 
this investigation 4 ml of 0.6 M HCl was used with Chromafix PS-H+ (S) cartridges containing 
230 mg resin, which resulted in 98 % adsorption. However, in this study the desorption from 
this resin was found to be only about 54 %, compared to the 94 % reported by Martin (2014), 
using HCl/NaCl solution. These results demonstrate how the mass of the cationic resin may 
influence its efficiency at adsorbing and desorbing the 68Ga. Due to the unfavourable results 
in this investigation, Chromafix PS-H+ (S) resin was not selected for further investigation in 
this study. 
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Based on displaying the highest 68Ga activity recovered from the cation exchange column (in 
Fr2) (accompanied with the lowest residual activity on the resin after collection of Fr2, as 
shown in Table 7.1), the Bond Elut SCX cartridge showed the most promising overall 
properties for further investigation. This involved finding a means to improve the adsorption 
ability of the 68Ga activity on the resin (reduction of the amount of activity in waste vial Fr1) 
by lowering the HCl concentration of the eluate. 
 
Considering the combined results in Table 7.1, further investigation of the Bond Elut SCX 
(100 mg) cartridge was carried out to determine the optimal HCl concentration of the eluate 
and volume of the diluted 68Ga aliquot to improve the adsorption and subsequent recovery of 
68Ga.  
 
In Table 7.2 and Figure 7.1 data are presented of various concentrations of HCl (0.3 – 0.6 M 
HCl) and volume of 68Ga-containing load solutions in HCl on the retention of 68Ga activity 
on the Bond Elut SCX cartridge. 
 
From Table 7.2, the best overall results (based on the activity in the waste vial (Fr1), Fr2 and 
residual activity in the Bond Elut SCX cartridge) were obtained with 0.3M HCl (4 ml of 0.6 
M HCl 68Ga aliquot + 4 ml water). This implies that if a SnO2-based generator is eluted with 
4 ml of 0.6 M HCl and the eluate is diluted to 8 ml with water, the eluate can be passed through 
the SCX resin cartridge with minimal activity loss. From the results obtained, 4 ml of 0.6 M 
HCl diluted to 6 ml (to render 0.4 M) also resulted in a small loss of activity, which may 
indicate that either of these dilutions can be used. The 0.3 M HCl and 8 ml of diluted 68Ga 
aliquot is however preferred. The SCX purification/concentration method under these 
conditions resulted in the availability of almost 98 % of the 68Ga eluate from the generator for 
radiolabelling, which concurs with the result (> 98 %) obtained by Mueller et al. (2012). 
 
7.6 Conclusion 
A cationic resin-based eluate purification method based on that developed by Mueller et al. 
(2012) for eluates from a TiO2 generator, was successfully adapted for the SnO2-based 
generator, which is eluted with higher concentrations of HCl, by diluting the eluate. The 68Ga 
was efficiently adsorbed on a Bond Elut SCX (100 mg) cartridge and then desorbed by 
acidified solutions of NaCl. It offers the advantage over the acetone-based cationic processes 
of avoiding the organic solvent during the labelling process.  
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Chapter 8: Purification of metal-spiked 68Ga eluates on a strong cation exchange (SCX) resin 
8.1 Introduction 
Radiolabelling procedures with 68Ga are influenced by the presence of certain metals 
(Zhernosekov et al. 2007). Metal contamination may affect radiolabelling processes that 
require high specific activities. Velikyan et al. (2008) report the imaging of low-density cell 
receptor sites requires radiopharmaceuticals with high specific activity. Metals present during 
the radiolabelling reaction may bind to the peptide ligands, resulting in non-radioactive 
peptides, which would compete with the 68Ga-labelled peptides for receptor occupancy. 
Metals may be introduced in the radiolabelling process and their presence may largely result 
from metal contamination of the HCl eluent or reagents, or ions that may leak from the 
generator column. Metal contaminants include Zn2+, which is the non-radioactive decay 
product of 68Ga. Oehlke et al. (2013) investigated the influence of various metal cations on 
the radiolabelling yield of [68Ga]DOTATATE and found that the metal ion/ligand ratio (and 
not the metal concentration) plays an important role in labelling yields. They found that the 
metal ions that have the largest effect were Pb2+, Cu2+, Fe3+ and Zn2+. They also found that 
[68Ga]DOTATATE was stable in the presence of high concentrations of Fe3+ and Zn2+, but 
transmetalates with Cu2+ at 95 °C, which exerts the greatest influence on the 
[68Ga]DOTATATE complexation. They found that the effect of Cu2+ showed a pH 
dependency with a decrease in labelling yield with increasing pH. They showed that complete 
labelling (100 %) was observed when the metal/ligand ratio was below 1:1. Their results were 
consistent with previous studies (Šimeček et al., 2013; Velikyan et al., 2008) that Al3+ had a 
very low influence of the 68Ga3+ complexation with DOTA ligands. They also corroborate the 
findings of Velikyan et al. (2008) that Fe3+ competes strongly with Ga3+ in the labelling 
reaction. 
 
Eluate fractionation or eluate pre-concentration and pre-purification can be used to partially 
remove unwanted metals. Various ion exchange resins have been used in studies on the 
purification and concentration of 68Ga eluates. One of the most comprehensive studies on this 
topic has been described by Zhernosekov et al (2007). They investigated the pre-concentration 
and purification of the 68Ga eluates from a TiO2 generator on a Bio-Rad AG 50W-X8 cation 
exchange resin using HCl/acetone as an eluent. The relative distribution of various metals 
[Ga3+, Ge4+, Zn2+, Ti4+ and Fe3+] in various eluate fractions was determined. They found that 
the initial quantities of Zn2+, Ti4+ and Fe3+ were reduced by factors of 105, 102, and 10, 
respectively. The 68Ga desorption agent used in this cationic method contains the organic 
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solvent acetone, which requires additional quality control of the labelled products and could 
also lead to breakdown impurities in combination with HCl (Mueller et al 2012). 
 
Ocak et al. (2010) investigated the purification of the 68Ga eluate using a Bio-Rad AG 50W-
X4 cation exchange resin as well as a Phenomonex Strata-X-C cation exchange cartridge 
using a TiO2 generator. They also employed the HCl/acetone method used by Zhernosekov et 
al. (2007). The Fe, Al and Ti quantities in the eluate were significantly lower for the AG 50W-
X4 cation exchange resin compared to the Strata-X-C resin. The Zn and Cu concentrations 
were however found to be higher.  
 
In order to eliminate the use of acetone, a user-friendly cationic method was developed and 
described in a study by Mueller et al (2012), using NaCl instead of acetone. The latter study, 
however, does not include any data on the removal of various metals from eluates, using this 
system. A slightly modified version of the Mueller method was described in Chapter 7, 
specifically addressing the concentration/purification of eluates from a SnO2-based generator. 
The intent of the investigation in this chapter was therefore to determine the ability of the 
modified SCX/NaCl/HCl purification technology to remove the most likely metal 
contaminants from SnO2-based generator  eluates. 
 
8.2 Aim 
The aim of this investigation was to establish the ability of the cationic Bond Elut SCX (100 
mg) cartridge to remove known quantities of Zn2+, Cu2+, Ga3+ and Fe3+ which were 
deliberately introduced into the 68Ga eluate obtained from a SnO2-based generator. These 
metal ions were selected based on their most likely presence in the SnO2 generator. Al3+ was 
not included due to its low influence on the radiolabelling process. 
 
8.3 Materials and Methods 
General methods are summarised in chapter 3. This section describes variations and details 
specific to the work described in this chapter. 
 
The 68Ga was eluted from an 1110 MBq (30 mCi) SnO2-based 68Ge/68Ga generator with 0.6 
M HCl (see 3.4.1).  
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8.3.1 Spiking of eluate with metal mixtures containing zinc (Zn), iron (Fe), copper (Cu) and gallium 
(Ga) 
1000 ppm standards of each metal in 5 % (0.8 M) nitric acid (HNO3) (catalogue numbers: Zn 
– 88118, Fe – 88073, Cu – 88061 and Ga – 88066) from Alfa Aesar (Haverhill, Massachusetts, 
United States) were used. The following mixtures of Cu, Zn, Fe and Ga were prepared: 
250 ppm of each metal in 1 ml, 0.08 ml and 0.04 ml mixture of the 4 metals (Zn, Cu, Ga and 
Fe):  
A 250 µg metal mixture was prepared in 1 ml, by combining 0.25 ml of each metal stock 
solution together in a vial. Addition of 4 ml eluate to this vial, rendered a metal content of 250 
µg metal of each metal in 5 ml, i.e. 50 ppm of each metal. 
A 20 µg metal mixture was prepared in 0.08 ml, by combining 0.02 ml of each metal stock 
solution together in a vial. Addition of 4 ml eluate to this vial, rendered a metal content of 20 
µg metal of each metal in 4.08 ml, i.e. 4.9 ppm of each metal. 
A 10 µg metal mixture was prepared in 0.04 ml, by combining 0.01 ml of each metal stock 
solution together in a vial. Addition of 4 ml eluate to this vial, rendered a metal content of 10 
µg metal of each metal in 4.04 ml, i.e. 2.48 ppm of each metal. 
 
These solutions were further diluted with 5 ml ultrapure pharmaceutical grade water, which 
resulted in solutions with 25 ppm, 2.2 ppm and 1.11 ppm of each metal in the respective 
solutions. 
 
8.3.2 Purification of metal-spiked eluates on Bond Elut SCX cartridge 
A Bond Elut SCX 100 mg (1 ml) cartridge was pre-conditioned as described in chapter 3. The 
metal-spiked eluate above was mixed by a vortex action to ensure homogeneity and the 
activity was loaded onto the Bond Elut SCX cartridge and eluted into a borosilicate vial. The 
resin was run dry and rinsed with 1 ml water into the same waste vial (Fr1). This vial was 
sealed and replaced with another vial. The resin cartridge was loaded with 0.5 ml of a mixture 
of 5 M NaCl and 5.5 M HCl 40:1 (v/v) and the 68Ga was eluted from the resin. The resin was 
run dry, the vial (Fr2) sealed and the activities in both vials (Fr1 and Fr2), as well as the 
residual activity in the cartridge, were determined.  
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8.3.3 Metal analysis of the eluates 
The metal contaminants (Zn, Fe, Cu and Ga) in the eluates (Fr1 and Fr2) were determined 
using a Horiba Jobin Yvon Ultima inductively coupled plasma optical emission spectrometer 
(ICP-OES). The concentration of metals in the samples was determined from calibration 
curves ranging from 1 ppm to 25 ppm. 
 
8.4 Results 
8.4.1 Metal analysis of the eluates 
The results in Table 8.1 and Table 8.2 present data on the metal content in parts per million 
(ppm) and microgram (µg) respectively, of various SCX fractions after passing diluted metal-
spiked 68Ga eluates through a Bond Elut SCX (100 mg) cation resin cartridge and recovery of 
68Ga activity with 5 M NaCl/5.5 M HCl 40:1 (v/v) solution. Based on these results, the 
information below summarises the percentage (%) metals in each of these SCX fractions. 
 
The addition of metal spiked 68Ga eluates, containing 250 µg (25 ppm) of each metal, to the 
SCX cartridge resulted in the following metal content (expressed as percentage of spiked 
metal) in the waste vial (Fr1) after passing the eluates through the SCX resin: 59 % Fe; 89 % 
Zn; 76 % Cu and 92 % Ga. The corresponding metal content in Fr2 was as follows: 0.9 % Fe; 
0.6 % Zn; 0.5 % Cu and 0.2 % Ga. 
 
The addition of metal spiked 68Ga eluates, containing 20 µg (2.2 ppm) of each metal, to the 
SCX cartridge resulted in the following metal content in the waste vial (Fr1) after passing the 
eluates through the SCX resin: 83 % Fe; 90 % Zn; 58 % Cu and 85 % Ga. The corresponding 
metal content in Fr2 was as follows: 3.5 % Fe; 2 % Zn; 1.5 % Cu and 0.5 % Ga. 
 
The addition of metal spiked 68Ga eluates, containing 10 µg (1.11 ppm) of each metal, to the 
SCX cartridge resulted in the following metal content in the waste vial (Fr1) after passing the 
eluates through the SCX resin: 78 % Fe; 100 % Zn; 48 % Cu and 88 % Ga. The corresponding 
metal content in Fr2 was as follows: 2 % Fe; 4 % Zn; 1 % Cu and 1 % Ga. The combined 
metal content in Fr1 and Fr2 sometimes exceeded 100 % due to the percentage error in 
measurement of small quantities of metal. 
 
From the tables, it can be observed that for all three concentrations of metals (10, 20 and 250 
µg) that were introduced, consistently an average of 79 % of the total “spiked” metals (Fe, 
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Zn, Cu and Ga) were eluted in the waste vial (Fr1) and only 0.6 – 2 % of the total introduced 
metals (for all three concentrations of “spiked” metal) were desorbed into Fr2. Based on the 
total of the percentages of the metals in the waste vial (Fr1) and Fr2, there appeared to be 
residual quantities of metal retained on the SCX cartridge. The metal content in Fr2 was 
therefore used as the indicator for metal removal efficiency and for all three concentrations of 
“spiked” metal, the SCX resin most effectively removed the Ga, then the Cu and finally the 
Fe and Zn.  
 
Table 8.1: Removal of metals by SCX cartridge (ppm) 
Metal content in parts per million of various SCX fractions measured after passing diluted metal-
spiked 68Ga eluates through a Bond Elut SCX 100 mg cartridge and recovery of activity with 5 
M NaCl/5.5 M HCl 40:1 (v/v) solution 
Metal content of 
diluted metal-spiked 
68Ga eluates before 
SCX 
Metal content after SCX (ppm) 
SCX Fr1  
(10 – 11 ml waste) 
SCX Fr2  
(0.5 ml 5 M NaCl/5.5 M HCl 40:1)  
(µg) (ppm) Fe Zn Cu Ga Fe Zn Cu Ga 
250 25 13.4 ± 1.4 20.1 ± 0.8 17.1 ± 0.8 21.6 ± 0.6 4.7 ± 0.5 2.8 ± 0.4 2.5 ± 0.1 1.2 ± 0.1 
20 2.2 1.7 ± 0 1.8 ± 0.2 1.1 ± 0.1 1.7 ± 0.1 1.3 ± 0.2 0.9 ± 0.1 0.5 ± 0 0.2 ± 0 
10 1.11 0.8 ± 0.3 1.0 ± 0.2 0.5 ± 0.1 0.9 ± 0 0.4 ± 0 0.7 ± 0.1 0.2 ± 0 0.2 ± 0 
*n = 3 
 
Table 8.2: Removal of metals by SCX cartridge (µg) 
Metal content in microgram of various SCX fractions measured after passing diluted metal-
spiked 68Ga eluates through a Bond Elut SCX 100 mg cartridge and recovery of activity with 5 
M NaCl/5.5 M HCl 40:1 (v/v) solution 
Metal content of 
diluted metal-spiked 
68Ga eluates before  
SCX 
Metal content after SCX (µg) 
SCX Fr1  
(10 – 11 ml waste) 
SCX Fr2  
(0.5 ml 5 M NaCl/5.5 M HCl 40:1)  
(µg) (ppm) Fe Zn Cu Ga Fe Zn Cu Ga 
250 25 147 ± 15 222 ± 8 189 ± 9 230 ± 9 2.3 ± 0.2 1.4 ± 0.2 1.2 ± 0.1 0.6 ± 0.1 
20 2.2 16.6 ± 0.2 18 ± 2.4 11.5 ± 1.1 16.9 ± 0.5 0.7 ± 0.1 0.4 ± 0.2 0.3 ± 0 0.1 ± 0 
10 1.1 7.8 ± 3.3 10.4 ± 1.8 4.8 ± 0.9 8.8 ± 0.3 0.2 ± 0 0.4 ± 0.1 0.1 ± 0 0.1 ± 0 
*n = 3 
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8.5 Discussion 
The metals Fe, Zn, Cu and Ga were chosen based on the most likely metals present in higher 
concentrations in eluates from the SnO2-based generator and their ability to influence the 
labelling process. The chosen range of the concentrations of metals introduced (“spiking”) 
was based on likely concentrations of metal ions that may be present in a radiolabelling setup 
(10 – 20 µg) to an exaggerated quantity (250 µg) that exceeded the pharmacopoeia limits for 
metal contaminants in generator 68Ga eluates. De Blois et al. (2011) found the total metal ions 
(Ga, Ge, Zn, Ti, Sn, Fe, Al and Cu) in the eluate from the SnO2-based generator to consistently 
be < 10 ppm (with Zn < 3 ppm and for all the other metals < 1ppm). The 250 µg was included 
to assess the ability of the Bond Elut SCX (100 mg) resin to remove metal ions over a wide 
concentration range. 
 
From previous studies (Oehlke et al., 2013) it was found that Fe3+, Cu2+ and Zn2+ were among 
the metal ions found to have the largest influence on radiolabelling. They also found that 
complete labelling was always possible when the metal/ligand ratio was below 1:1. From the 
results obtained above and based on 35 µg of DOTATATE used in the labelling process, Fe 
was the only metal ion in Fr2 that exceeded this metal to ligand ratio (1.69:1), when metal 
spiked 68Ga eluates, containing 250 µg of each metal, were added to the SCX cartridge. The 
addition of metal spiked 68Ga eluates, containing 250 µg of each metal to the SCX cartridge, 
resulted in 0.78:1 Cu and 0.86:1 Zn in Fr2 (similarly based on 35 µg or 24.3 nmol of 
DOTATATE used in the labelling process). The addition of metal spiked 68Ga eluates, 
containing 20 µg of each metal, to the SCX cartridge, resulted in the following metal ion: 
ligand ratio in Fr2: 0.53:1 Fe, 0.21:1 Cu and 0.25:1 Zn (based on 35 µg or 24.3 nmol of 
DOTATATE used in the labelling process). The addition of metal spiked 68Ga eluates, 
containing 10 µg of each metal, to the SCX cartridge, resulted in the following metal ion: 
ligand ratio in Fr2: 0.16:1 Fe, 0.08:1 Cu and 0.25:1 Zn (based on 35 µg or 24.3 nmol of 
DOTATATE used in the labelling process). The ratio of Cu:ligand in Fr2 was consistently 
lowest for all three (10, 20 and 250 µg) metal-spiked eluates and Fe:ligand was the highest 
for the two higher metal-spiked eluates (20 and 250 µg). For the lower metal-spiked eluates 
(10 and 20 µg), the Zn:ligand ratio in Fr2 was consistently 0.25:1. This implies that under the 
conditions of this investigation, when the 68Ga eluates were spiked with 10 – 20 µg of each 
metal, the SCX resin efficiently removed the metals to achieve a metal/ligand ratio of less 
than 1:1 for ideal labelling conditions (Oehlke et al., 2013). Even when unrealistically high 
quantities of metals of up to 250 µg were introduced, only the Fe:ligand ratio exceeded this 
ratio. 
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8.6 Conclusion 
This investigation showed that, of the initial quantities (10, 20 and 250 µg) of introduced Fe, 
Zn, Cu and Ga in the 68Ga eluate, only about 2 % of these total metals remained in the purified 
68Ga fraction after passing the “spiked” eluate through a Bond Elut SCX (100 mg) cartridge. 
It is highly unlikely that 68Ga eluates would contain as much as 250 µg of any metal if 
sufficient care is taken to avoid the introduction of metals during the labelling process (e.g. 
avoiding the use of metal needles and using only analytical grade chemicals). The levels of 
metals, particularly the most influential Fe, Zn and Cu, were sufficiently low when the 68Ga 
eluates were contaminated with less than 20 µg of each metal. The metal/ligand ratio for all 
the metals was less than 1:1, a condition that would result excellent labelling of DOTA-
peptides. 
  
Stellenbosch University  https://scholar.sun.ac.za
 
 
83 
Chapter 9: Optimization of radiolabelling method of 68Ga-labelled DOTATATE, using SCX-
processed 68Ga eluates  
9.1 Introduction  
An optimized radiolabelling method using fractionated eluates from a SnO2-based 68Ge/68Ga 
generator was described in Chapter 5. All the parameters that were developed during that 
study (e.g. buffer content of labelling mixture) would not necessarily apply when using 68Ga 
eluates that were processed differently. The pH of the labelling mixture would be affected by 
the different HCl content of differently processed eluates. A radiolabelling method of DOTA-
peptides was described in Mueller et al. (2012), using 68Ga that had been purified on a silica-
based strong cation exchange resin (SCX cartridge). The method involved the use of 
ammonium acetate buffer and the labelling reaction was conducted in a relatively large 
volume of approximately 3.7 – 3.9 ml. No post-labelling purification was conducted.  
 
The composition of the purified eluate described in Chapter 7 of this work was similar to that 
of the Mueller et al. (2012) method. It was, however, decided not to copy the Mueller labelling 
method exactly, but rather to develop a method based on the labelling conditions described 
earlier in Chapter 5. This method used a sodium acetate (instead of ammonium acetate) buffer 
system, smaller reaction volumes and different DOTA-peptide content. Sodium acetate was 
used as a buffer because it ensured a radiolabelling mixture with a consistent pH throughout 
the labelling process and it has been successfully used in the work described in chapters 5 and 
6 as well as in other well-published DOTA-labelling studies (Hoffman et al., 2001; Henze et 
al., 2001; Breeman et al., 2005; de Blois et al., 2011; Rossouw and Breeman, 2012; 
Decristoforo et al., 2007; Mukherjee et al., 2014a, 2014c; Das et al., 2014). There was no 
further optimization of the DOTA-peptide content, as that had already been done in Chapter 
5. Instead, this systematic approach was rather to develop an optimum pH range for labelling, 
with the aim to improve radiolabelling yields and to reduce losses of activity during post-
labelling purification.  
 
9.2 Aim 
The main aim was to optimize the labelling method using pre-concentrated 68Ga eluates from 
a Bond Elut SCX (100 mg) cation exchange resin. Labelling conditions, based on the acidity 
of the concentrated eluate, and therefore the pH of the labelling mixtures, were investigated. 
For this purpose, only DOTATATE was selected as a source of DOTA-peptide because 
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previous results in this study showed that the labelling results obtained from the three DOTA-
peptides (DOTATATE, DOTATOC and DOTANOC) were quite similar. 
 
9.3 Materials and Methods 
General methods are summarised in chapter 3. This section describes variations and details 
specific to the work described in this chapter. 
 
9.3.1 Elution of the generator 
The 68Ga was eluted from an 1110 MBq (30 mCi) SnO2-based 68Ge/68Ga generator with 12 
ml 0.6 M HCl (see chapter 3) and collected in a borosilicate glass vial. The 12 ml eluate was 
divided into three 4 ml aliquots, which were each allocated for the purification on an SCX 
resin, followed by labelling of DOTATATE. The activities in these aliquots ranged from 141 
MBq to 185 MBq depending on the age of the generator and the decay of the 68Ga eluate. 68Ga 
activities were measured in a dose calibrator. 
 
In addition, elution was carried out in the following way to assess whether more concentrated, 
higher activity eluates would yield the same labelling results as the lower activity eluates: 4.0 
ml was first eluted and collected in a vial, followed by a second fraction of 6 ml which was 
discarded. The first 4ml fraction (activities ranging from 396 MBq to 415 MBq) was allocated 
for SCX resin purification followed by higher activity labelling of the peptide ligand.  
 
9.3.2 Dilution of the 68Ga eluate for SCX processing 
The 4 ml 0.6 M 68Ga eluate fraction or aliquot (see 9.3.1) was diluted with 4 ml ultrapure 
pharmaceutical grade water and mixed by vortex to render a concentration of 0.3 M HCl. The 
activity was measured in a dose calibrator. 
 
9.3.3 Concentration of 68Ga eluates on the Bond Elut SCX cation exchange resin 
See 3.4.10 for pre-conditioning and concentration of 68Ga eluates on the Bond Elut SCX 
cation exchange resin. In the concentration of the 68Ga eluates, the diluted 68Ga eluate (see 
9.3.2 above) was loaded onto the pre-conditioned Bond Elut SCX (100 mg) cartridge. The 
concentrated 68Ga fraction Fr2 (0.5 ml) was obtained as described in 3.4.10.  
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9.3.4 Radiolabelling of the DOTATATE with concentrated eluates and post-purification thereof 
DOTATATE stock solution (1 mg/ml, 35 µl) was added to the purified 68Ga solution Fr2 (0.5 
ml). Various volumes of 2.5 M NaOAc, ranging from 40 – 60 µl, were added to the 68Ga 
DOTATATE mixture. After addition of 2 ml ultrapure pharmaceutical grade water, the 
contents of the vial were gently mixed and the pH was measured. Under these conditions the 
DOTATATE molar concentration was 9.4 – 9.5 µM. The vial was then sealed with a rubber 
stopper and an aluminium cap. The mixture was homogenised for 5 seconds by means of 
gentle swirling in a vortex mixer and the vial containing the labelling mixture was heated for 
15 minutes in a controlled heating block at 95 °C. The radiolabelled DOTA-peptide reaction 
mixture was removed from the heating block and homogenised again by means of gentle 
swirling. An aliquot was removed for HPLC testing before the reaction mixture was 
transferred onto a purification unit consisting of a 500 mg C18, 3 cc, Sep-Pak cartridge. See 
3.4.2 for the post-radiolabelling purification process.  
 
9.3.5 Quality evaluation 
9.3.5.1 pH of the concentrated eluates 
The pH value of the concentrated 68Ga eluate and 2.5 M NaOAc mixture, diluted in 2 ml 
ultrapure pharmaceutical grade water, was determined using pH indicator strips (Merck, 
Darmstadt, Germany). A Horiba pH meter was also used to verify the pH obtained with the 
pH strips and the results were consistent. 
 
The quality of the 68Ga-labelled DOTATATE was evaluated as described below. 
 
9.3.5.2 Radiolabelling efficiency and radiochemical yield 
Radiolabelling efficiency or labelling efficiency (LE) was obtained from the HPLC analysis 
of an un-purified labelling mixture. Radiochemical purities of 68Ga-labelled DOTA-peptides 
before and after Sep-Pak purification were determined by means of HPLC as described in 
chapter 3. 
 
For radiochemical yield, refer to 3.4.2. The activities in the collected fractions (S1 and S2), 
as well as the remaining activities in the reaction vial and on the Sep-Pak C18 cartridge were 
measured in a dose calibrator. 
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9.4 Results 
9.4.1 Determination of the optimal volume of 2.5 M NaOAc (pH) on radiolabelling results 
The results in Table 9.1 present data on the influence of the volume of sodium acetate 
(controlling the pH of labelling mixtures) on radiolabelling and Sep-Pak C18 purification 
results (radiochemical yields) of [68Ga]DOTATATE, using 35 µg DOTATATE and SCX-
processed 68Ga eluates. 
 
Table 9.1: Influence of volume of sodium acetate on radiolabelling results of 
[68Ga]DOTATATE, using SCX-processed 68Ga eluates 
Influence of volume of sodium acetate (pH) on radiolabelling and Sep-Pak C18 purification 
results of [68Ga]DOTATATE, using 35 µg DOTATATE and SCX-processed 68Ga eluates 
showing mean values of decay-corrected activities in various fractions, expressed as percentages 
of the starting activity (141 – 185 MBq or higher activity concentrations 396 – 415 MBq**), 
number of experiments given within brackets; S1 = first Sep-Pak fraction collected with 8 ml 
saline; S2 (Radiochemical Yield) = second Sep-Pak fraction collected with 0.7 ml ethanol:saline 
[50:50] + 2.25 ml saline; S3 = remaining activity in vial; and S4 = remaining activity in Sep-Pak 
after collecting S2 
Vol. 2.5 M 
NaOAc (µl) 
pH range of 
labelling 
mixture 
*Labelling 
efficiency 
(%) 
S1 
(%) 
S2 
(%) 
S3 
(%) 
S4 
(%) 
40 (n=4) 2.0 – 2.5 93 ± 6 6 ± 3 82 ± 4 2 ± 0.5 11 ± 2 
42 (n=4) 2.5 – 3.0 96 ± 4 3 ± 2 83 ± 2 2 ± 0 12 ± 2 
44 (n=4) 2.5 – 3.0 98 ± 1 2 ± 0 83 ± 3 3 ± 1 12 ± 3 
46 (n=12) 3.0 99 ± 1 2 ± 0.4 84 ± 3 7 ± 4 7 ± 4 
**46 (n=4) 3.0 97 ± 2 3 ± 0.5 81 ± 2 5 ± 1 12 ± 3 
48 (n=4) 3.0 98 ± 0.5 3 ± 1 82 ± 2 8 ± 2 7 ± 3 
50 (n=3) 3.5 99 ± 1 3 ± 1 64 ± 6 24 ± 4 9 ± 1 
55 (n=1) 4.0 79  10  24  55  12  
60 (n=1) 4.5 70  12  20  54  14  
*Determined by means of HPLC 
 
The addition of 40 – 50 µl NaOAc (labelling mixture pH 2.0 – 3.5) resulted in a consistent 
increase in the average radiolabelling efficiency of 93 % to 99 % but a significant decrease of 
79 % to 70 % when volumes of 55 – 60 µl (pH 4.0 – 4.5) of NaOAc were added. The average 
radiochemical yield (S2) remained fairly constant (81 – 84 %) with the addition of 40 – 48 µl 
NaOAc but decreased significantly (64 – 20 %) when volumes of 50 – 60 µl (pH 3.5 – 4.5) 
NaOAc were added. The average activity remaining on the vial was 2 – 8 % for the addition 
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of 40 – 48 µl (pH 2.0 – 3.0) NaOAc, but increased dramatically thereafter with as much as 
around 55 % when volumes of 55 – 60 µl (pH 4.0 – 4.5) of NaOAc were added. 
 
9.4.2 Radiolabelling efficiency and radiochemical yield results under optimized conditions 
The results in Table 9.2 present data on individual radiolabelling efficiency and Sep-Pak C18 
purification results (radiochemical yields) of [68Ga]DOTATATE, using SCX-processed 68Ga 
(68Ga generator eluate in 0.6 M HCl, diluted to 0.3 M HCl and processed on SCX). 
The radiochemical purity post Sep-Pak C18 purification was always in the order of 100 % 
(not tabulated). The radiolabelling efficiency results ranged from 95 – 99 % and the 
radiochemical yields (S2) ranged from 83 – 89 %. The remaining activity on vial (S3) was 
fairly consistent between 5 – 6 % and the activity remaining on the Sep-Pak cartridge (S4) 
was 3 – 10 %. 
 
Table 9.2: Individual radiolabelling results of [68Ga]DOTATATE, using SCX-processed 
68Ga eluates 
Individual radiolabelling efficiency and Sep-Pak C18 purification results of [68Ga]DOTATATE, 
using SCX-processed 68Ga activity (68Ga generator eluate in 0.6 M HCl, diluted to 0.3 M HCl 
and processed on SCX), labelling conducted at pH = 3 (46 µl NaOAc), using 35 µg DOTA-
peptide, showing values of decay-corrected activities in various fractions, expressed as 
percentages of the starting activity; S1 = first Sep-Pak fraction collected with 8 ml saline; S2 
(Radiochemical Yield) = second Sep-Pak fraction collected with 0.7 ml ethanol:saline [50:50] + 
2.25 ml saline; S3 = remaining activity in vial; and S4 = remaining activity in Sep-Pak after 
collecting S2 
Labelling efficiency 
(HPLC) (%) 
S1 
(%) 
S2 
(%) 
S3 
(%) 
S4 
(%) 
99 2 83 5 10 
95 3 84 6 7 
99 2 89 6 3 
 
9.5 Discussion 
The results in Table 9.1 summarize a systematic investigation of the influence of pH 
(determined by the volume of 2.5 M NaOAc added) on the labelling yields as well as 
adsorption of activity on the reaction vial (S3). 
 
The radiolabelling of DOTA peptides is highly pH dependent (Velikyan, et al., 2004; 
Breeman, et al., 2005). Breeman et al. (2005) found that pH 3.5 – 4.0 was the optimal pH for 
incorporation of Ga3+ in the labelling process. Velikyan, et al. (2010 and 2012) performed 
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labelling of DOTA-peptides at a pH of about 4.6. Meyer et al. (2003a) also found the optimal 
pH range for the radiolabelling to be 4.3 – 5.0. However, in the current study, at pH 3.5, 
although the radiolabelling efficiency was 99 %, the radiochemical yield (S2) started dropping 
below 65 % with almost 25 % of the activity remaining on the vial. At pH range of 4.0 – 4.5, 
the radiolabelling efficiency dropped below 80 %, the radiochemical yield dropped to below 
25 % and as much as 55 % of the activity remained on the glass vial. This may be due to the 
less acidic conditions that may result in hydrolysis of the 68Ga. These discrepancies between 
labelling efficiencies and actual radiochemical yields clearly illustrate that under certain non-
optimal labelling conditions, labelling efficiency on its own could be a misleading 
measurement and be not a true reflection of actual radiochemical yield. 
 
The optimal pH for the radiolabelling process in this study was found to be 3.0 based on the 
radiolabelling results (radiolabelling efficiency and radiochemical purity). In Table 9.2 (where 
individual radiolabelling efficiency and Sep-Pak C18 purification results at pH 3 after addition 
of 46 µl 2.5 M NaOAc, are given), the average activity remaining on the vial (S3) under 
optimized labelling conditions was 6 ± 0.6 % compared to 16 ± 4 % (for DOTATATE 
radiolabelling), in Chapter 5 (see Table 5.3). This may be due to the pH of the radiolabelling 
process having been too high (3.5 – 4.0) in the previous study. 
 
The radiolabelling conditions given in Section 9.3.4 with regards to the molar concentration 
of DOTATATE (9.4 – 9.5 µM) also concur with the optimum conditions established in 
Chapter 5 (9.2 – 9.4 µM). 
 
It was found that both elution methods (using a concentrated or less concentrated 4 ml 68Ga 
eluate, see 9.3.1) resulted in similar labelling results (see Table 9.1, entry 5**) and hence the 
first elution method was predominantly used to increase the number of studies that could be 
performed with a single elution. When higher activity is required, however, eluates with 
higher activity concentration can be introduced into labelling mixtures (without altering the 
eluate volume). 
  
Stellenbosch University  https://scholar.sun.ac.za
 
 
89 
9.6 Conclusion 
The successful development of a labelling method using pre-concentrated 68Ga eluates from a 
Bond Elut SCX (100 mg) cation exchange resin was achieved. The method produced a high 
radiolabelling efficiency yield of around 99 % and high radiochemical yield of almost 85 %. 
The labelling results for DOTA-peptide labelling at a pH of 3 were found to be superior to 
those at a higher pH (3.5 – 4.0). It should be possible to adapt this method to an automated 
synthesis module and the procedure makes 68Ga-labelled products accessible with the 
advantage (over the acetone-based methods) of reducing the preparation time due to not 
having to remove organic solvents in the process, and avoid testing for acetone in the final 
product, which reduces the costs in the radiopharmacy or clinical setup. 
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Chapter 10: Development and evaluation of user-friendly single vial DOTATATE kit 
formulations, using SCX-processed 68Ga eluates 
10.1 Introduction 
The cation exchange-based post-processing method described in Chapter 7 reduces 68Ga 
eluate volumes and removes most chemical contaminants and 68Ge breakthrough. In order to 
improve the user-friendliness of the radiolabelling method of DOTA-peptides, using SCX-
processed 68Ga eluates obtained from a SnO2-based generator (described in Chapter 9), there 
is a need to develop DOTA-peptide kit formulations based on this optimised radiolabelling 
method. 
 
In most previously published reports, DOTA-peptide kit formulations for labelling were based 
on the use of 68Ge/68Ga generators eluted with relatively low HCl concentrations. In both the 
studies by Mukherjee et al. (Mukherjee et al., 2014a, 2014c), the 68Ga eluates (in 0.1 M HCl) 
from a nanoceria-polyacrylonitrile (PAN), composite-sorbent-based 68Ge/68Ga generator 
were directly added to the kit formulation without any pre- or post-processing methods. In 
another study by the same author (Mukherjee et al., 2014b) DOTATATE kits for 
radiolabelling with both 68Ga and 177Lu were formulated as a theranostic radiopharmaceutical 
preparation. The 68Ga was eluted from a SnO2 generator with 0.1 M HCl, which was loaded 
on a Strata-X-C cartridge and the purified 68Ga was eluted in an acetone/HCl solution and 
directly added to the kit vial. Das et al. (2014) conducted their study using a TiO2-based 
generator and freeze-dried peptide kits containing equal quantities of DOTATATE and 
DOTANOC. The 68Ga eluates were purified on a Strata-X-C cation exchange cartridge using 
HCl/acetone solution and further purification of the 68Ga-labelled peptides was carried out on 
a Sep-Pak C18 reverse phase cartridge. A study by Asti et al. (2015) to develop and optimise 
direct labelling of DOTATOC through a kit-based approach was conducted using fractionated 
eluates from a TiO2-- and a silica-based generator.  
 
The advantages of using kit-type formulations for the radiolabelling of DOTA-peptides with 
68Ga have been earlier described in Chapter 6. Those formulations, however, were developed 
for use with fractionated eluates. This investigation describes the development of single vial 
DOTATATE kits, formulated with sodium acetate as a buffer and to be used with SCX-
processed 68Ga eluates, using a SnO2-based 68Ge/68Ga generator as the source of 68Ga. It 
includes the monitoring of radiochemical yields of the 68Ga-labelled DOTATATE, 
Stellenbosch University  https://scholar.sun.ac.za
 
 
91 
radiolabelling efficiency and other quality control parameters (pH, sterility and apyrogenicity) 
over a 3-month period.  
 
10.2 Aim 
After optimized labelling conditions were established by using SCX-processed 68Ga eluates 
(see Chapter 9), the following aim was to investigate the development of single vial 
DOTATATE kit formulations and to test their radiolabelling efficiency using the processed 
eluates as the source of 68Ga. As was the case in Chapter 6, the primary objective of this 
investigation was to improve the convenience and user-friendliness of the labelling procedure. 
The next step was to evaluate the quality of the kits over a period of at least 3 months in order 
to establish the stability over this period when kept frozen at -20 °C. The efficiency of the kits 
(prepared using four different methods) was also investigated. Additionally, an alternative 
quality control method for the un-purified labelled DOTATATE was used to determine the 
possible presence of colloids, which are un-detectable by HPLC. This would provide a 
guideline whether C18 post-labelling purification is required when labelling is done in 
conjunction with the SCX eluate processing method. 
 
10.3 Materials and methods 
General methods are summarised in chapter 3. This section describes variations and details 
specific to the work described in this chapter. 
 
10.3.1 Elution of the generator 
The 68Ga was eluted from an 1110 MBq (30 mCi) SnO2-based 68Ge/68Ga generator with 12 
ml 0.6 M HCl (see 3.4.1) and collected in a borosilicate glass vial. The 12 ml eluate was 
divided into three 4 ml aliquots, which were each purified on the (Bond Eut SCX) cation 
exchange resin and eventually used for labelling of DOTATATE. The activities in these 
aliquots ranged from 63 MBq to 185 MBq depending on the age of the generator and the 
decay of the 68Ga eluate. 68Ga activities were measured in a dose calibrator. 
 
10.3.2 Preparation of DOTATATE single vial kits 
DOTATATE stock solution (1 mg/ml) was prepared using ultra-pure pharmaceutical grade 
water and stored at -20 °C (see 3.3.2). The solution of 2.5 M NaOAc was made with ultra-
pure pharmaceutical grade water and filtered through a 22-micron sterile filter. Single vial 
kits were prepared using the following four different methods: 
Stellenbosch University  https://scholar.sun.ac.za
 
 
92 
10.3.2.1 DOTATATE Single Vial Kits A 
A pre-calculated mass of 15.64 mg of sodium acetate trihydrate salt was weighed into 
individual sterile vials and 35 µl of DOTATATE stock solution was added into each vial. The 
unsealed single vial kits were individually vacuum-dried under sterile conditions in a 
desiccator connected with a N 726 FT.18 vacuum pump (KNF Neuberger Inc., Trenton, USA) 
for 3 hours at room temperature, the vials were then sealed with rubber stoppers and 
aluminium caps, and stored at -20 °C until use. 
 
10.3.2.2 DOTATATE Single Vial Kits B 
A volume of 46 µl of 2.5 M NaOAc was pipetted into each sterile labeled vial and 35 µl of 
thawed DOTATATE stock solution (containing 35 µg peptide) was added to each of these 
vials. The unsealed single vial kits were individually vacuum-dried under sterile conditions in 
a desiccator connected with a vacuum pump for 3 hours at room temperature, the vials were 
then sealed with rubber stoppers and aluminium caps, and stored at -20 °C until use. 
 
10.3.2.3 DOTATATE Single Vial Kits C 
A volume of 46 µl of 2.5 M NaOAc was pipetted into each sterile labeled vial and 35 µl of 
thawed DOTATATE stock solution (containing 35 µg peptide) was added to each of these 
vials. No vacuum drying was applied. The single vial kits were sealed with rubber stoppers 
and aluminium caps. The contents of the vials were mixed with a vortex action and the vials 
stored at -20 °C until use. 
 
10.3.2.4 DOTATATE Single Vial Kits D (freeze dried) 
A volume of 46 µl of 2.5M NaOAc was pipetted into each sterile labeled vial and 35 µl of 
thawed DOTATATE stock solution (containing 35 µg peptide) was added to each of these 
vials. These single vial kits were frozen with liquid nitrogen and loaded into the freeze dryer 
with a shelf temperature of -50 ºC for 4 h. The shelf temperature was increased to 35 ºC to 
sublime the ice. Each vial was vacuum-sealed, weighed and stored in a freezer at -20 °C until 
use. 
 
The frozen single vial kits were stored in a freezer at -20 °C up to 3 months and removed from 
the freezer and brought to room temperature before being used in each labelling process.  
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10.3.3 Concentration of 68Ga eluates on the SCX cation exchange resin 
See 3.4.10 for pre-conditioning and concentration of 68Ga eluates on the Bond Elut SCX (100 
mg) cation exchange cartridge. The concentrated fraction Fr2 (0.5 ml) was eluted directly 
from the SCX resin into a sterile kit vial (containing the DOTATATE and 46 µl 2.5 M NaOAc 
or 15.64 mg sodium acetate trihydrate) instead of an empty vial.  
 
10.3.4 Radiolabelling of the DOTATATE single vial kits and post-purification process 
Ultrapure pharmaceutical grade water (2 ml) was added to the 10 ml vial containing purified 
68Ga and the kit, the vial was gently mixed and the pH was measured. Under these conditions 
the DOTATATE molar concentration was 9.7 µM. The vial was then sealed with a sterile 
rubber stopper and an aluminium cap. The mixture was homogenised for 5 seconds by means 
of gentle swirling in a vortex mixer and the vial containing the labelling mixture was heated 
for 15 minutes in a controlled heating block at 95 °C. The radiolabelled DOTA-peptide 
reaction mixture was removed from the heating block and homogenised again by means of 
gentle swirling. An aliquot was removed for HPLC and iTLC testing before the reaction 
mixture was transferred onto a purification unit consisting of a 500 mg C18, 3 cc, Sep-Pak 
cartridge. See 3.4.2 for the post-radiolabelling purification process.  
 
10.3.5 Quality Evaluation of the DOTA-peptide kits 
The quality and stability of the DOTATATE single vial kits (A, B, C and D) were evaluated 
at monthly intervals over a 3-month period as described below. 
 
10.3.5.1 Radiolabelling efficiency and radiochemical yield 
Radiolabelling efficiency or labelling efficiency (LE) of DOTATATE, using single vial kits 
and 68Ga eluates that had been processed on the Bond Elut SCX resin, was determined by 
HPLC analysis (see 3.4.3), as well as by an iTLC method in order to detect for possible 
colloids (see below). Radiochemical purities of Sep-Pak C18-purified 68Ga-labelled DOTA-
peptides were also determined by means of HPLC. 
 
For radiochemical yield, refer to 3.4.2. The activities in the collected fractions (S1 and S2), 
as well as the remaining activities in the reaction vial and on the Sep-Pak C18 cartridge were 
measured in a Dose Calibrator. 
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Radiolabelling efficiency, radiochemical purity and radiochemical yields were monitored 
over a 3-month period.  
 
10.3.5.2 Colloid determination of the pre-Sep-Pak un-purified 68Ga-labelled DOTA-peptides, using 
an iTLC method 
The method of Mukherjee et al. (2014c) was used. 1 M ammonium acetate:methanol (1:1) 
mobile phase for iTLC was prepared as follows: A mass of 77.08 g of ammonium acetate 
(Sigma-Aldrich, catalogue number 431311) was weighed out and diluted to 1 litre with ultra-
pure water. Equal volumes of 1 M ammonium acetate solution and methanol (catalogue 
number 34860 from Sigma-Aldrich) were added together immediately before use to make a 
1:1 ammonium acetate:methanol solution.  
 
Radiolabelling efficiency was determined as described below: 
The iTLC-SG strips were prepared as follows: 9 cm long, 1.5 cm wide and the spot with 
activity (approximately 0.37 MBq) was placed at 1.5 cm from the bottom of the strip. The 
iTLC strip was then inserted in a chromatography tank containing 10 ml of the mobile phase 
and allowed to develop. Development time was approximately 10 minutes. The strip was 
removed from the tank and allowed to air dry before it was scanned using an Omni-rad EZ 
Scan (Carroll & Ramsey Associates, Berkeley, CA, United States), coupled to a Chromatopac 
C-R8A integrator (Shimadzu, Kyoto, Japan). The chromatograms displayed peaks with 
retention times in minutes (Rt), which were converted to the retention factor (Rf) values using 
the method of Davids (2017). The radiolabelling efficiency (iTLC) was obtained directly from 
the integrated values on the iTLC chromatogram. It was expressed as the amount of labelled 
DOTA-peptide with Rf value = 0.9, expressed as a percentage of the total amount of 
radioactivity species recorded on the iTLC radio-chromatogram. See Annex 1 for an example 
of the chromatogram. 
 
10.3.5.3 Microbiological evaluation of DOTATATE cold kits 
Sterility testing on the formulated DOTATATE cold kits was performed according to the 
methods prescribed in the European Pharmacopoeia (2013). A total of twelve samples of the 
DOTATATE single vial kits (3 of each kit type) were tested. These DOTATATE single vial 
kits were each dissolved (up to 0.5 ml) in a mixture of 5 M NaCl and 5.5 M HCl 40:1 (v/v) 
and then analysed for bacterial growth using soybean-casein digest medium for aerobic 
bacteria and fungi, and fluid thioglycollate medium for anaerobic bacteria. The sterile 5 M 
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NaCl and 5.5 M HCl 40:1 (v/v) was used to closely represent the 68Ga eluate that would be 
added to the kit but avoid false negative results that may occur due to the presence of the 68Ga. 
The 5 M NaCl and 5.5 M HCl was prepared using ultrapure pharmaceutical grade water and 
filtered (through a 0.22-micron filter) before use. See Chapter 3 for sterility testing method. 
 
Endotoxin testing was performed on a total of twelve DOTATATE cold single vial kits (3 of 
each kit type) dissolved in sterile saline.  The testing was performed according to the European 
Pharmacopoeia (2013) using the chromogenic method as described in Chapter 3. The 
calibration curve was used to determine the concentration of endotoxins in the DOTATATE 
kits.  
 
10.3.5.4 pH 
The pH value of the radiolabelled DOTA-peptide reaction mixture was determined using pH 
indicator strips (Merck, Darmstadt, Germany).  
 
10.3.5.5 Testing for 68Ge in radiolabelled preparations 
The same method described in 3.4.6 was used. 
 
10.4 Results 
10.4.1 Determination of kit composition parameters and preparation of single vial kits 
Based on the results in Chapter 5, where fractionated 68Ga eluates were used, 35 µg of DOTA-
peptide was used in the formulation of the kits and for all the radiolabelling experiments. The 
results in Chapter 9, emanating from the use of SCX-processed 68Ga eluates, were used to 
calculate the required quantity of NaOAc for the kits. The inclusion of 15.64 mg of sodium 
acetate trihydrate salt (in Kits A) or 46µl of 2.5M NaOAc (in Kits B, C and D) as buffer in 
the kit formulation ensured a radiolabelling mixture with a consistent pH of 3.0.  
 
10.4.2 Quality Evaluation of the DOTA-peptide kits  
10.4.2.1 Radiolabelling efficiency (HPLC) and radiochemical yield 
The results in Table 10.1 present data on the radiolabelling efficiency of [68Ga]DOTATATE, 
using SCX-processed 68Ga eluates and single vial kits containing 35 µg DOTATATE, stored 
for various periods at -20 ˚C. 
Over the 12-week storage period, radiolabelling efficiency results obtained from all four the 
DOTATATE single vial kit types were consistently above 98 %, irrespective of the type of 
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kit used. The average radiolabelling efficiency of 68Ga-labelled DOTATATE obtained from 
the DOTATATE single vial kits A at the end of the 12-week storage period was 98.3 %, for 
DOTATATE single vial kits B it was 98.7 %, for DOTATATE single vial kits D it was  
99.0 % and it was the highest for DOTATATE single vial kits C, at 99.7 %. 
 
Table 10.1: HPLC pre-Sep-Pak purification radiolabelling efficiency results of 
[68Ga]DOTATATE, using SCX-processed 68Ga eluates and single vial kits  
Peptide Storage 
Period 
Radiolabelling efficiency (%) 
Kit A Kit B Kit C Kit D 
1 week (n=3) 99.7 ± 1 99.0 ± 1 99.0 ± 1 - 
4 weeks (n=3) 99.3 ± 1 99.0 ± 1 99.0 ± 2 99.0 ± 0 
8 weeks (n=3) 99.3 ± 1 98.7 ± 2 99.3 ± 1 99.0 ± 0 
12 weeks (n=3) 98.3 ± 1 98.7 ± 2 99.7 ± 1 99.0 ± 1 
*For kit preparation, see 10.3.2 
 
Over the 12-week storage period, Sep-Pak C18 radiochemical yields obtained with the single 
vial DOTATATE single vial kit types ranged from 75 – 89 % (see Table 10.2). No obvious 
decline in the radiochemical yields was observed over a 12-week kit storage period. The 
average radiochemical yield obtained from the DOTATATE single vial kits A after a 12-week 
storage period was 80 % compared to 84 % for the DOTATATE single vial kits B and C. The 
average radiochemical yield obtained from the DOTATATE single vial kit D was the highest 
(87 %) after the same storage period. 
 
The radiochemical purity post Sep-Pak C18 purification was always in the order of 100 % 
(not tabulated). 
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Table 10.2: Sep-Pak C18 radiochemical yields of [68Ga]DOTATATE, using single vial kits 
containing 35 µg DOTATATE, prepared using four different methods and stored 
for various periods at -20 ˚C 
Kit Storage Period at 
-20 ˚C 
Radiochemical Yield (%) 
Kit A Kit B Kit C Kit D 
1 week (n=3) 82 ± 2 77 ± 2 82 ± 3  - 
4 weeks (n=3) 78 ± 7 75 ± 11 86 ± 1 75 ± 7 
8 weeks (n=3) 79 ± 4 82 ± 4 89 ± 5 77 ± 2 
12 weeks (n=3) 80 ± 6 84 ± 5 84 ± 4 87 ± 1 
*For kit preparation, see 10.3.2 
 
10.4.2.2 Colloid determination of the pre-SEP PAK un-purified [68Ga]DOTATATE, using an iTLC 
method 
The Rf results of Mukherjee et al. (2014c), whose iTLC method was used in this investigation, 
served as a guideline to identify the location of the various radioactive species on the 
developed iTLC chromatogram. The Rf-value of the labelled peptide was given as 0.9 – 1, 
while the Rf of free 68Ga as well as colloidal 68Ga was given as 0 – 0.1. Under those iTLC 
conditions, no detectable quantities of colloids were present in the un-purified 68Ga-labelled 
DOTATATE, as indicated by the iTLC analysis results presented in Table 10.3. Over the 12-
week storage period, radiolabelling efficiency (iTLC) results on pre-purified 68Ga-labelled 
DOTATATE, using the DOTATATE single vial kit types and labelled with SCX-processed 
68Ga, were consistently above 99 %, with the exception of DOTATATE single vial kits D 
which was only slightly less (98.7 %). The average radiolabelling efficiency (iTLC) of 68Ga-
labelled DOTATATE obtained from the DOTATATE single vial kits A at the end of the 12-
week storage period was 99.5 %, for DOTATATE single vial kits B and C was 100 %, and 
was the lowest for DOTATATE single vial kits D, at 98.7 %. 
 
Radiochemical purities of Sep-Pak C18-purified 68Ga-labelled DOTA-peptides were also 
determined by means of HPLC. 
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10.4.2.3 Microbiological evaluation of DOTATATE cold kits 
All the samples were found to be clear and sterile with no aerobic bacterial, anaerobic bacterial 
or fungal growth. The average endotoxin content of the radiolabelled DOTATATE single vial 
Kits C was the lowest at 1.1 IU/ml (0.97 – 1.39 IU/ml), followed by 1.4 IU/ml for Kits B (1.27 
– 1.50 IU/ml), then 1.6 IU/ml for Kits D (1.57 – 1.68 IU/ml) and highest for Kits A at 1.8 
IU/ml (1.70 – 2.0 IU/ml) (see Table 10.3). The European Pharmacopoeia (2013) specification 
for bacterial endotoxin is less than 175 IU/V, where V is the maximum volume to be used for 
the preparation of a single patient dose, if intended for use in the manufacture of parenteral 
preparations without a further procedure for the removal of bacterial endotoxins. The 
maximum volume of the pre-purified solution (Fr2 and kit) is 0.581 ml and the total volume 
of the solution (S2) post-purification is 3.55 ml. 
 
10.4.2.4 pH 
The pH values of the DOTATATE radiolabelling solutions (for Kits A, B, C and D) were all 
consistently 3.0 over the 3-month period. 
 
A summary of the quality control results between DOTATATE single vial kits A, B, C and D 
after a storage period of 12 weeks at -20 °C is given in Table 10.3. 
 
Table 10.3: Radiolabelling and microbiological quality control results, using SCX-processed 
68Ga eluates and single vial kits containing 35 µg DOTATATE, after storage for 
3 months at -20 ˚C  
Quality Control Parameters Kit A Kit B Kit C Kit D 
Radiolabelling Efficiency (%) (HPLC) 98.3 ± 1 98.7 ± 2 99.7 ± 1 99.0 ± 1 
Radiolabelling Efficiency (%) (iTLC) 99.5 ± 1 100 ± 0 100 ± 0 98.7 ± 1  
Radiochemical Yield (%) (Sep-Pak) 80 ± 6 84 ± 5 84 ± 4 87 ± 1 
Activity lost in reaction vial (%) 6 ± 2 3 ± 0.6 3 ± 0.6 5 ± 1.5 
Endotoxin count (of cold kit) (IU/ml) 1.8 ± 0.2 1.4 ± 0.1 1.1 ± 0.2 1.6 ± 0.1 
Sterility (of cold kit) Sterile  Sterile  Sterile  Sterile  
pH 3.0  3.0  3.0  3.0  
*n = 3 
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10.5 Discussion 
Various investigators (Asti et al., 2015; Das et al., 2014; Mukherjee et al, 2014a, 2014c) 
developed DOTA-peptide kits that were formulated for use with 68Ga eluates obtained from 
TiO2- or nanoceria-PAN- based generators. These types of generators are eluted with a low 
concentration of HCl (0.1 M). Das et al. (2014) and Mukherjee et al. (2014b) developed 
DOTA-peptide kits for use with cationic resin-purified 68Ga. These cationic resin purification 
processes involved the use of the acetone/HCl elution method. Kit freeze-drying was 
employed in all of these methods. Das et al. (2014) and Mukherjee et al. (2014b) performed 
further purification of the 68Ga-labelled peptides on a C18 reverse phase Sep-Pak cartridge.  
 
This investigation focused on the formulation and evaluation of DOTATATE kits, which were 
formulated specifically for radiolabelling with SCX resin-purified 68Ga eluates from a SnO2-
based 68Ge/68Ga generator. The formulation was based on work described in Chapter 6, with 
some modifications. The initial investigation was performed with DOTATATE, DOTATOC 
and DOTANOC kits and the radiolabelling and quality results (not shown) were found to be 
similar. Further evaluation in this investigation was performed on the DOTATATE kits only. 
Based on previous other investigations it was decided that 35 µg of DOTATATE was an 
optimal quantity of DOTA-peptide to include in the single vial kit formulations for 
radiolabelling purposes (see Chapters 5 and 9). The pre-determined mass of sodium acetate 
trihydrate buffer (or volume of 2.5 M NaOAc) required for the DOTA-peptide single vial kits 
was based on the quantity of buffer required to adjust the pH of the solution to a pH of 3.0 
suitable for DOTA-peptide labelling (see Chapter 9). The radiolabelling conditions given in 
Section 10.3.4 with regards to the molar concentration of DOTATATE (9.7 µM) concur with 
the optimum conditions established in Chapter 5 (9.2 – 9.4 µM). 
 
The radiolabelling efficiency results obtained by HPLC for all four kit types, was more than 
98 % over the 3-month storage period. The radiochemical yield for the 68Ga-labelled 
DOTATATE with Kit C gave the best results (above 80 %) for the entire 3-month period. 
There was no decline or clear trend in the radiochemical yield for any of the kit types over the 
3-month storage period. Based on the results, the different methods of kit preparation do not 
have a significant influence on the radiolabelling results. This implies that any one of the four 
methods can be used to prepare the kits in a radiopharmacy or clinical environment depending 
on the convenience and available infrastructure. The results in Table 10.2, however, show that 
the labelling yields obtained from Kit C were the most consistent over the entire 12-week 
period. The ultimate use of this kit preparation method might therefore be the most 
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advantageous, also in terms of ease and user-friendliness, as it requires no extra weighing of 
ingredients or drying of the kit. Freeze-drying (method D) is the most commonly used method 
in the literature for peptide kit preparation, but may not be possible in a clinical or 
radiopharmacy set-up that does not possess a freeze-dryer. 
 
The radiolabelling efficiency results obtained from the iTLC method in Table 10.3, which 
was almost all above 99 %, imply the absence of colloids. No 68Ge was found in any of the 
68Ga-labelled DOTATATE preparations due to the SCX-processing (although the results were 
not reported above). These two results suggest that there might be no need for the post-
labelling purification of the 68Ga-labelled peptide when labelling is done under these 
conditions. In a radiopharmacy setup, a simple iTLC analysis may be performed to detect 
colloids or free 68Ga, before the preparation can be diluted for injection. The absence of a need 
for post-labelling purification would have a big advantage in terms of the length of the whole 
procedure and therefore the overall radiochemical yield. 
 
The average endotoxin count for the DOTA-peptide kits was 1.1 – 1.8 IU/ml with the lowest 
count (1.1 IU/ml) for Kit C type and the highest (1.8 IU/ml) for Kit A. Based on the 
microbiological evaluation results, the radiolabelled DOTA-peptide kits were found to be 
sterile, pyrogen-free and microbiologically suitable for clinical intravenous application 
according to the European Pharmacopoeia (2013) specifications. 
 
The pH of the DOTA-peptide kits was consistently 3.0 over the 3-month storage period, which 
falls within the acceptable pH range required for the DOTA-peptide labelling process. The 
results in Table 10.3 show that the activity remaining in the reaction vial after labelling ranged 
from 3 to 6 % for all the kit types. This concurs with the results obtained in Chapter 9, in 
which 5 to 7 % was lost, using the same quantity of buffer salt (and therefore the same pH) as 
in this study. The results in Chapter 5 show activity losses in vials of 16 ± 4 % (for 35 µg 
DOTATATE radiolabelling), while those in Chapter 6 show losses of 9 % (for kits containing 
35 µg DOTATATE after 1- to 4-month storage period). The higher activity losses in the latter 
two studies may be due to the pH of the radiolabelling process having been too high (3.5 – 
4.0) in those studies. The observation made in Chapter 6 that the lower activity lost during kit 
labelling may be due to slightly higher stability of the DOTA-peptide in the kit formulation 
might also be applicable here. This means that a combination of a lower pH and using kit- 
instead of non-kit-labelling may have an enhanced effect on the inhibition of activity losses, 
and therefore result in higher radiochemical yields. 
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The use of these kits reduces the labelling process time that is an advantage because due to 
the short half-life of 68Ga, longer processing times result in losses of activity for patient use. 
Based on the results in Table 10.3, the stability of the single vial DOTATATE kits, allows for 
the preparation and storage of these user-friendly kits for a period of at least up to 3 months. 
Additional investigation of the DOTA-peptide kits over longer storage periods may even 
extend this period further. The results in Chapter 6, Table 6.2, which show that the kit 
performance after a period of one year was still acceptable, suggest that the kits prepared in 
this investigation might exhibit a similar stability. 
 
This study is a first, according to the best of the investigator’s knowledge, which presents the 
use of 68Ga eluates from a SnO2 generator, purified with the acidified NaCl/SCX cationic resin 
technology, in DOTA-peptide kit labelling.  
 
10.6 Conclusion 
The objective of formulating user-friendly stable single vial kits of DOTATATE specifically 
for SCX-processed 68Ga eluates has been achieved. The single vial kits containing 
DOTATATE and sodium acetate buffer, may be prepared in 4 slightly different (fairly robust) 
ways. The kit manufacturing procedures described in this study are relatively simple and one 
of the procedures does not require a lyophilisation or vacuum-drying step. The kits can be 
radiolabelled with 68Ga reliably and consistently in a clinical environment. Results showed 
that post-labelling purification might not be required, as no significant quantities of free or 
colloidal 68Ga were detected in the labelling experiments. The preceding SCX purification 
step had also ensured the removal of all traces of 68Ge breakthrough. The results of this kit 
labelling procedure therefore suggest that a post-labelling Sep-Pak C18 purification should be 
optional, pending validation of a reliable quality control procedure.  
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Chapter 11: Summary of findings and final conclusion 
11.1 Summary of findings 
The most significant findings relating to the SnO2-based 68Ge/68Ga generator in this study are 
listed below:  
An increase in the HCl concentration of the eluent resulted in increasing generator elution 
yields but also higher 68Ge breakthrough, especially with HCl concentrations in excess of 0.6 
M. The latter finding is in contrast with those of a few other investigators. Zn is the only metal 
tested for that shows a consistent increase with increasing HCl concentrations. This could 
affect labelling if eluents contain very high concentrations of HCl and eluates are not pre-
purified, even taking into account that Zn2+ has a lower effect on labelling than metals such 
as Fe3+ and Cu2+. The increased 68Ge breakthrough, resulting from the use of eluents 
containing high concentrations of HCl, could be problematic with regards to radiation safety 
and radioactive waste control. Even if 68Ge can be efficiently excluded from 
radiopharmaceutical products by means of pre-labelling purification of eluates and/or post-
labelling purification of labelled products, the proper disposal of 68Ge-containing waste should 
still be reckoned with. In order to compromise optimal elution yield with minimal 68Ge 
breakthrough, based on the results of this study, 0.6 M HCl should therefore be the eluent of 
choice for a SnO2-based generator. 
 
For all three DOTA-peptides, a molar concentration of 9.2 – 9.4 µM (35 µg in 2.61 ml) was 
found to be the optimum to ensure radiolabelling efficiencies consistently greater than 95 % 
and average radiochemical yields above 70 %. Extended heating periods and the use of various 
heating modes offer no advantage in terms of obtaining higher radiochemical yields. Results 
also suggest that radiochemical yields close to 70 % can be still achieved if generators are left 
non-eluted for up to 7 days. Even after 21 days of non-elution of the 68Ge/68Ga generator, 
average radiolabelling efficiencies were above 90 % and average radiochemical yields in 
excess of 60 %. The purification of 68Ga-DOTANOC on C18 Sep-Pak cartridges requires only 
a slight adjustment on the ethanol content of the eluent.  
 
After fractional elution, the use of DOTA-peptide single vial kits offers a significant 
advantage in terms of convenience, stability and user-friendliness of the radiolabelling 
procedure. The kit manufacturing procedure described in this study is relatively simple and 
does not require a lyophilisation step. An added advantage is the reduced activity lost during 
C18 purification of the [68Ga]-DOTA-peptide, resulting in slightly higher radiochemical 
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yields. The use of the labelling kit formulations (using the fractionated elution method) 
appears to be highly feasible and the quality of the DOTA-peptide kits was found to be 
superior over DOTA-peptide stock solutions, as reflected by the radiochemical yield results 
obtained after an extended kit storage period. 
 
A cationic resin-based eluate purification method based on that developed by Mueller et al. 
(2012) for eluates from a TiO2 generator, was successfully adapted for the SnO2-based 
generator, which is eluted with higher concentrations of HCl, by diluting the eluate. The 68Ga 
was efficiently adsorbed on a Bond Elut SCX (100 mg) cartridge and then desorbed by 
acidified solutions of NaCl. It offers the advantage over the acetone-based cationic processes 
of avoiding the organic solvent during the labelling process.  
 
This investigation showed that, of the initial quantities (10, 20 and 250 µg) of introduced Fe, 
Zn, Cu and Ga in the 68Ga eluate, only about 2 % of these total metals remained in the purified 
68Ga fraction after passing the “spiked” eluate through a Bond Elut SCX (100 mg) cartridge. 
It is highly unlikely that 68Ga eluates would contain as much as 250 µg of any metal if 
sufficient care is taken to avoid the introduction of metals during the labelling process (e.g. 
avoiding the use of metal needles and using only analytical grade chemicals). The levels of 
metals, particularly the most influential Fe, Zn and Cu, were sufficiently low when the 68Ga 
eluates were contaminated with less than 20 µg of each metal. The metal/ligand ratio for all 
the metals was less than 1:1, a condition that would result excellent labelling of DOTA-
peptides. 
 
The successful development of a labelling method using pre-concentrated 68Ga eluates from a 
Bond Elut SCX (100 mg) cation exchange resin was achieved. The method produced a high 
radiolabelling efficiency yield of around 99 % and high radiochemical yield of almost 85 %. 
The labelling results for DOTA-peptide labelling at a pH of 3 were found to be superior to 
those at a higher pH (3.5 – 4.0). It should be possible to adapt this method to an automated 
synthesis module and the procedure makes 68Ga-labelled products accessible with the 
advantage (over the acetone-based methods) of reducing the preparation time due to not 
having to remove organic solvents in the process, and avoid testing for acetone in the final 
product, which reduces the costs in the radiopharmacy or clinical setup. 
 
The objective of formulating user-friendly stable single vial kits of DOTATATE specifically 
for SCX-processed 68Ga eluates has been achieved. The single vial kits containing 
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DOTATATE and sodium acetate buffer, may be prepared in 4 slightly different (fairly robust) 
ways. The kit manufacturing procedures described in this study are relatively simple and one 
of the procedures does not require a lyophilisation or vacuum-drying step. The kits can be 
radiolabelled with 68Ga reliably and consistently in a clinical environment. Results showed 
that post-labelling purification might not be required, as no significant quantities of free or 
colloidal 68Ga were detected in the labelling experiments. The preceding SCX purification 
step had also ensured the removal of all traces of 68Ge breakthrough. The results of this kit 
labelling procedure therefore suggest that a post-labelling Sep-Pak C18 purification should be 
optional, pending validation of a reliable quality control procedure.  
 
A few limitations of this study were however identified and are listed below. 
 
11.2 Limitations of study 
• All experiments (elution, labelling and quality control) were performed manually and the 
number of experiments was limited, based on radiation exposure to the investigator.  
• The study was performed on radiolabelling of three DOTA-peptides (DOTATATE, 
DOTATOC and DOTANOC) and further investigation with chelators such as 1,4,7-
triacyclononane-N,N',N"-triacetic acid (NOTA) and other peptides such as Prostate-
Specific Membrane Antigen (PSMA) would provide additional value. 
• Pre-clinical and clinical work was not included in this study. 
• Possible chemical impurities could not be identified with the HPLC equipment used. 
 
Based on the findings, recommendations for users of this SnO2-based generator were 
identified and listed below. 
 
11.3 Recommendations 
• Based on the elution yield and 68Ge breakthrough, the SnO2-based generator must be 
eluted with 0.6 M HCl. 
• The use of single vial DOTA-peptide kits compared to DOTA-peptide stock solutions in 
radiolabelling is encouraged because of the reduction in processing time and improved 
radiolabelling results. 
• Users of this generator should be aware of the 68Ge breakthrough and accommodate for 
this in their waste disposal systems. 
Stellenbosch University  https://scholar.sun.ac.za
 
 
105 
• The generator should preferably be eluted daily (to reduce 68Ge and zinc contaminants in 
the eluate) and just prior to the radiolabelling process. 
• Metal contamination (e.g. through the use of needles and poor quality chemicals) should 
be avoided as far as possible during the elution and labelling process. 
• Alternative cationic resins should be further investigated by optimizing resin column sizes 
as well as 68Ga loading and desorbing solutions from the resin. 
• The cationic concentration/purification method is preferred over the fractionation method 
due to the reduced 68Ga eluate volume and no further need for Sep-Pak C18 post-
purification. 
• The optimized labelling procedures and single vial kits should be developed for the use in 
an automated system. 
• Kits for clinical application should be prepared under full cGMP conditions. 
• The pH of the 68Ga-labelled kits is below the European Phamacopoeia pH specification of 
4.0 – 8.0 and further stability and compatibility studies are required for addition of an 
appropriate buffer to adjust the pH prior to patient administration. 
• These kits were specifically developed for the the SnO2-based 68Ge/68Ga generator and 
compatibility of using these kits with other 68Ge/68Ga generators should be explored. 
 
11.4 Final conclusion 
This work provides further insights into the application of the SnO2-based 68Ge/68Ga generator 
as the source of the PET radionuclide 68Ga, as well as the radiolabelling of somatostatin 
DOTA-peptide derivatives with 68Ga eluted from this generator, using differently processed 
68Ga eluates. Investigation into the elution characteristics of the generator with various HCl 
concentrations indicated that elution with HCl concentrations in excess of 0.6 M is not 
recommended. This recommendation is based on the findings that the level of 68Ge 
breakthrough increased significantly at concentrations of 0.8 M HCl and higher. The benefit 
of higher elution yields obtained at these high HCl concentrations is outweighed by the 
drawback of generating increasing levels of radionuclidic waste in the form of 68Ge. The 
results of labelling studies using differently processed 68Ga eluates should provide a guideline 
for researchers at various institutions who are engaged in the manual radiolabelling of DOTA-
peptides and who are using this generator to decide which eluate processing method would be 
the method of their choice in their own unique clinical environment. Based on the results of 
this study, the cationic resin purification of 68Ga eluates prior to labelling should, however, be 
encouraged. It has three major advantages, namely the complete removal of 68Ge 
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contaminants, the efficient removal of unwanted metals that could interfere with labelling as 
well as the reduction of eluate volumes. The use of single vial DOTA-peptide kit labelling 
over DOTA-peptide stock solutions is advantageous largely based on the stability, user-
friendliness and reduced process time which results in increased available 68Ga activity (due 
to a shorter period allowed for decay). No Sep-Pak C18 processing is required post SCX cation 
processing provided there is no free 68Ga and/or colloids. Users should confirm this through 
validation studies in their own settings. 
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Annex 1 
Examples of chromatograms 
 
 
Chromatogram 1: HPLC chromatogram of 68Ga-DOTANOC before Sep Pak purification 
 
 
 
Chromatogram 2: HPLC chromatogram of 68Ga-DOTATOC before Sep Pak purification 
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Chromatogram 3: HPLC chromatogram of 68Ga-DOTATATE before Sep Pak purification 
 
 
 
 
Chromatogram 4: iTLC chromatogram of 68Ga-DOTATATE before Sep Pak purification 
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Annex 2 
Publications and presentations arising from the work presented in this Dissertation 
Published papers 
• Prince, D., Rossouw, D., Davids, C., Rubow, S., 2017. Development and evaluation of 
user-friendly single vial DOTA-peptide kit formulations, specifically designed for 
radiolabelling with 68Ga from a tin dioxide 68Ge/68Ga generator. Mol Imaging Biol. 19, 
817-824 
 
List of planned publications 
At least two further publications have been identified from this study: 
• Optimization of a labelling and kit preparation method for 68Ga-labelled DOTATATE, 
using cation exchange resin purified 68Ga eluates obtained from a tin dioxide 68Ge/68Ga 
generator  
• An adapted cationic resin pre-treatment method for the concentration and purification of 
68Ga eluates from a tin dioxide 68Ge/68Ga generator  
 
 
Presentations 
The following poster presentation was made at the South African Society of Nuclear Medicine 
(SASNM) 17th Biennial Congress, September 2016: 
Influence of non-elution of the 68Ge/68Ga generator on the characteristics and radiolabelling quality 
of 68Ga eluates 
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